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General Abstract 
Background and Aims  
Exercise-associated gastrointestinal (GI) symptoms are widespread and estimated to occur in 
30-50% of endurance athletes. GI symptoms are multi-factorial but primarily caused by
physiological, mechanical and/or nutritional triggers. Symptoms generally occur during 
exercise or within the few hours following exercise.  Gluten is touted by many to be detrimental 
to GI health in athletes particularly with a compromised gut barrier caused by reduced 
splanchnic blood flow, which most commonly occurs during higher exercise intensities.  It is 
suggested that exercise-induced injury to the gut barrier could in turn increase susceptibility to 
dietary triggers, such as gluten. Gluten is further perceived to elicit undesirable pro-
inflammatory responses in healthy athletes, partially through compromised gut epithelial 
barrier function, allowing the passage of gluten peptides or the interaction of these peptides 
with tight junction proteins.  However, these theories alongside the overall idea that a gluten-
free diet (GFD) provides an ergogenic benefit have yet to be substantiated.  
Athletes persistently explore dietary strategies perceived to offer ergogenic benefits or 
beneficial impacts on parameters influencing performance, such as reducing GI symptoms. 
There has been an explosion in the prevalence and use of gluten-free products in recent years, 
which is exacerbated by unsubstantiated commercial health and sport performance claims.  
This has led to numerous athletes touting a gluten-free lifestyle as the secret to their success. It 
is well known that a GFD is necessary for the treatment of clinical conditions such as coeliac 
disease or noncoeliac gluten (wheat) sensitivity (NCGS). However, anecdotal reports suggest 
that many athletes believe a GFD directly improves exercise performance and parameters 
influencing performance, particularly GI symptoms as well as inflammation and immune 
ii 
health. 
Dietary changes may occur alongside the avoidance of gluten-containing foods that could 
influence health parameters or GI symptoms. A predominant dietary change that occurs 
subsequent to eating a GFD also includes a reduction in the intake of short-chain carbohydrates, 
otherwise known as fermentable, oligo-, di-, monosaccharides and polyols (FODMAPs). 
Significant FODMAP reduction may actually modulate GI symptoms, and not necessarily the 
gluten itself.  Given the absence of peer-reviewed data on the effects of either gluten or 
FODMAPs on athlete performance, the studies that comprise this thesis were first aimed to 
understand and quantify the prevalence of GFD adherence, and relatedly, high FODMAP food 
avoidance among noncoeliac athletes (NCA). A second step was to undertake intervention 
studies to investigate the efficacy of these diets on GI symptoms, performance and related 
parameters in an athletic population. 
Methods and Results 
An electronic-based questionnaire (n=910) was distributed internationally to athletes to 
determine athlete-specific GFD and high FODMAP avoidance food behaviours and beliefs. 
Specifically, this questionnaire was designed to evaluate GFD practises, demographics, 
experiences, and sources of dietary recommendation and information. Our initial findings 
established that 41% of NCAs followed a GFD at least 50% of the time. Negative GI symptoms 
(e.g. diarrhoea, bloating) were the most highly reported indicators believed to be triggered by 
gluten with 84% of respondents indicating symptom improvement with gluten-removal. 
Athletes adhering to a GFD also perceived a GFD to improve body composition for sport 
(74.4%), reduce inflammation (73.3%), decrease GI distress (61.1%), and improve exercise 
performance (56.3%). Self-diagnosed gluten-related conditions were the primary reason for 
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adopting a GFD with non-medical dietary prescription and advice from coaches/other athletes 
reported as the most common source of GFD information.  
 
Given the high uptake of a GFD in athletes and the belief that a GFD improved exercise 
performance, GI health and wellbeing, the next study within this thesis aimed to investigate 
the effects of a GFD on performance in endurance-based NCA. Thirteen competitive NCA 
(endurance cyclists) were allocated to a 7-day gluten-containing diet (GCD) or GFD (16 g 
gluten.day-1) using a controlled, double-blind, crossover intervention design. During each diet, 
cyclists completed GI questionnaires (daily and during exercise), the Daily Analysis of Life 
Demand for Athletes (DALDA) and an exercise test on day seven of each dietary period. Blood 
samples were taken pre-exercise, after a 45-minute steady state exercise bout at 70% Wmax and 
following a 15-minute time trial (TT) to measure acute intestinal injury and inflammatory 
markers. Exercise and dietary intake was tightly controlled and replicated during each dietary 
period. A GFD had no beneficial or negative effect on 15-minute cycling TT performance 
(GCD 245±53 and GFD 245±55 kJ). GI symptoms, DALDA evaluation and biomarkers of 
acute epithelial injury and systemic inflammation were also similar in the GCD and GFD 
periods.  
The GFD intervention did not show a GFD to be ergogenic; however, when a GFD is adopted, 
FODMAPs may be reduced. The low rates of GI symptoms reported in our initial study may 
have been confounded by a reduction in fructans on both trials, which are part of the FODMAPs 
family. Initial findings led to subsequent studies investigating FODMAP avoidance or 
reduction in NCA. First, athletes’ dietary behaviours regarding FODMAPs were established 
via FODMAP-specific questions in the preliminary questionnaire-based study. Offending 
foods that happened to be part of the FODMAP family were quantified as a popular strategy 
employed by 51% of NCA to reduce GI symptoms with 83% of this group reporting symptom 
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improvement.  To examine the effects of short-chain carbohydrate restriction on GI symptoms, 
a short-term low FODMAP dietary intervention was conducted utilizing a case-study 
methodology in a multisport athlete with persistent exercise-associated GI distress. A 6-day 
low FODMAP compared to a habitual high FODMAP diet was implemented and the athlete 
was evaluated for GI symptoms and DALDA scores indicating ‘worse than normal.’ On each 
day of the intervention a measurable reduction, from symptom severity scores of 0-9 to 0, in 
exercise and daily GI symptoms was observed. DALDA scores remained stable across the 
habitual and intervention periods. The GI symptom improvement in this athlete suggested the 
necessity for a larger crossover intervention to further explore the use of a FODMAP restricted 
diet as a tool to reduce GI distress in healthy symptomatic endurance athletes.  
To further explore the potential of a low FODMAPs intervention to reduce GI symptoms, a 
larger preliminary trial was conducted. GI symptoms and perceptual wellbeing were assessed 
during a high FODMAP vs. low FODMAP diet in runners (n=11) with persistent exercise-
associated GI symptoms, but no diagnosed functional gastrointestinal disorder or food 
intolerance. Runners were randomized to low (<9 g FODMAP.day-1) and high FODMAP (>20 
g FODMAP.day-1) dietary periods of 6-days each with prescribed strenuous running sessions 
completed on day-4 and day-5 and a single day washout before crossing over to the other diet. 
Exercise and diet were replicated with study meals and snacks provided alongside suitable low 
or high FODMAP food choices. During each dietary trial runners recorded dietary intake and 
exercise and completed electronic GI symptom and DALDA questionnaires. Large variability 
in GI symptoms was apparent with no statistical difference in exercise GI symptom frequency 
or severity and DALDA score. While exercise GI symptoms were not different, daily GI 
symptoms were lower each day of the low FODMAP dietary period.  Short-term FODMAP 
reduction may be a novel tool in improve daily GI symptoms in healthy runners with exercise-
associated GI distress. Future work in this area should incorporate exercise protocols with 
  v 
higher intensity and longer duration to better assess the impact of this diet on GI symptoms 
occurring during exercise.  
Conclusions  
This progressive work has quantified widespread adherence to a GFD amongst NCA. 
Although, many NCA adhere to a GFD due to beliefs underpinned by unsubstantiated health, 
GI and performance benefits, a short-term GFD was not found to have a beneficial (or negative) 
effect on performance, GI health, systemic inflammation or overall wellbeing. FODMAP 
intake may be consequently reduced with a GFD and is proposed to modulate GI symptoms, 
rather than gluten itself. Relatedly, elimination of high FODMAP foods were found to be a 
common dietary strategy employed by athletes aimed at attenuating GI symptoms with high 
rates of self-reported success. Results from our successive intervention studies showed 
improvement in GI symptoms with elimination of high FODMAP foods. Based on these 
findings, FODMAP manipulation, rather than gluten-elimination, may be a more successful 
and novel intervention to consider for the sport nutrition practitioner’s toolbox for management 
of GI distress in athletes. A practitioner supported systematic and individualized approach will 
be essential for the potentially successful implementation of these dietary approaches.   
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Chapter 1: Thesis Introduction and Overview  
Optimal athletic performance relies on the multifaceted interplay of numerous components 
including physical training, physiological adaptations, psychological wellbeing and the 
nutrition strategies to support all of these elements. In athletes, particularly endurance-based, 
gastrointestinal (GI) distress is a common occurrence (128). Exercise-associated GI symptoms 
occurring during exercise, and up to several hours afterwards, have the potential to derail 
training capacity, impair optimal athletic performance as well as subsequent nutritional 
recovery and performance (37). Dietary modulation and training the gut to tolerate fuels are 
foremost strategies implemented by athletes with the aim to reduce GI distress (32, 35, 79).  
Athletes commonly avoid certain foods or follow dietary regimes with the aim to improve 
performance and reduce GI symptoms (35, 37). Gluten-free diets (GFD) and elimination of 
high fermentable oligo-, di-, monosaccharides and polyols (FODMAP) foods have become 
popular strategies to reduce GI distress (19), however no evidence exists supporting the 
beneficial outcomes of these dietary practices. GFD are further touted by many to reduce 
inflammation, improve psychological wellbeing and provide an ergogenic edge (50), again 
with a lack of scientific evidence in noncoeliac athletes (NCA). Triggers of GI distress involve 
many factors; however, it is possible that the unique stress placed on the gut from intensive 
exercise may increase susceptibility to dietary triggers and consequential GI symptoms. 
Evolving research continues to investigate and integrate novel nutritional approaches to reduce 
GI distress and thus benefit athletic performance. This thesis follows the following concepts: 
First exploration and quantification of GFD and high FODMAP food elimination behaviours 
in NCA. Secondly, human based studies will be the foundation for investigations of the effects 
of GFDs and FODMAP restriction, primarily on GI symptoms, but also exercise performance 
CHAPTER 1 
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and related parameters, in NCA. Lastly, the seminal findings from the work within the thesis 
will be tied together with contemporary literature to summarize the current state of knowledge 
of GFD and FODMAP modification in NCA.   
1.1 Background 
1.1.1 GI distress in athletes  
GI symptoms are reported to occur in 30-50% of endurance athletes and if severe enough, 
impair training capacity, performance and/or recovery (39, 159). Frequently experienced 
symptoms include upper and lower GI symptoms, such as: reflux, vomiting, bloating, loose 
stool, diarrhoea and abdominal cramping (39, 131). Aetiology of GI symptoms is multifactorial 
involving physiological, mechanical and nutritional elements as well as a likely genetic 
predisposition (35, 39). During exercise, particularly throughout strenuous bouts, blood flow 
is shunted to working muscles and blood flow to the gut may be reduced by up to 80% (159). 
As a result, GI ischemia compromises epithelial barrier function and is recognized as the 
primary pathophysiology mechanism accountable for the changes in GI permeability and 
potentiating GI symptoms (167). High-impact mechanics, such as those related to running, can 
furthermore injure the epithelium alongside postural factors eliciting upper and lower GI 
symptoms (37, 172). Nutrition intake, the primary focus of this thesis, is also a confounding 
factor with a significant effect on GI wellbeing (36, 37).  
1.1.2 Current nutrition strategies employed to reduce GI symptoms in athletes   
Nutritional strategies are often employed as a first-line approach to reduce GI symptoms (117). 
General strategies include reduced fibre or low residue diets, increasing carbohydrate and fluid 
tolerance as well as decreasing fat and protein intakes (37). More recently, going gluten-free 
has seen a global upsurge and a GFD has become an extremely popular dietary strategy touted 
to improve GI health in athletes. A strict GFD eliminates all forms of gluten; a storage protein 
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composite (3) found in wheat (gliadin), rye (secalin) and barley (horedin) are the primary 
peptides associated with immunologic reactions in CD. It is also present in other food products 
through the addition of grain-based foodstuffs or via cross-contamination (86). Avoidance of 
gluten is essential for individuals with clinical conditions requiring a GFD and symptoms are 
generally improved with this diet (142). In NCA gluten avoidance is believed to improve 
psychological wellbeing, reduce inflammation, improve body composition for sport and 
provide an ergogenic performance edge. Healthy athletes or NCA, without a clinical necessity 
for gluten-avoidance, are a predominant cohort adopting a gluten-free lifestyle based on 
anecdotal beliefs and perceptions around unsubstantiated health and performance benefits (50, 
137).  
1.1.3 From Gluten to FODMAPs  
Adherence to a GFD has become exceedingly prevalent amongst athletes with the aim to reduce 
inflammation, overall wellbeing and improve GI health (19). Eating a GFD not only eliminates 
gluten-containing foods but also subsequently decreases consumption of FODMAPs (52, 118). 
FODMAPs are a family of short-chain carbohydrates that are incompletely absorbed in the GI 
tract and are rapidly fermented by gut bacteria causing adverse GI symptoms in sensitive 
individuals, mainly with clinical conditions such as irritable bowel syndrome (IBS) (54). 
Fructans, in particular, are concentrated in wheat-based foods and are made of fructose 
molecule chains which are poorly absorbed because the small intestine lacks hydrolases to 
break their fructose-fructose bond (14, 146). Researchers suggest that FODMAP reduction 
consequent to elimination of gluten-containing foods may actually be the reason for improved 
GI symptoms (52, 118). In athletes reporting symptom improvement with the change to a GFD, 
it may actuallybe the associated general reduction in FODMAP intake tempering GI symptoms. 
In addition, many athletes, who may or may not eliminate gluten are avoiding foods high in 
FODMAPs such as lactose or legumes, to reduce GI symptoms (41).   
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1.1.4. FODMAP reduction as a strategy to reduce exercise-associated GI distress   
A low FODMAP diet, which reduces short chain carbohydrate intake, has been implemented 
with notable success for the treatment of IBS (34, 54, 148). There are several unidentified 
mechanistic elements potentiating GI symptoms and sensitivity to FODMAPs. However, the 
symptomology displayed in exercise-associated GI symptoms and IBS is analogous (39, 63). 
A low FODMAP diet may be appropriate beyond treatment for IBS symptoms and could be a 
novel tool to reduce GI distress in an athletic context. Ingestion of carbohydrates, particularly 
solutions with a high osmolality, have been linked to the development of GI symptoms during 
exercise (131, 136, 159). Short chain carbohydrates’ osmotic actions and the presence of pre-
existing high dietary FODMAP concentrations in the GI tract may further increase luminal 
fluid volume, distention and related symptoms experienced by some athletes. Lower in the GI 
tract fermentation of FODMAPs potentially amplify flatulence, bloating, abdominal pain and 
diarrhoea, predominantly associated with mechanical jostling and ischemia (55, 148). 
Although, healthy non-athletic populations have not been shown to benefit from FODMAP 
restriction, the repeated stress placed on the endurance athlete’s gut could increase 
susceptibility to dietary triggers. Unique training regimes undertaken by endurance athletes’ 
typically include 25 to 30 hours per week of training and even up to 30 to 35 hours per week 
of competition in events such as the Tour de France (2, 141). This intensive exercise is coupled 
with ingestion 250 to 300 kcals of energy per hour, primarily consisting of carbohydrate (144) 
can place extreme stress on the GI system. Intensive exercise stress combined with 
concentrated carbohydrate intake creates the perfect storm for GI issues in endurance athletes. 
1.2.5. Clinical conditions requiring a gluten-free diet  
In clinical conditions, such as coeliac disease (CD), wheat allergy and noncoeliac gluten/wheat 
sensitivity (NCGS) gluten avoidance is necessary to prevent adverse health consequences 
resulting from the ingestion of gluten peptides. At present, the gold standard protocol for NCGS 
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diagnosis is the resolution of symptoms upon gluten exclusion and manifestation of symptoms 
with systematic food reintroduction protocols (27, 30).  Using a gluten-challenge to establish 
NCGS is cumbersome with confounding elements, such as, belief effects and additional 
subsequent dietary changes that could actually be the modulator of symptom changes. The lack 
of diagnostic criteria for NCGS has left many athletes self-diagnosing gluten-related conditions 
based on symptoms or even no symptoms at all. Recently researchers have identified objective 
biomarkers of systemic immune activation (Immunglobulin (Ig) G, IgA and IgM antibodies, 
serum lipopolysaccharide binding protein, CD12) in conjunction with compromised intestinal 
epithelium (fatty acid binding protein) in patients eating a gluten-containing diet and meeting 
the criteria for NCGS (164). Continued investigation in this area promises to solidify diagnostic 
criteria in clinical situations. However, in a healthy athletic population it is important to 
consider if repeated epithelial injury caused by the physiological stress of intensive training 
(167) potentially increases susceptibility to dietary triggers, such as FODMAPs as compared 
to non-athletic populations.  
1.1.6. Intestinal Permeability and Inflammation  
Beyond perceived performance benefits, enhancing gut health and immune system regulation 
are fundamental reasons why athletes may avoid certain foods or adopt dietary practises. As 
the largest immune organ in the body the intestinal barrier is of unique importance to athletes, 
as strenuous training is recognised to compromise this barrier and optimal immune function 
(77). Increases in intestinal permeability through rearrangement of tight junction proteins result 
in intestinal barrier damage and alterations in the movement of endotoxins across the lumen of 
the GI tract into circulation  (177). The immune system recognizes endotoxins, which are 
components of gram negative bacteria, initiating inflammatory cascades (56). Certain 
inflammatory processes are considered a necessary component of training adaptation. 
Disproportionate pro-inflammatory cytokine responses have however been associated with 
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lower GI symptoms (77). Excessive exercise-associated epithelial barrier injury and resulting 
inflammatory response could theoretically be amplified by gluten and FODMAPs (35, 37, 
167),  resulting in exacerbated adverse intra- and extra-intestinal symptoms.  
1.1.7. Belief Effect Associated with Dietary Interventions  
Extending across clinical and sport continuums the belief in the positive effects of an 
intervention has been evidenced to improve various outcomes, such as perceived GI symptoms 
and performance (11, 66, 82). In IBS patients, self-reported improvements in GI symptoms 
resulted even when an openly labelled placebo pill was administered (82). Sport scientists have 
also established the performance-enhancing effects of belief in a novel intervention and 
estimated that performance may be relatedly improved by 1-3%, regardless of the establish 
efficacy (10, 66). Dietary placebos have not been well tested in athletes, however it is 
reasonable to propose that the novelty of a GFD or special manipulation of high FODMAP 
foods may result in a positive (placebo) effect on performance, experienced both objectively 
and/or subjectively (e.g. reduced pain, exertion or GI symptoms) (10, 66) in the field. Placebo 
effects are used strategically in sport, however, the complications potentially accompanying 
unnecessary dietary restriction could be unfavourable to health and performance due to issues 
of dietary inadequacy and other complications (e.g. orthorexic behaviours). Overall, anecdotal 
experiences reporting the benefits of a GFD for athletes may be consequential of the belief 
effect and this should be considered when assessing the outcomes of any dietary intervention.  
1.1.8. Conclusion 
An increasing number of athletes believe avoidance of gluten and food high in FODMAPs are 
fundamental for optimal GI wellbeing, health and athletic performance (41). Achievement of 
desired body composition and enhancement of athletic performance are also strong rationales 
for food avoidance amongst athletes, regardless of the lack of established efficacy of these 
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practises (19). To date, there is scarce evidence supporting the beneficial effects of a GFD or 
FODMAP avoidance for healthy athletes. It is easy to dismiss these trends as a ‘bandwagon’ 
effect and to justify the reported beneficial outcomes as a result of belief effect or due to other 
subsequent dietary changes. However, it is plausible that the unique stress placed on an 
athlete’s GI system increases susceptibility to gluten and/or FODMAPs, particularly in 
endurance athletes. Gluten-free and low FODMAP diets have been successfully implemented 
in the treatment of clinical GI conditions (4, 152). Commonalities between the physiological 
mechanisms and symptomology in clinical and exercise associated GI distress support the 
investigation of these dietary modifications for the management of exercise-associated GI 
symptoms (39, 53). The primary purpose of this thesis is to investigate if a GFD or low 
FODMAP diet influences GI wellbeing or parameters influencing performance in healthy 
endurance athletes, as is widely perceived.  
1.2. Significance of the research  
GI distress in, primarily, endurance athletes is abundant (30-50%) and can subsequently impair 
performance. Despite increasing numbers of athletes adopting a GFD or eliminating high 
FODMAP foods, there is a lack of evidence-based research supporting the efficacy of these 
strategies. Unnecessary food restriction may compromise optimal fuelling, nutritional status, 
beneficial gut bacterial populations and generate psychological strain and early stages of 
orthorexia nervosa. Examination of the effects of GFDs and/or FODMAP restriction to 
attenuate GI symptoms and related parameters is of significance primarily to determine the 
efficiency of these diets in NCA. Secondly, evidence-based research is necessary to provide 
practitioners and athletes trustworthy information to guide decisions surrounding the 
appropriateness of these dietary regimes. Findings from this research may begin to reconcile 
beliefs in the beneficial effects of a GFD or FODMAP reduction and offer novel dietary 
strategies to reduce GI distress and improve performance in athletes.    
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1.3 Research Aims  
The aims of the research presented in this thesis were to investigate:  
1. Various beliefs and reasons supporting the popularity and rapid uptake of GFDs as well 
as high FODMAP food avoidance amongst NCA via questionnaire based approaches.  
2. Quantify GFD adherence rates of GFD and high FODMAP food elimination in NC.  
3. Efficacy of GFD on performance, GI health, systemic inflammation and perceptual 
wellbeing via a randomized, placebo-controlled, crossover blinded intervention study.   
4. Efficacy of FODMAP reduction as a strategy to reduce GI symptoms in clinically 
healthy athletes with exercise-associated GI distress in an initial case study intervention 
followed by a randomized, placebo-controlled, crossover, blinded trial.  
 
1.4 Thesis organization 
This doctoral thesis contains a series of four studies which are aimed at quantifying, 
understanding and determining the effects of GFDs and high FODMAP foods primarily on GI 
symptoms, as well as inflammation and perceptual wellbeing, as potential parameters 
influencing performance, in NCA. 
Chapter 1: Contains a general introduction of the themes comprising the thesis and expresses 
the rationale, aims, study designs, and general layout of the thesis.  
Chapter 2:   The first study utilized an online questionnaire, which was developed to assess 
the current state of beliefs and GFD adherence rates of NCAs for subsequent human-based 
dietary intervention studies (research aim 1). Internationally distributed, this questionnaire 
collected data pertaining to demographics, dietary practises, prevalence rates, beliefs, 
experiences, GI-related descriptions and sources of information pertaining to GFDs and high 
FODMAP foods amongst NCA.  
An edited version of this manuscript was published as:  
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Lis D, Stellingwerff T, Shing CM, Ahuja K DK, Fell W J. Exploring the popularity, 
experiences, and beliefs surrounding gluten-free diets in noncoeliac athletes. Int J Sport 
Nutr Exerc Metab 2015; 25:37-45.  
Chapter 3:  The second study and publication followed up on the findings of study one. This 
double-blind, placebo controlled, crossover dietary intervention assessed the effects of a GFD 
on athletic performance by investigating several key parameters influencing performance in 
NCA: GI symptoms, epithelial injury, perceptual wellbeing, systemic inflammation and, the 
primary outcome, exercise performance (research aim 3).  
Lis D, Stellingwerff T, Kitic CM, Ahuja KD, Fell J. No effects of a short-term gluten-
free diet on performance in noncoeliac athletes. Med Sci Sports Exerc. 2015; 
47(12):2563-70. 
Chapter 4: Presents a summary of additional findings from study one (questionnaire-based 
study) pertaining to elimination behaviours of high FODMAP foods with the aim to reduce GI 
symptoms in athletes (research aim 1, 2). This is the third publication arising from this thesis. 
Lis D, Ahuja KD, Stellingwerff T, Kitic CM, Fell J. Food avoidance in athletes: 
FODMAP foods on the list. Appl Physiol Nutr Metab. 2016;41(9):1002-4. 
Chapter 5:  To lay the foundation work for investigations of low FODMAP diets in 
symptomatic athletes this chapter is an innovative case study intervention conducted with a 
multisport athlete presenting with no functional gastrointestinal disorders but persistent 
exercise-associated GI distress (research aim 4). This case study compared a low FODMAP 
nutrition intervention to a habitually high FODMAP diet to assess the efficiency of short-term 
FODMAP reduction on GI distress during exercise and outside of exercise. The methodology 
examined through the case study was applied to study four (Chapter 6).  
Lis D, Ahuja KD, Stellingwerff T, Kitic CM, Fell J. Case Study: Utilizing a low 
FODMAP diet to combat exercise-induced gastrointestinal symptoms. Int J Sport Nutr 
Exerc Metab. 2016. 26(5): 481-7. 
CHAPTER 1 
 21 
Chapter 6: The final study of this thesis presents a single-blinded crossover dietary 
intervention aimed at evaluating the effects of a short-term high FODMAP compared to a low 
FODMAP diet on GI symptoms and perceptual wellbeing in clinical health runners with 
persistent exercise-associated GI distress (research aim 4).  
Chapter 7: This chapter is an invited review of the current literature published in 2016 (98) 
which explores the themes of this thesis. Research converging GFD and FODMAP avoidance 
in an athlete population was scarce at the outset of this investigation and the inclusion of our 
seminal work, purposefully positioned towards the end of this thesis, within the literature 
review, provides a more extensive overview. This chapter first summarizes clinical conditions 
requiring gluten-avoidance and occurrence rates of these compared those of NCA. Secondly, 
athletes’ perceptions, rationale and experiences in going gluten-free alongside the evidence 
pertaining to gluten and its effects on GI health, inflammation, athletic performance and body 
composition are reviewed. Third, GFD nutrition adequacy, psychosocial implications and 
belief effects are discussed. Lastly, as a progression from GFDs, FODMAPs are introduced 
and discussed as a potential modulator for GI symptoms in NCA athletes.  
Lis D M, Fell J W, Ahuja K D, Kitic C M, Stellingwerff T. Commercial hype versus 
Reality: Our current scientific understanding of gluten and athletic performance. Curr 
Sports Med Rep. 2016;15(4):262-8.  
Chapter 8: Translation of sport nutrition research is most impactful if it can be succinctly 
interpreted for use in the field with athletes. This conclusion section presents preliminary 
applied sport nutrition recommendations for practitioners based on this thesis work as well as 
potential limitations, proposed future studies and concluding comments. 
Some repetition between chapters is the result of these chapters being written as scientific 
papers for publication in various peer reviewed journals 
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Chapter 2: Exploring the popularity, experiences and beliefs 
surrounding gluten-free diets in non-coeliac athletes 
An original version of this chapter has been published in the International Journal of Exercise, 
Sport Nutrition and Metabolism as an original research investigation and appears in the 
literature as: 
Lis D, Stellingwerff T, Shing CM, Ahuja K, DK, Fell J. Exploring the popularity, experiences, 
and beliefs surrounding gluten-free diets in noncoeliac athletes. Int J Sport Nutr Exerc Metab. 
2015; 25:37-45. 
Thompson Reuters journal impact factor: 2.2 
SJR journal ranking: Q2, 1.03  
Altmetrics score: 82  
Table 2.2 has been edited by modifying the caption from the published manuscript to better 
describe the population-based findings and to improve the description of the result.  
The acronym gluten sensitivity (GS) has been changed to non-coeliac gluten sensitivity 
(NCGS) to reflect more recently established terminology.  
2.1 Rationale  
In recent years, a rapid surge in the uptake of GFDs amongst athletes has prompted the need 
for a greater understanding of the GFD movement. It is known that gluten-avoidance is a 
requirement for clinical conditions. However, the number of NCA adhering to this diet for 
health and performance motives seems to massively exceed the number estimated to clinically 
require gluten avoidance. Anecdotal reports suggest that NCA adopt this diet with the 
perception that a GFD is healthier, improves GI wellbeing, body composition and has an 
ergogenic performance benefit, regardless of the lack of reliable evidence supporting these 
perceptions. To gain a more comprehensive understanding of the underpinnings supporting 
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GFD adherence in NCA we conducted an international questionnaire-based study. This 
preliminary work was the first to describe the demographics and report GFD adherence rates 
in NCA. Data collected in this study further quantified the experiences, beliefs, perceptions 
and sources of information pertaining to this diet in both NCA adhering and not adhering to a 
GFD. 
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2.2 Abstract  
Purpose: Adherence to a gluten-free diet (GFD) for non-coeliac athletes (NCA) has become 
increasingly popular despite a paucity of supportive medical or ergogenic evidence. This study 
aimed to quantify the demographics of NCA and determine associated experiences, perceptions 
and sources of information related to a GFD. Methods: Athletes (n=910, female=528, no 
gender selected=5) completed a 17-question online survey. Results: Forty-one percent of NCA 
respondents, including 18-world and/or Olympic medallists, follow a GFD 50-100% of the 
time (GFD>50): only 13% for treatment of reported medical conditions with 57% self-
diagnosing their gluten sensitivity. The GFD>50 group characteristics included predominantly 
endurance sport athletes (69.9%) at the recreationally level (32.3%), between 31-40 years of 
age (29.1%). Those who follow a GFD>50 reported experiencing, abdominal/gastrointestinal 
(GI) symptoms alone (16.7%) or in conjunction with two (30.7%) or three (35.7%) additional 
symptoms (e.g. fatigue) believed to be triggered by gluten. Eighty-four percent of GFD>50 
indicated symptom improvement with gluten-removal. Symptom-based and non-symptom-
based self-diagnosed gluten-sensitivity (56.7%) was the primary reason for adopting a GFD. 
Leading sources of GFD information were: online (28.7%), trainer/coach (26.2%) and other 
athletes (17.4%). Conclusions: Although 5-10% of the general population is estimated to 
benefit clinically from a GFD a higher prevalence of GFD adherence was found in NCA 
(41.2%). Prescription of a GFD amongst many athletes does not result from evidence-based 
practise suggesting that adoption of a GFD in the majority of cases was not based on medical 
rationale and may be driven by perception that gluten removal provides health benefits and an 
ergogenic edge in NCA.   
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2.3 Introduction 
For approximately 1-1.5% of the population with coeliac disease (CD), and 0.1% with wheat 
allergies, a gluten-free diet (GFD) is a necessity, while a GFD is beneficial for an additional 5-
10% of the population with clinically diagnosed non-coeliac gluten sensitivity (NCGS)  (61, 
102, 142).  NCGS is defined as the presence of morphological, functional and immunological 
disorders that respond to gluten exclusion, without the features that define CD (163). Although 
these types of sensitivities to gluten are different in origin, they are all treated with a GFD (67).  
General public adherence to a GFD has grown rapidly in recent years illustrated by a growth 
rate of 28% from 2008 to 2012 in gluten-free foods and beverages sales in Canada (124). 
Adherence to a GFD has also increased in prevalence in non-coeliac athletic (NCA) 
populations for additional reasons including: clinically or self-diagnosed NCGS, the belief that 
gluten-free is healthier, and/or the belief that elimination of gluten will decrease inflammation 
and gastrointestinal (GI) distress (67). Many NCA have adopted a GFD for perceived 
performance and health improvements. These athletes may believe gluten removal is associated 
with the same health benefits as a GFD for individuals with CD, wheat allergy or NCGS, 
although to date there is no evidence-based research to support prescription of a GFD for non-
clinical populations. Some of the perceived benefits of a GFD in NCA include decreased GI 
symptoms and fatigue, better performance and increased motivation to train (22). Burks et al 
(2013), who surveyed 279 endurance cyclists, indicated a GFD to be the most popular special 
diet among this group. Although approximately 12% of respondents had coeliac disease, 43% 
reported following a GFD with 84% of this group commenting that deviations from a GFD 
created self-perceived symptoms detrimental to training. It is unknown if these reported 
improvements are a function of undiagnosed CD or NCGS, or attributable to the perception by 
athletes that a GFD benefits performance (22).  
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GI dysfunction is a common occurrence (15-30%) among endurance athletes and can be 
attributed to several mechanisms including exercise-induced gut dysfunction and high 
carbohydrate intake (130, 131). Athletes may avoid gluten as a result of the perception that 
gluten removal reduces GI dysfunction. While the effect of gluten removal in NCA is unknown, 
gluten removal in irritable bowel syndrome patients does not seem be an reliably effective 
approach for symptom reduction (13). Biesiekierski et al. (16), demonstrated that in a 
population of irritable bowel syndrome patients who believed gluten removal had improved 
symptoms, only 8% reported gluten-specific symptoms when fed gluten in a blinded crossover 
trial. Research available on GFD in non-coeliac individuals is further limited to investigations 
in non-athlete clinical populations with irritable bowel syndrome, which may not accurately 
reflect a healthy athletic population (13, 16).  
Some of the potential negative issues surrounding adherence to a GFD in non-coeliac athletes 
may include: the restrictive nature of the diet; the risk of suboptimal nutrient intake; increased 
difficulties with obtaining optimal food abroad for the travelling athlete; the potential 
diminution of beneficial gut bacterial populations; and, increased food costs (on average of 
242% for specialty items (145, 155). To our knowledge, beyond consumer reports, only one 
study has quantified a GFD in an athlete population (22). Therefore, the aim of this broad-
reaching questionnaire-based study was to determine: (1) the demographics of NCAs athletes 
following a GFD and degree of adherence; (2) experiences and perceptions of a GFD in regards 
to health and exercise performance; and, (3) the sources of information and types of 
prescriptions provided for a gluten-free diet accessed by athletes.  
2.4 Methods 
2.4.1 Participants  
Athletes (from recreational to Olympic medallists) were recruited to complete an online survey. 
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Recruitment was via email to professional and academic networks (Professionals in Exercise, 
Nutrition and Sport, Dietitians of Canada Sport Nutrition Network, Sport Dietitians of 
Australia), social media outlets and sport governing bodies (National Sport Institutes, 
Provincial, State and National sport governing bodies throughout Canada, the United States of 
America, Australia, Europe and Asia). Informed consent was obtained through completion of 
the survey; withdrawal was possible at any point and questions could be passed.  Participation 
was anonymous, self-selected and the exclusion criteria included athletes diagnosed with 
coeliac disease (defined by a clinical diagnosis of CD) and athletes under 18 years of age.  
Ethics approval was obtained from the University of Tasmania, Social Science Human 
Research Ethics Committee (H12933). 
2.4.2 GFD Survey and Survey Development 
The 17-question survey was made available online through Survey Monkey 
(www.surveymonkey.com) from January 24th, 2013 to March 2nd, 2013 (38 days). The survey 
collected data relating to five topics (Table 2.1) addressing the popularity of GFD amongst 
athletes: (1) demographics (age, gender, sport, level of competition); (2) GFD adherence, if 
any; (3) rate of GI symptoms occurrence and additional symptoms attributed to dietary intake; 
(4) perceptions pertaining to a GFD and athletic performance ascribed to a GFD; and (5) 
sources of GFD information and advice. Survey questions allowed one or multiple responses 
to be selected or text to be entered where appropriate. Athletes were permitted to leave 
questions unanswered.  
The survey was developed and refined following feedback from six registered dietitians 
working in sport nutrition at the National and Olympic level in North America; this feedback 
included: expand descriptive details for questions addressing level of competition and provide 
further clarification on rate of GI distress and dietary triggers (see Table 2.1 for survey 
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overview). These other recognized dietary triggers were incorporated intentionally to reduce 
the potential bias of a leading question pointing athletes to select gluten. Survey categories 
were initially expanded to allow for the collection of a comprehensive range of detailed 
responses and were subsequently collapsed for some questions upon analysis to appropriately 
categorize responses. Survey feedback and piloting ensured that representative information 
was being queried to minimize biases for or against a GFD by expanding questions and 
response options to include other known food triggers such as short chain fermentable 
carbohydrates (14).  
Table 2.1 Survey topics covered and information queried  
 
  
Topics Question Focus 
1. Demographics Age 
Gender 
Sport 
Level of Competition  
2. GFD adherence  Description of GFD adherence.  
3. Rate of GI and other symptoms 
attributed to dietary intake 
Rate of GI issues during exercise.  
Viewpoints about a GFD (e.g. reduced inflammation) 
Experience of symptoms perceived to be associated 
with dietary intake (e.g. abdominal bloating) 
Dietary components perceived to cause symptoms 
(e.g. dairy)  
Elimination of perceived dietary trigger and result 
4. Perceptions of a GFD  Dietary changes perceived concurrent with a GFD (e.g. 
increased fruit and vegetable intake)  
Physiological changes perceived concurrent with a 
GFD (e.g. less fatigue from training) 
Perceived effect of GFD on performance 
5. Sources of GFD information and 
advice  
Description of basis of GFD and advice provided 
Source of GFD information 
CHAPTER 2 
 29 
2.4.3 Data Management and Statistical Analysis  
Some responses were grouped and response categories combined where appropriate prior to 
data analysis. Reponses to the sport an athlete identified with were grouped into general sport 
categories based on activity demands (e.g. endurance, power).  GFD viewpoints were 
amalgamated into categories, which included; GI distress, health parameters (immune 
function, inflammation, nutrient absorption), exercise parameters (fatigue, recovery, energy) 
and only appropriate for individuals with a clinical requirement (CD or NCGS) categories. 
Symptoms questions were merged into abdominal/gastrointestinal, nutritional (nutrient 
deficiencies, bone density loss, anaemia), physiological (numbness, fatigue) and skin 
indicators (rash). If athletes indicated more than one symptom they were reclassified 
corresponding to the total number of symptoms. Dietary changes were amalgamated into more 
conscientious of diet overall, less processed (which included less sugary foods), increased fruit 
and vegetable intake, increased gluten-free whole grains, more balanced nutrition intake 
overall and no known dietary changes.  Physiological changes were condensed into improved 
exercise performance and health (which included overall healthier, decreased fatigue daily and 
training-specific, improved recovery post-exercise, decreased muscle soreness/stiffness, better 
training adaptations), better body composition (for sport-specific performance), decreased GI 
distress and only for individuals with CD or NCGS (do not experience any gluten-related 
symptoms, not informed about GFD). Sources of GFD information were combined into online 
(online forums, online academic journals, own research, coeliac disease or gluten-free 
websites), trainer/coach (trainer, coach, chiropractor and physiotherapist), naturopath, other 
athletes and nutritionist/dietitian. Dietitian/nutritionist were merged into a single group, as the 
distinction between the two professional titles is not clearly delineated worldwide.  
Although the survey design targeted GFD adherence in three sub-categories (adherence to a 
GFD 50-75%, 75-89% and 90-100% of the time) responses frequencies were analogous among 
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all three groups to support grouping 50%-100% of GFD adherence into one group for analysis. 
Athletes were categorized into two distinct groups for GFD adherence: GFD<50 athletes who 
adhered to a GFD less than 50% of the time and GFD>50 athletes who adhered to a GFD over 
50% of the time. Logistic regression (STATA version SE12; Statacorp LP, College Station, 
TX) was used to compare two sets of data, the GFD<50 and GFD>50 groups, for rates of GI 
distress and physiological/dietary beliefs between the GFD<50 and GFD>50 groups.  
Comparison results are presented as odds ratio (OR) and 95% confidence intervals (CI), where 
appropriate.  
2.5 Results 
2.5.1 Study Participants and Demographics  
Nine hundred and twenty-four athletes completed the survey. Twelve athletes were removed 
due to not meeting the inclusion criteria. Analysis was conducted on 910 athletes (female=528, 
male=377, no gender selected=5), between the ages of 18 to over 50 years. The athletes were 
from a broad-range of sports and competitive levels, including 18 World and Olympic 
medallists. Total responses for sport categories, competitive level and age categories are 
presented in Table 2.2.  
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Table 2.2 Demographic characteristics of athletes 
GFD<50: athletes adhering to a GFD less than 50% of the time; GFD>50: athletes adhering to 
a GFD over 50% of the time; *Endurance athletes at the recreational level between the ages of 
31 - 40 years most highly representative group to adhere to a GFD over 50% of the time.  
2.5.2 GFD Adherence 
Fifty-nine percent of athletes followed a GFD less than 50% of the time (GFD<50). Of the 
GFD<50 group, 10.7% purchased gluten-free products once in a while, 9.3% followed a GFD 
sporadically (a few days per month), 0.7% followed a GFD 1-2 weeks before competition and 
38.8% did not follow this diet at all. Of the 41.2% (n=375) of athletes that followed a GFD>50, 
       GFD<50  
      (n=535) 
      GFD>50 
      (n=375) 
Age n (%) n (%) 
18-24 years 169 (31.6%) 95 (25.3%) 
25-30 years 127 (23.8%) 98 (26.1%) 
31-40 years* 126 (23.6%) 109 (29.1%) 
41-50 years 64 (12.0%) 48 (12.8%) 
>50 years 29 (5.4%) 20 (5.3%) 
Sport category n (%) n (%) 
Endurance* 335 (62.6%) 262 (69.9%) 
Power 40 (7.5%) 26 (6.9%) 
Skill 10 (1.9%) 11 (2.9%) 
Swim/rowing 38 (7.1%) 19 (5.1%) 
Intermittent 77 (14.4%) 28 (7.5%) 
Weight classified/ aesthetic 19 (3.6%) 7 (1.9%) 
Winter 9 (1.7%) 9 (2.4%) 
Fitness 7 (1.3%) 13 (3.5%) 
Level of competition n (%) n (%) 
Recreational* 116 (21.7%) 121 (32.3%) 
Recreational competitive 122 (22.8%) 9 (2.4%) 
Provincial/state 62 (11.6%) 26 (6.9%) 
National 104 (19.4%) 60 (16.0%) 
International 57 (10.7%) 33 (8.8%) 
World/Olympic qualifier 35 (6.5%) 21 (5.6%) 
World/Olympic medallist 29 (5.4%) 18 (4.8%) 
Professional 10 (1.9%) 5 (1.3%) 
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50% adhered to a GFD 90-100% of the time, 7.5% adhered 75-89% of the time and 42% 
adhered 50-74% of the time. Of the athletes in the GFD>50 group, 69.9% were endurance sport 
athletes (n=262) at the recreational level (32.3%, n=121), with most between the ages of 31-
40 years of age (29.1%, n=109; Table 2.2).  
2.5.3 Information sources  
The most prevalent source of GFD information for the GFD>50 athletes were: online (28.7%, 
n=290), trainer/coach (26.2%, n=264), other athletes (17.4%, n=176), registered 
dietitian/nutritionist (14.4%, n=171), naturopath (7.4%, n=75), other persons with CD (5.4%, 
n=36) and medical professionals (0.5%, n=3). Athlete level influenced GFD primary 
information sources. Recreational competitive athletes accessed information primarily from 
trainers/coach (26.9%, n=71) and World/Olympic medallist accessed GFD information 
primarily from other individuals with CD (34.0%, n=18).   
2.5.4 Prescription of GFD 
Of the GFD>50 athlete group a GFD was prescribed for the following reasons: self-diagnosed 
NCGS based on symptoms or no symptoms (56.7%, n=211), clinically diagnosed NCGS 
through gluten-challenge test (9.9%, n=37) or irritable bowel syndrome with symptoms thought 
to be triggered by gluten (8.9%, n=33), recommended by coach, trainer, chiropractor, 
physiotherapist or Paleo diet (8.9%, n=33), naturopath bloodwork (7.0%, n=26), family history 
of CD (3.2%, n=12), other (4.8%, n=18) and recommended by nutritionist/registered dietitian 
(0.5%, n=2) (Figure 2.1).  
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Figure 2.1 – GFD>50 basis of prescription for adherence to a GFD. NCGS: non-coeliac gluten 
sensitivity, IBS: irritable bowel syndrome, BW: bloodwork, dx: diagnosis, hx: history, CD: coeliac 
disease, RD: registered dietitian. 
 
2.5.5 Experiences / Symptoms  
Gluten removal was reported to resolve physical symptoms including abdominal bloating, gas, 
diarrhoea and fatigue thought to be triggered by gluten in 80.7% (n=303) of GFD>50 athletes. 
For 1% gluten removal did not resolve symptoms, and 6.5% had not removed gluten for long 
enough to determine a change. Abdominal/gastrointestinal symptoms alone (16.7%, n=49) and 
in conjunction with two (30.7%, n=90) or three (35.7%, n=105) additional symptoms were the 
most highly reported to be triggered by gluten in GFD>50 athletes. Less frequently reported 
symptoms included self-prescribed physiological (2.4%, n=7), nutritional (3.3%, n=8), skin 
(0.3%, n=4) and more than 4 symptoms together (10.2%, n=30).   
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The GI distress occurrence rates were similar (all P>0.12) between the GFD>50 and GFD<50 
groups in all categories (Figure 2.1).  At the GI distress incidence rate of less than 25% of the 
time both groups reported similar frequencies (84.5%, n=452 vs. 80.8%, n=303). Also, 
comparable between the two groups were reported GI distress rates within the incidence range 
of 26-50% of the time (13.6%, n=66 vs. 12.3%, n=51) and over 50% of the time (3.2%, n=21 
vs. 5.6%, n=17).  
 
Figure 2.2 – Frequency of gastrointestinal (GI) distress between gluten-free diet adherence gluten-
free diet adherence less than 50% of the time (GFD<50 n) versus 50-100% of the time (GFD>50 
n) groups.  Frequency of GI distress are categorized as occurring less than 25% of the time, 26 to 
50% of the time and more than 50% of the time. 
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2.5.6 Beliefs (dietary habits)  
The key differences between the GFD>50 and GFD<50 groups in perceived dietary changes 
that occur alongside a GFD included more conscientious of overall nutrition intake (77.9 vs. 
58.5%; OR 2.50, 95% CI 1.85 to 3.36, P< 0.001), less processed food choices (43.7 vs. 64.5%; 
OR 0.43, 95% CI 0.32 to 0.57, P<0.001) and no dietary changes known (6.9 vs. 8.8%; OR 0.34, 
95% CI 0.16 to 0.71, P=0.005) (Figure 2.3a). There were no differences between GFD<50 and 
GFD>50 groups concerning the beliefs that a GFD may also incorporate increased fruit and 
vegetable intake (58.7 vs. 57.8%; OR 1.03, 95% CI 0.70 to 1.35, P=0.78), increased gluten-
free whole grain intake (41.1% vs. 37.8%; OR 1.14 95% CI 0.87 to 1.5, P=0.31) and more 
balanced nutrition intake overall (33.1 vs. 29.3%; OR 1.19, 95% CI 0.89 to 1.58, P=0.23). 
2.5.7 Beliefs (physiological)  
Key differences between the GFD>50 and GFD<50 groups were found in perceived 
physiological changes that occur alongside a GFD. The GFD>50 compared to the GFD<50 
group believe more frequently that improved exercise performance (56.3 vs. 23.9%; OR 4.09, 
95% CI 3.08 to 5.44, P < 0.001); decreased inflammation/illness (73.3 vs. 30.3%; OR 6.33, 
95% CI 4.72 to 8.50, P < 0.001), decreased GI distress (61.1 vs. 30.8%; (OR 3.82, 95% CI 
2.87 to 5.10, P < 0.001), improved body composition for sport performance (74.4 vs. 43.2%; 
OR 3.52, 95% CI 2.67 to 4.64, P < 0.001) and no physiological effects (2.4 vs. 6.7%; OR 0.34, 
95% CI 0.016 to 0.71, P=0.005) occurred alongside a GFD (Figure 2.3b). There were no 
differences between the GFD<50 and GFD>50 groups in the belief that physiological effects 
were only applicable to CD or NCGS (0.3 vs. 1.5%; OR 0.18, 95% CI 0.02 to 1.41, P=0.10).  
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Figure 2.3 – (a) GFD>50 and GFD<50 athletes perceived dietary changes that occur with 
adherence to a GFD.  (b) GFD>50 and GFD<50 perceived physiological changes that occur with 
adherence to a GFD.  *Significantly different between GFD>50 versus GFD<50. CD: coeliac 
disease, NCGS: gluten sensitivity. *Gluten-free diet adherence 50% - 100% of the time (GFD>50 
n); less than 50% of the time (GFD<50 n). 
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2.6 Discussion 
Our survey is the first to determine the prevalence of a GFD across a variety of sports and in 
world-class athletes, which included ~10% world or Olympic qualifiers and/or medallists. Of 
these we found that 41.2% of athletes adhered to a GFD over 50% of the time and that this diet 
was most prominent within the endurance sport community amongst athletes at the recreational 
level (70% of GFD>50) between 31 to 40 years of age. This high frequency of adherence to a 
GFD over 50% of the time is surprising considering that researchers estimate only 5-10% of 
the population may benefit medically from a GFD (61). Our survey results further highlight 
that the decision to adhere to a GFD over half of the time was often not made based on clinical 
recommendations, but mostly as a result of a self-diagnosed gluten issue (57%). Description of 
GFD adherence varied from occasionally to all of the time. However, of those who adhered to 
a GFD over 50% of the time the largest cohort followed this diet 90-100% of the time. Reasons 
for adhering to a GFD in NCAs include perceived reductions in GI distress, reduced 
inflammation, improved exercise performance and the belief that the diet supports a favourable 
body composition for sport.  
This survey shows that primarily athletes involved in endurance-based sports adopt a GFD. 
Burks et al. (22) also found that a GFD diet was the most popular ‘special diet’ amongst 
endurance cyclists with similar reports that a GFD was perceived to improved GI symptoms in 
approximately 80% of survey respondents. The attraction of gluten elimination may be 
prominent within this sub-group due to the higher frequency of GI dysfunction reported by 
endurance athletes (15-30%) compared to other types of athletes (78, 130, 131). While exercise 
may increase intestinal permeability due to reduced splanchnic perfusion, dietary factors such 
as high carbohydrate intake may also contribute to GI dysfunction (130, 131). There was belief 
among this athlete-group that gluten removal decreased the rate of GI symptoms (Figure 2.2b). 
Increased rates of GI distress and a greater awareness of nutrition information may also 
CHAPTER 2 
 38 
contribute to the increased popularity of a GFD within this demographic (69, 173).  
The GFD>50 athletes reported reductions in abdominal/GI distress to be the primary outcome 
of gluten-elimination. Abdominal/GI symptoms along with two to three other symptoms, 
including physiological, nutritional and skin-related symptoms, were perceived to be triggered 
by gluten and resolved with gluten-avoidance in the majority of GFD>50 respondents. Clinical 
and case-report data confirms a list of symptoms, such as nutrient deficiencies, abdominal 
boating and fatigue to resolve with GFD adherence in athletes diagnosed with CD (17). 
However, alongside CD, a spectrum of gluten-related disorders have been defined. The most 
well-known of these is NCGS with over 100 associated symptoms, including gluten ataxia, 
which due to reductions in neurological and muscular coordination would be detrimental to 
athletic performance (61). According to Gibson & Sheppard (2010) an estimated 15% of the 
population may have a functional GI disorder, which could be worsened with the intake of 
dietary triggers. The rise in gluten as a dietary trigger for a range conditions and the upsurge in 
NCGS and CD may be due to increased awareness and diagnosis of GI and related disorders. 
However, self-prescription of a GFD based on symptoms or no symptoms was the dominate 
rationale for gluten-avoidance (~57%) which may or may not be concomitant with gluten itself 
(52). The rate of GI distress reported in both the GFD<50 and GFD>50 groups was similar and 
this further demonstrates that the removal of gluten itself may not be the key modulating factor 
in a GFD and perceived symptom improvements. Given the complexity and importance of an 
athlete’s diet, diagnosis of CD or NCGS should be established before removing gluten from 
the diet (67). The appropriate diagnoses of NCGS or the medical requirement for a GFD is 
significant to athletes as this diet can be time-consuming, complex and compromise optimal 
energy and carbohydrate intake.  
In addition to the belief that a GFD reduces GI dysfunction the current study has shown 
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perceptions among athletes that a GFD improves exercise performance, decreases 
inflammation, and improves body composition (Figure 2.3b). NCA further indicated that other 
positive dietary factors were believed to simultaneously result from a change to a GFD, such 
as an increase in conscientiousness of nutrition intake, increased fruit, vegetable and gluten-
free whole grains and decreased processed food consumption (Figure 2.3a). According to our 
survey results a small number of athletes believe that decreased energy and carbohydrate intake 
may result with a GFD which may compromise energy and fuel availability for athletes (101). 
Given that other dietary factors identified to positively affect heath and performance were 
believed to happen alongside the adoption of a GFD in NCA it is unknown if reported 
performance improvements identified were simply perceived, a function of undiagnosed CD, 
NCGS, other dietary factors, or related to the GFD itself (107, 110, 165). Other dietary changes 
may occur alongside a GFD and evaluation of any effects of a GFD must take into account 
other coincidental dietary variations and possible placebo effects (109).  
Currently there is a lack of diagnostic criteria for NCGS, where no allergic or autoimmune 
mechanisms are involved, and NCGS diagnosis is confirmed by gluten-exclusion and followed 
by monitored reintroduction of gluten-containing foods (142). However, this approach lacks 
specificity and is subject to the risk of placebo if not blinded (142). The effect size of ergogenic 
aids and belief in an intervention are similarly estimated to improve performance by 1-3% (66). 
With the findings that many athletes believe that GFD adherence improves performance for 
NCAs it is important to consider that belief may influence performance outcomes with this 
dietary intervention (66). Results from this survey will assist nutrition practitioners to better 
understand the scope of the GFD movement, to consider the psychological aspects of the NCA 
athlete following or considering this diet, and the potential placebo affects; all of which are 
principal nutrition counselling tools to comprehend and apply when working with athletes.  
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Self-prescription of a GFD among athletes may be reinforced by non-peer reviewed literature 
or opinions from coaches/trainer of a GFD being overall healthier and improving performance. 
Non-peer reviewed or anecdotal GFD information was primarily sourced from online 
resources, other athletes and from coaches/trainers. Nutritionists/registered dietitians were 
reported much less often as sources of GFD information; a theme common in sport nutrition 
practise which further highlights that sources of GFD advice may be from non-qualified 
nutrition professionals (74). Since the avoidance of gluten restricts a range of foods, it has the 
potential of causing nutrient deficiencies (B vitamins, fibre and iron), compromising gut health 
by reducing beneficial gut bacteria, especially without appropriate nutrition counselling (49, 
145, 147). Further, reduced enjoyment, ease of eating and increased food cost, estimated to be 
up to 242% higher for a number of gluten-free replacement items, are also an important 
consideration concerning the appropriateness of a GFD for NCA (70, 155). Although more 
nutrient dense GF foods are introduced to grocery shelves almost daily, the long-term effects 
of a strict GFD in NCAs is unknown and it is preferable to assess the necessity of this diet 
before assigning unnecessary food restrictions. 
While our survey excluded individuals with coeliac disease, self-selection may have biased an 
un-proportional number of responses from athletes interested in or following a GFD. However, 
the proportionately high rate of athlete respondents that did not follow a GFD, or were 
unfamiliar with a GFD, support that our findings are most likely representative of an athletic 
population. Overall, our survey data indicated a high proportion of athletes adhere to a GFD 
without evidence-based necessity. It is possible that athletes follow a GFD due to perceived 
physiological improvements that may coincide with other dietary changes and/or the 
perception that gluten elimination will provide the same health benefits as it does in individuals 
with a clinical necessity for a GFD. Attractively, perception exists that a GFD provides 
ergogenic edge in NCA.  
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An athlete’s diet is a key element to training adaptations and athletic performance and all 
elements affecting nutrition intake must be considered when deciding to adopt a GFD for non-
medical reasons. Our survey results indicate that many NCA have adopted a GFD due to 
perceived, yet unconfirmed, health and performance benefits resultant from gluten removal. 
Given the restrictive nature of this diet and the unknown effects of long-term adherence to a 
GFD in NCA, further research in this area is essential to determine the effects of a GFD on 
parameters of exercise performance and gut health. 
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Chapter 3: No effects of a short-term gluten-free diet on 
performance in noncoeliac athletes 
This chapter has been published in Medicine & Science in Sport and Exercise as an original 
research investigation and appears in the literature as:  
Lis D, Stellingwerff T, Kitic CM, Ahuja KD, Fell J. No effects of a short-term gluten-free diet 
on performance in noncoeliac athletes. Med Sci Sports Exerc. 2015;47(12):2563-70. 
Thompson Reuter journal impact factor: 4.6 
SJR journal ranking: Q1  
Altmetrics score: 389 
3.1 Rationale  
This study was conducted to investigate the reported perceptions, beliefs and experiences 
pertaining to GFD in NCA endurance athletes. Furthering the results from Chapter 2, this 
double-blind, crossover dietary intervention assessed the effects of a GFD versus GCD on 
performance and parameters potentially influencing performance, including: GI health, 
systemic inflammation and perceptual wellbeing. This is the first study to assess the effects of 
a short-term gluten elimination in NCAs. As a contemporary and topical subject of study, the 
results from this published manuscript have received international recognition and established 
a formative presence in the field of sport nutrition as evidenced with an Altmetrics score of 
389.   
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3.2 Abstract  
Purpose: Implementation of gluten-free diets (GFD) amongst noncoeliac athletes has rapidly 
increased in recent years due to perceived ergogenic and health benefits. The aim of this study 
was to investigate the effects of a GFD on exercise performance, gastrointestinal (GI) 
symptoms, perceived wellbeing, intestinal injury, and inflammatory responses in noncoeliac 
athletes. Methods: Thirteen competitive endurance cyclists (8 males, 5 females) with no 
positive clinical screening for coeliac disease or history of irritable bowel syndrome 
(mean±SD; age: 32±7 years; weight: 71.1±13.4 kg; height 177.0±11.8 cm, VO2max 59.1±8.0 
ml.kg-1min-1) were allocated to a seven-day gluten-containing diet (GCD) or GFD separated 
by a 10-day washout in a controlled randomized double-blind, crossover study. Cyclists ate a 
GFD alongside either gluten-containing or gluten-free food bars (16 g wheat gluten per day) 
while habitual training and nutrition behaviours were controlled. During each diet, cyclists 
completed the Daily Analysis of Life Demand for Athletes (DALDA) and GI questionnaires 
(post-exercise and daily). On day seven cyclists completed a submaximal steady-state (SS) 45-
minute ride at 70% peak power followed by a 15-minute time-trial (TT). Blood samples were 
taken pre-exercise, post SS and post TT to determine intestinal fatty acid binding protein 
(IFABP) and inflammatory markers (cytokine responses: IL-1b, IL-6, IL-8, IL-10, IL-15, TNF-
a). Mixed effect logistic regression was used to analyse data. Results: TT performance was 
not significantly different (P=0.37) between the GCD (245.4±53.4kJ) and GFD 
(245.0±54.6kJ). GI symptoms during exercise, daily, and DALDA responses were similar for 
each diet (P>0.11). There were no significant differences in IFABP (P=0.69) or cytokine 
(P>0.13) responses. Conclusions: A short-term GFD had no overall effect on performance, GI 
symptoms, wellbeing, and a select indicator of intestinal injury or inflammatory markers in 
noncoeliac endurance athletes.   
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3.3 Introduction  
Gluten-free diets (GFD) are a clinical necessity for 5-10% of the general population for health 
purposes including coeliac disease, wheat allergy and noncoeliac gluten sensitivity (61). 
However, general population market reports indicate that the adoption of a GFD has far 
exceeded the requirement for clinical populations, with GFD uptake exploding amongst 
noncoeliac athletic populations (58, 97). Correspondingly, our recently published 
questionnaire-based study, which investigated the frequency, perceptions and beliefs 
surrounding GFD, found that in 942 noncoeliac athletes over 40% reported following a GFD 
at least 50% of the time (97).  Startlingly, this group of noncoeliac athletes mostly relied on 
self-diagnosis of a gluten-related disorder and subsequent self-treatment with a GFD (97).   
General population gluten avoidance has become prevalent due to a belief that a GFD is 
“healthier,” or owing to self-diagnosed gluten-related gastrointestinal (GI) disorders (42). 
Noncoeliac athlete populations adopt a GFD in the belief that it is not only healthier and 
augments weight loss, but will also decrease GI distress and systemic inflammation and 
improve psychological wellbeing and athletic performance (97).  This rise in GFD uptake may 
be further influenced by advertising campaigns around the medical necessity and health 
benefits, while athlete testimonies support the idea that at GFD might offer an ergogenic 
performance edge (103). While there is one study showing improved glucose metabolism and 
reduced obesity with gluten elimination in noncoeliac rodents (151), there is no scientific 
evidence to date that shows a GFD positively influences elements of health or performance in 
non-clinical populations.  
Dietary triggers such as wheat (which contains the protein gluten) have been shown to damage 
the intestinal barrier in clinically sensitive individuals (e.g. coeliac disease (143)).  Conversely, 
high intensity exercise also reduces the integrity of the GI barrier (177). A primary mechanism 
causing GI distress during exercise is gut ischemia, resulting from the redistribution of blood 
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from the splanchnic area to tissue with increasing exercise intensities. Splanchnic 
hypoperfusion ultimately gives rise to a cascade of responsive events including epithelial 
injury, increased permeability, bacterial translocation and systemic inflammation (87). 
Recurrent GI stress and injury, which is common among endurance athletes, may create an 
environment resulting in greater susceptibility to adverse reactions to common dietary triggers 
(37, 169). GI injury in response to gluten ingestion has been well classified in coeliac disease 
patients but in noncoeliac gluten-sensitivity this condition is less apparent and evidence varies 
(45, 120).  
Other nutritional changes that may take place subsequent to gluten elimination can either 
improve or compromise an athlete’s diet (97). Athletes believe that GFD adherence increases 
conscientiousness of eating a healthy and balanced diet (97).  However, adopting a GFD 
without appropriate nutrition counselling may be associated with increased expense, (+242% 
(49) inadequate intake of B vitamins, fibre and iron, as well as compromised gut health through 
reduced beneficial gut bacteria populations (49). More recently, Shepherd & Gibson (147) 
suggest that the inadequacies found in a GFD may be linked to dietary gluten-free food choices 
rather than the diet itself, which all need to be considered before adopting such a diet.  
Given that our published observational data suggests that many noncoeliac athletes have 
adopted a GFD due to perceived, yet unconfirmed, health and performance benefits (97),  our 
primary aim is to determine the effects of a short-term GFD in noncoeliac athletes on exercise 
performance. Secondary aims are to determine the effects of a GFD on several parameters that 
possibly influence performance, including: (1) GI symptoms, (2) perceived wellbeing, (3) 
intestinal injury, and, (4) systemic inflammation. Our a priori hypothesis was that a 7-day GFD 
would not affect time trial (TT) performance or associated parameters in noncoeliac athletes.  
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3.4 Methods 
3.4.1 Participants 
Thirteen competitive cyclists (inclusion criteria: 18-40 years of age, VO2max >60.0 (male) and 
>50.0 (female) ml.kg-1min-1, respectively) participated in this study. A mixed sex cohort was 
chosen to represent the population adhering to a GFD as presented in our questionnaire-based 
study (97). Exclusion criteria were: coeliac disease (determined by AGA, tTG IgA, tTG IgG 
screened by an accredited pathology laboratory); known familial history of coeliac disease; 
history of wheat allergy; clinically diagnosed noncoeliac gluten sensitivity or irritable bowel 
syndrome; were following a gluten-free or vegetarian diet, or; had any pre-existing medical 
condition that could be affected by dietary intervention. Ethics approval was obtained from the 
Tasmanian Health and Medical Human Research Ethics Committee (H0013244). Prior to 
inclusion participants were informed about the study procedure, completed a physical activity 
readiness questionnaire, and provided signed informed consent.  
3.4.2 Experimental Design  
VO2max Test: Cyclists’ maximal oxygen uptake (VO2max) and peak power (Wmax) were 
determined using an incremental test to exhaustion on a calibrated cycle ergometer (Excalibur 
Sport Cycle Ergometer, Groningen, The Netherlands) approximately 10 days prior to the 
experiment trials. Following a 5-minute warm up at 100W cyclists began an incremental 
protocol at 100W with increases of 50W for males and 25W for females in 3-minute stages 
until volitional fatigue. Every 15 seconds of the test expired air was analysed using a metabolic 
cart (Parvo Medics TrueOne 2400, Salt Lake City, USA) to determine oxygen uptake (VO2). 
Heart rate (HR) (RS800CX, Polar Instruments Inc., Oy, Finland), cadence and power output 
were recorded very 15 second and rating of perceive exertion (6-20 Borg scale) was recorded 
at the end of each stage (18). 
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Prior to study commencement a one-time GI history questionnaire and a 24-hour food recall 
was collected. Utilizing a double-blind, placebo controlled, crossover design participants were 
randomized by an independent observer according to a computer-generated list to receive either 
a gluten-containing diet (GCD) or a GFD for seven days, separated by a 10-day washout, and 
then received the alternative diet. A registered dietitian provided dietary education to 
participants on label reading, gluten-free eating and nutrition intake recording as participants 
were permitted to self-select gluten-free foods in addition to the study food provided (i.e. fresh 
fruits and vegetables, yogurt) stipulating that all food was replicated in the subsequent trial. 
Exercise performance testing took place on day seven of each dietary intervention and blood 
samples were taken immediately pre-exercise, post steady state (SS) and post TT.  
Gastrointestinal and Wellbeing Monitoring: Throughout the study, three questionnaires were 
required to be completed each day: (1) post-exercise GI questionnaire, (2) daily GI 
questionnaire, and (3) Daily Analysis of Life Demands (DALDA). The presence and severity 
of upper and lower abdominal and other symptoms were determined using a 10-point scale 
ranging from 0 “no problem at all” to 9 ‘‘the worst it has ever been.” Section 1 of the 
questionnaire addressed upper abdominal symptoms: reflux/heartburn, belching, bloating, 
stomach cramps/pain, nausea, vomiting. Section 2 addressed lower abdominal symptoms: 
intestinal/lower abdominal cramps, flatulence, urge to defecate, side ache/stitch, loose stool, 
diarrhoea and intestinal bleeding. Section 3 addressed other symptoms (dizziness, headache, 
muscle cramp and urge to urinate) (131).  We analysed the frequency of all levels of GI and 
other symptoms (GI symptoms score 0-9) (131). All standardized GI questionnaires have been 
utilized in prior exercise and GI symptom research (31, 128, 131). 
To assess the general stress levels (Part A) and to determine stress-reaction symptoms (Part B) 
of the participants the DALDA tool was used (139). This questionnaire requires participants to 
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rate each variable as “worse than normal,” “normal,” and “better than normal.”  Scores were 
tabulated and the “worse than normal” scores compared between trials. Each questionnaire was 
completed at the same time of day except for the post-exercise questionnaire, which was 
completed immediately following training.   
Food Preparation: Participants were provided with gluten-free food including lunch and 
dinner meals prepared and frozen in a gluten-free commercial kitchen (Birdseed Catering), 
breakfast provisions (gluten-free cereals, breads, muffin, pancake mix), baking staples and 
snack foods (Orgran, Brookfarm, Byron Bay, PureBred). Participants were permitted to add 
gluten-free foods to their meals and self-select gluten-free snacks provided dietary intake was 
replicated for the subsequent trial. The prototype study menu presented a macronutrient profile 
based on g.kg-1 body weight containing carbohydrate 6-8 g.kg-1, protein 1.2-1.7 g.kg-1 and fat 
0.8-1.0 g.kg-1 (FoodWorks Professional 7, Xyris, Brisbane, Australia; (138). Two quinoa-based 
food bars were consumed per day that contained either vital wheat gluten or whey protein. The 
bars were designed to deliver 16 g of wheat gluten per day (Manildra Group, Gladesville, 
Australia) or the equivalent dose of whey protein isolate (Vital Strength, Marrickville, 
Australia). Wheat gluten and whey protein were weighed using a digital food scale accurate to 
one decimal place (Terraillon, Croissy-Sur-Seine, France). Two food bars containing 8 g gluten 
each were ingested and spread throughout the day to simulate typical gluten intake patterns. 
Pilot blinded analysis in 10 healthy individuals, and two pre-trial participants confirmed that 
the food bars containing gluten could not be differentiated from the gluten-free food bars.  
Familiarization to Performance Test: Before the first dietary intervention a familiarization 
session was undertaken to accustom participants to the testing protocol (91). Information from 
the incremental exercise test was used to prescribe the intensity of the SS exercise ride: 45-
minute SS at 70% Wmax (169) (234±56 W) followed by a 15-minute TT; a well-established and 
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validated TT performance measure (76). For the TT the ergometer was set in linear mode where 
the linear factor was based on individual participant’s 70% Wmax and preferred cycling cadence 
during the VO2max test (76). We also purposely chose participants were given 0.5 ml.kg-1 
distilled water every 10-minutes throughout the SS ride.  
Performance Test: Preceding each performance testing session participants were provided with 
guidelines for gluten-free pre-exercise fuelling. Guidelines for a moderate carbohydrate load 
24 hours before the performance test were provided which included the study food, self-
selected gluten-free food, and instruction for increasing carbohydrate intake. A selection of 
gluten-free foods was provided to participants for each seven day trial. In combination with 
this, participants were provided with guidelines for food and fluid intake prior to their 
performance test. These guidelines included a moderate ingestion of carbohydrate (1-4 g.kg-1 
body mass) 1-4 hours prior to exercise and 5-7 ml.kg-1 body mass fluid in the two hour period 
before exercise. Participants were permitted to self-select pre-exercise fuels (either provided 
study meal or snack foods) based on preference and this was evaluated pre-exercise and 
replicated for each testing session. Each testing session was performed at the same time of day 
and climatic conditions (20°C, 40% humidity, 767-769 mmHg). Participants refrained from 
the use of non-steroid anti-inflammatories, caffeine, alcohol and strenuous exercise 24 hours 
prior to testing.   
Prior to the 45-minute SS ride cyclists completed a 5-minute warm-up at 100W. The 45-minute 
SS ride and 15-minute TT were performed in the same manner as the familiarization and 
participants were encouraged to complete as many kJ in the TT as possible. During the SS ride 
verbal feedback on time completed was provided every 5-minutes. During the 15-minute TT, 
verbal feedback on time completed was given at minute 3, 6 and 9 then every minute for the 
final 5-minutes, with no other information given. Standardized verbal feedback was provided 
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with any feedback outside of the script recorded and replicated for the subsequent trial. All 
verbal feedback and encouragement were provided by the same investigator, standardized and 
replicated in each trial. Data was collected every 3-minutes for kJ completed, power, cadence 
and HR.  
3.4.3 Biochemical Measurements 
At each exercise performance test venous blood samples (5 mL lithium heparin and 5 mL 
EDTA) were collected from a forearm vein pre-exercise, post SS and post TT. Full blood cell 
counts were obtained immediately via an automated cell analyser (XS-1000i, Sysmex, Kobe, 
Japan) while haemoglobin and haematocrit were immediately determined in duplicate using a 
HemoCue® Hb 20 (HemoCue®, Angelholm, Switzerland) and the capillary centrifugation at 
12,000g for 5-minutes, respectively. Blood samples were centrifuged at 1000g for 15-minutes 
and plasma was aliquoted and stored at -80°C until analysis. All plasma variables were 
adjusted for changes in plasma volume (44). 
Intestinal Fatty Acid Binding Protein (IFABP): Plasma IFABP, a sensitive and acute marker 
of small intestinal cell damage, was determined using an ELISA (Hycult Biotechnology, 
Uden, The Netherlands) according to manufacturer’s instructions. All samples were analysed 
in duplicate with a 5% intra-assay CV.  
Markers of Inflammatory Response: Plasma cytokines concentrations of Il-1b, Il-6, IL-8, IL-
10, IL-15 and TNF-a were determined using a multiplex bead array assay (Millipore, MN, 
USA). The minimal detectable concentration of IL-1b was 0.8 pg.ml-1, IL-6 was 0.9 pg.ml-1, 
IL-8 was 0.4 pg.ml-1, IL-10 was 8.6 pg.ml-1, IL-15 was 1.2 pg.ml-1, and TNF-a was 0.7 pg.ml-
1. Samples were analysed in duplicate and the intra-assay coefficient of variation was 9% for 
IL-1b, 9% for IL-6, 5% for IL-8, 10% for IL-10, 8% for IL-15, 8% for TNF-a.  
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3.4.4 Statistical Analysis 
Before analysis, all data were tested for normality using a Kolmogorov-Smirnov test. Where 
normally distributed, mixed effects linear regression was performed. When assumptions of 
linear regression (heteroscedasticity, skewness, kurtosis or linearity) were violated, data were 
analysed using repeated-measures ordered logistic regression and all analysis were performed 
for intervention and order effect. Poisson regression was used to compare frequency of GI 
symptom severity between GCD and GFD daily and during exercise. Analysis was performed 
using Stata 13.0 (Statacorp LP, College Station, TX). A sport specific Microsoft Excel 
spreadsheet (73) was used to estimate the likelihood that a GFD would be beneficial, negligible 
or harmful based upon the smallest important change (5.17 kJ) (76).  
Two methods for sample size calculation were applied, including magnitude-based inferential 
statistics for comparing performance (total kJ completed in 15-minute TT) and power-based 
sample size calculations for post-exercise IFABP and cytokines. Sample size analysis based on 
performance was determined using Hopkin’s statistical spreadsheet, Estimating Sample Size 
for Magnitude-Based Inferences (72). The spreadsheet estimates sample size requirements 
when the typical error and smallest important change (Cohen’s smallest important effect - 0.2 
of the between subject SD) are entered for the primary performance measure. The typical error 
(6.53 kJ) and smallest important change (5.17 kJ) were obtained from previously published 15-
minute TT reliability data (76). Sample size calculation using these values indicated the need 
for 12 participants. For the blood markers of IFABP and one chosen marker of inflammation 
(TNF-a), sample size was determined using power calculations to detect an intervention 
difference at a two-sided 5% significance level with a power of 80%. Assuming a post-exercise 
IFABP value of 474±74 pg.ml-1 (168), and detecting a 20% difference: a total of 10 participants 
were required. Assuming a post-exercise TNF-a value of 28±4 pg.ml-1 (23), and detecting a 
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10% difference a total of 11 participants were required. Thirteen participants were recruited to 
allow for one drop out. 
3.5 Results 
3.5.1 Participants 
Thirteen participants (8 males: VO2max 63.7±6.5 ml.kg-1min-1, 5 females: VO2max 51.6±2.8 
ml.kg-1min-1; 32±7 years of age, weight 71.1±13.4 kg, height 177±11.8 cm) completed the 
study. Blood results were available for 10 to 12 participants. There were no significant 
differences between males or females for any of the variables measured (P>0.05).  
3.5.2 Performance Test  
Exercise performance data is shown in Figure 3.1. There was no significant difference in total 
work completed over the 15-minute TT on day-7 between the GCD and GFD (245.4±53.4 kJ 
vs 245.0±54.6 kJ, P=0.37). Power (267±60 vs 267±57 W, P=0.80), HR (168±9 vs 167±8 bpm, 
P=0.56) and cadence (94±8 vs 95±8 rpm, P=0.31) were also similar during the TT for both the 
GCD and GFD trials.  Analysis of the performance data (work completed) using magnitude-
based inference indicated a 100% “negligible” effect of a GFD on performance. 
 
Figure 3.1 – Overall 15-minute time trial performance (kJ) in response to gluten-containing diet 
(GCD) and gluten-free diet (GFD). ¾ individual performance  n means (SD), n=13. 
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3.5.3 Gastrointestinal Wellbeing  
Frequency of all GI symptoms ratings daily (outside of exercise) and during exercise for upper 
and lower GI symptoms are displayed in Figure 3.2. There were no significant differences in 
GI symptoms between GCD and GFD for daily upper (P>0.32), lower (P>0.15) and other 
(P>0.40) symptoms. Similarly, during exercise GI symptoms were not significantly different 
between dietary interventions for upper (P>0.27), lower (P>0.11) and other (P>0.08) 
symptoms.  
 
Figure 3.2 – Frequency of GI symptoms daily over 7-day period for gluten-containing diet 
(nGCD) and gluten-free diet (nGFD). Values are median (range), n=13. 
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3.5.4 Overall Wellbeing  
DALDA scores were tabulated and the “worse than normal” scores were compared between 
each trial. No difference in the sum of 7-day DALDA scores between the GCD (26±19) and 
GFD (27±18) was found (P=0.26). 
3.5.5 IFABP 
IFABP levels increased post SS cycling and post TT from pre-exercise for both groups (GCD 
and GFD, pre-exercise: 94±83 and 99 ±57 pg.ml-1, post SS: 233±188 and 192 ±159 pg.ml-1; 
post TT: 304 ±191 and 301±252 pg.ml-1). There were no significant differences in IFABP 
concentration at any time point between the GCD and GFD (P>0.69).  
3.5.6 Cytokines 
Plasma concentrations of Il-1b, Il-6, IL-8, IL-10, Il-15 and TNF-a, measured to determine 
systemic inflammatory responses, were not significantly (P>0.05) different between the GCD 
and GFD (Table 3.1).  
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Table 3.1 Cytokines responses from pre-exercise, post steady state (~70% Wmax) and 
immediately after 15-minute TT after 7-days of a gluten-containing diet versus a gluten-free diet. 
 
Values and mean±SD.  There were no statistically significant differences between the gluten-
containing diet (GCD) vs gluten-free diet (GFD) pre-exercise, post steady-state (SS) and post 
time-trial (TT) (n=10). 
3.6 Discussion 
This is the first study to examine the effects of dietary gluten removal on exercise performance 
and associated parameters in noncoeliac athletes. Our previous observational data indicated 
that a much higher proportion of noncoeliac athletes (>40% of endurance athletes, more 
females than males) follow a GFD than would be required for medical reasons (5-10% of the 
general population) (61, 97). Belief in a GFD being healthier and reducing GI symptoms and 
inflammation alongside self-diagnosed gluten-related conditions are the primary motivations 
for adopting this diet in athlete populations (97). In line with our a priori hypothesis, our 
Cytokines 
(pg.ml-1) Diet Pre-exercise Post-SS Post-TT 
IL-1b 
GCD 7.64 ± 7.73 7.04 ± 6.76 8.17 ± 7.76 
GFD 9.71 ± 9.90 8.64 ± 8.72 9.04 ± 7.69 
IL-6 
GCD 4.33 ± 4.47 4.42 ± 4.11 6.39 ± 5.33 
GFD 7.21 ± 7.30 6.12 ± 5.73 7.93 ± 4.48 
IL-8 
GCD 8.83 ± 5.64 11.44 ± 11.34 8.00 ± 4.61 
GFD 10.11 ± 6.74 8.54 ± 3.88 8.75 ± 3.70 
IL-10 
GCD 14.71 ± 29.74 15.39 ± 24.80 18.53 ± 18.53 
GFD 24.68 ± 37.50 19.48 ± 34.37 18.50 ± 28.76 
IL-15 
GCD 12.65 ± 9.98 11.49 ± 9.22 12.04 ± 9.74 
GFD 15.17 ± 11.94 14.78 ± 13.94 12.56 ± 8.93 
TNFa 
GCD 7.77 ± 2.59 7.47 ± 1.77 8.61 ± 1.74 
GFD 10.30 ± 4.88 9.21 ± 3.01 9.26 ± 2.78 
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double-blind, placebo-controlled, crossover study found no effect of a 7-day GFD on exercise 
performance. We also found no difference in GI symptoms, overall wellbeing, markers of GI 
injury or systemic inflammation.  
A recent review by Halson and Martin summarized the “belief effect” which suggests the belief 
in an intervention can contribute a 1 to 3% improvement in performance regardless if it actually 
has ergogenic mechanisms (66). We have recently shown a current belief in the performance 
enhancing effects of gluten removal (97). Until findings of the present study, there have been 
no investigations that have determined the effect of a GFD on exercise performance. Through 
effective double-blinding, noncoeliac athletes and researchers were unable to differentiate each 
diet and TT performance was similar between trials (Figure 3.1).  Accordingly, other 
physiological parameters such as heart rate, power and cadence were not significantly different 
between diets. Given a mixed-sex cohort, the potential effects of menstrual cycle on 
performance were considered, and performance testing for female athletes was scheduled to 
avoid conflicting with early follicular or the mid-luteal phase. It is further pertinent to note that 
in undiagnosed coeliac disease or gluten-related clinical conditions, dietary gluten removal 
would potentially yield a performance benefit through exhibited improvement in biochemical 
measures and GI symptoms; however, to our knowledge, no published data yet exists to support 
this.    
Performance and training capacity can be affected by GI distress and a decrease in performance 
has also been shown as a consequence of this stress (121). No difference in GI symptoms was 
found during the performance test. Across each dietary trial, both exercise associated and daily 
GI symptoms were also similar (Figure 3.2). It has been reported that up to 70% of endurance 
athletes commonly experience GI distress during intense exercise and that many athletes 
believe gluten removal might reduce these symptoms (131). Anecdotally, a short-term GFD is 
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adopted before competition amongst some endurance athletes and many athletes follow a this 
diet intermittently (97). Short-term clinical interventions in patients with reported GI distress 
have found that in true noncoeliac gluten sensitivity symptoms triggered by gluten appear 
within a few hours to days after ingestion (13, 26, 43). Our findings do not support that gluten 
removal reduces the frequency or severity of GI symptoms daily, while training or during a 
simulated competitive TT. GI symptom severity in the present study was lower than previously 
reported during endurance competition (131). Whether a difference in GI symptoms possibly 
related to gluten would manifest with a more jarring exercise modality, such as running (131), 
or in environments that further exacerbate GI stress such as prolonged endurance exercise in 
the heat with fluid restriction, is unknown (88, 89).  
Psychological wellbeing is an additional factor that can be influenced by dietary intake and 
further effect performance and training capacity. We used the DALDA tool to monitor the 
effects that this dietary intervention had on life stress and stress-reaction associated with 
athletic performance, and no significant difference in DALDA response was found over a one-
week period (139). Although our study is the first to investigate the effects of a GFD on 
DALDA responses, previous literature has found alterations in psychological wellbeing with 
short-term dietary interventions (83). Observational data obtained from cyclists on a range of 
special diets by Burks et al. (22) summarized that 50% of respondents following a GFD 
reported increased feelings of tiredness/lethargy when deviating from this diet. A nine day 
dietary intervention of low carbohydrate during a period of intensified cycling has also been 
shown to increase mood disturbances compared to a high carbohydrate diet (83). The DALDA 
is as a sensitive tool to monitor wellbeing over a short-term dietary intervention (83) and given 
that nutritional intake for each trial in the present study was replicated, gluten does not appear 
to affect wellbeing in noncoeliac athletes.  
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Gibson & Muir (52) have suggested that gluten itself may not be the sole nutrient regulating 
factor in the reported symptom improvement with a GFD, but that the subsequent reduction in 
fructans and galactooligosaccharides  (part of the fermentable oligo-, di- and monosaccharides 
and polyols (FODMAPs) family) associated with gluten removal may be a modulating factor 
(52). Our study population was dissimilar to the clinical populations observed in the above 
research and we aimed to design a study with a high degree of ecological validity. Hence, 
dietary FODMAPs were included in the background diets of the participants, due to the fact 
that the vast majority of athletes do not comprehensively eliminate all sources of these short 
chain carbohydrates when following a GFD. Our study design also selected a short-term 
intervention to minimize the interference with training regime and alongside the evidence that 
gluten-related symptoms appear, as previously mentioned, in a matter of hours to days in 
clinical assessment of noncoeliac gluten sensitivity (47). Noncoeliac athletes GFD habits are 
shown to vary, however a large cohort (42%) only eat gluten-free 50-75% of the time and 
sometimes only 1-2 weeks before competition (97). Our data indicates that the pattern of short-
term or periodic gluten avoidance common for athletes to adopt does not influence 
performance, GI symptoms or wellbeing (97).  
Endurance athletes predictably experience GI ischemia, which is proposed as a primary 
mechanism causing GI distress during exercise. GI ischemia can ultimately give rise to a 
cascade of responsive events including epithelial injury and both GI and systemic inflammation 
(59). In the current study, a submaximal exercise pre-load known to induce GI hypoperfusion 
was used prior to a 15-minute TT to potentiate a high degree of GI stress (169). Increased 
epithelial injury also permits translocation of endotoxins across the gut barrier and into 
circulation, potentially contributing to increased systemic inflammatory responses (77, 177). 
Pre-exercise IFABP levels were within expected ranges of healthy controls and increased in 
accordance with similar exercise studies across both dietary trials during the performance test 
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(169). Increased IFABP levels are indicative of intestinal injury, known to occur under 
strenuous and acute exercise conditions. It is suggested that intestinal injury is a possible 
hindrance to training capacity, performance and recovery through adverse GI symptoms and 
decreased nutrient absorption (169). Our investigation found gut injury to be increased during 
strenuous exercise; nonetheless, gluten ingestion did not seem to augment this response before, 
throughout or at the end of a strenuous exercise bought. It is further noteworthy to postulate if 
recurrent injury, as would occur in endurance training such as in the present study (average 
training sessions per week, 13), would facilitate an environment of enhanced susceptibility to 
dietary triggers or influence markers of systemic inflammation in noncoeliac athletes.  
Systemic inflammatory responses measured were also similar between dietary interventions 
before, during and immediately after the performance test. Our data suggests that short-term 
gluten elimination in noncoeliac athletes does not influence the cytokine response around this 
specific exercise bout (Table 3.1). Interestingly, aside from inflammatory mechanisms 
associated with strenuous exercise, Soares et al. (151) found that an 8-week high-fat GFD 
attenuated inflammation associated with adiposity, reduced visceral fat and improved glucose 
homeostasis in noncoeliac rodents (151). Systemic inflammatory response patterns in both 
groups paralleled preceding literature with comparable exercise bouts (126), however it is yet 
to be determine if inflammation localized to the GI tract would be different in noncoeliac 
athletes.  
Future research with a longer duration of GFD adherence may help account for differential gut 
flora habituation, which could be influential on GI health, performance and other parameters. 
However, such outcomes may be difficult to monitor, as during a longer intervention, training 
adaptations would be likely to occur that may mask any dietary influenced performance 
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changes. Lengthier interventions are also more intrusive for the athlete, compromise dietary 
adherence, and challenge the ability to control and replicate training and food intake. 
Conclusions: In this tightly controlled study, our data suggests that a 7 day GFD does not have 
a beneficial or a negative effect on cycling performance, GI health, systemic inflammation or 
overall wellbeing in noncoeliac athletes. Based on these findings it is recommended that 
athletes seek evidence-based advice before adopting a GFD for non-clinical reasons to ensure 
that nutrition intake supports individualised and optimal fuelling for sport performance.
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Chapter 4: Food avoidance in athletes: FODMAP foods on the list  
An original version of this chapter has been published in Applied Physiology Nutrition and 
Metabolism as a short communication and appears in the literature as:  
Lis D, Ahuja KD, Stellingwerff T, Kitic CM, Fell J. Food avoidance in athletes: FODMAP 
foods on the list. Appl Physiol Nutr Metab. 2016;41(9):1002-4. 
Thompson Reuter journal impact factor: 2.2  
SJR journal ranking: Q2  
Altmetrics score: 13 
The abstract was modified slightly from the publication above to better explain the study 
findings.  
4.1 Rationale  
Adherence to a GFD is reported to improve GI symptoms. Subsequent to the avoidance of 
gluten containing foods intake of certain FODMAPs are reduced. A decrease in FODMAP 
ingestion, specifically fructans, may actually be responsible for reported symptom 
improvement, and not gluten itself. Athletes already individualize dietary regimes with the aim 
to reduce both acute and chronic GI symptoms and avoidance of high FODMAP foods is 
becoming an increasingly popular strategy. My questionnaire-based investigation described in 
Chapter 2 additionally quantified avoidance of FODMAPs and foods high in FODMAPs. This 
chapter is the first published manuscript to investigate and quantify athlete practices around 
high FODMAP food elimination with the aim to reduce GI symptoms. 
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4.2 Abstract  
We surveyed 910 athletes to assess behaviours towards self-selected food/ingredient avoidance 
to minimize gastrointestinal distress. Fifty-five percent eliminated at least one high FODMAP 
food/category, with up to 64.3% reporting symptom improvement after elimination. In athletes 
indicating that high FODMAP foods trigger GI symptoms, lactose (88.1%) was most 
frequently eliminated, followed by fructose (23.8%), galactooligosaccharides (22.4%), polyols 
(6.1%) and fructans (5.2%). Athletes avoid predominantly lactose and to a lesser extent other 
high FODMAP foods to reduce gastrointestinal distress.    
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4.3 Introduction 
Gastrointestinal (GI) distress is reported to occur in 30-50% of endurance athletes and has the 
potential to compromise training capacity and performance (39). Numerous elements can 
trigger or intensify GI symptoms during exercise including: mechanical, physiological, and 
dietary factors (39). Dietary elements including high fibre, fat and protein intakes; as well as 
concentrated carbohydrate loads, have been reported to elicit GI symptoms in triathletes (136). 
We have previously shown that 41% of athletes avoid gluten and that 81% of these athletes 
believe gluten-removal reduces GI symptoms (96). Likewise, emerging anecdotal reports 
indicate that some athletes implement various low fermentable oligosaccharides, disaccharides, 
monosaccharides and polyols (FODMAPs) dietary strategies to alleviate GI symptoms (41).  
For certain individuals, FODMAPs are poorly absorbed in the small intestine where they 
increase luminal fluid content and possibly affect gastric motility (54). Poorly absorbed, they 
subsequently transit to the colon and are rapidly fermented by colonic bacteria causing GI 
symptoms, such as, diarrhoea, luminal distension and flatulence (123); issues potentially 
negatively affecting performance.  
The aim of this brief communication is to report athlete behaviours in regards to: (1) the 
elimination of foods/ingredients that are high in FODMAPs; (2) foods/ingredients high in 
FODMAPs reported to trigger adverse GI symptoms (diarrhoea, bloating, abdominal pain, 
flatulence); and (3) perceived improvement in GI symptoms consequent to elimination of 
foods/ingredients high in FODMAPs alone or with gluten elimination.  Descriptive data 
collected from this questionnaire-based study enabled the quantification of self-reported food 
elimination, specifically high FODMAP foods, amongst athletes with GI symptoms.  
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4.4 Materials and Methods 
4.4.1 Participants 
Athletes (n=910, from recreational to Olympic medallists) were recruited to complete an online 
questionnaire as part of a larger published study examining the popularity, beliefs and 
experiences of gluten-free diets in non-coeliac athletes (97). Recruitment was international, via 
email to professional and academic networks and social media outlets. Informed consent was 
obtained through completion of the questionnaire; withdrawal was possible at any point and 
questions could be skipped.  Participation was anonymous, self-selected and excluded athletes 
clinically diagnosed with coeliac disease and under 18 years of age. Ethics approval was 
obtained from the University of Tasmania, Social Science Human Research Ethics Committee 
(H12933). 
4.4.2 Questionnaire Development 
As previously described by Lis et al. (94), the 17-item questionnaire run through the Survey 
Monkey platform from January 24th to March 2nd, 2013, addressed: (1) demographics; (2) GI 
symptoms attributed to food categories, focusing on gluten and high FODMAP foods, (lactose, 
fructose, fructans, galactooligosaccharides (GOS) and polyols); and (3) reported GI symptom 
reduction with offending food elimination. The primary aim of this questionnaire was to 
explore the popularity, perceptions and experiences of gluten-free diets in athletes, as described 
in Lis et al. (2014). A secondary aim was to gather data about athletes’ experiences and 
avoidance rates of other foods or dietary constituents that the athletes believed exacerbated 
their GI distress/symptoms. The lists of foods/categories provided were primarily high in 
FODMAPs. We also queried high fibre and fat intake, however, for the purpose of this brief 
communication we have focused on high FODMAP food categories. To avoid bias, the term 
FODMAP was not used in the survey itself. GI symptoms were described to include abdominal 
pain, bloating, cramping, flatulence and/or diarrhoea. For data handling and analysis, responses 
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pertaining to lactose sources, dairy (milk, cheese, yogurt) and lactose (milk, ice cream, custard, 
soft cheese) were amalgamated into a single lactose category as athletes may use different 
terminology to refer to the same food category. Excess fructose (apples, mango, honey) and 
fructose (applesauce, pears, agave) responses were also amalgamated to represent fructose 
categorically.  
4.4.3 Data Management and Statistical Analysis 
From the total survey population, the frequency of athletes indicating elimination of each high 
FODMAP category queried (lactose, fructose, fructans, GOS, polyols) was quantified. Figure 
4.1 shows the arrangement in which the elimination of high FODMAP food information was 
organized and quantified. The athletes eliminating high FODMAP foods were successively 
grouped into: (a) athletes that attributed at least one high FODMAP food(s) to GI symptoms 
but did not necessarily eliminate the offending food; (b) athletes that then eliminated high 
FODMAP food(s) due to adverse GI symptoms, and; (c) athletes that reported GI symptom 
improvement with removal of high FODMAP food(s). Frequency analysis (STATA version 
SE12; Statacorp LP, College Station, TX) was used to analyze the demographics, quantify high 
FODMAP food(s) elimination, identify the high FODMAP foods reported as GI symptom 
triggers and subsequent GI symptom improvement with removal. These analyses were 
conducted in the same manner on those athletes that avoided gluten alongside high FODMAP 
food(s); Figure 4.1). 	
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Figure 4.1 – Organization and quantification of FODMAP and gluten analysis. 
The left branch shows the frequency individual high FODMAP food or category elimination 
attributed to GI symptoms and the reported frequency of symptom improvement subsequent to 
removal. The right branch shows the frequency of individuals that attribute at least one high 
FODMAP food or category plus gluten to GI symptoms.  
*Athletes that avoid at least one high FODMAP food or food category of total questionnaire 
population. 
a Athletes that attribute at least one high FODMAP food or food category to GI symptoms. 
b Athletes that eliminate at least one high FODMAP food or food category due to GI symptoms. 
c Athletes that report GI symptom improvement subsequent to elimination of at least one high 
FODMAP food or food category due to GI symptoms.  
Unsure=not removed long enough to determine change in GI symptoms. 
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Supplementary figure S1. Organization and quantification of FODMAP and gluten analysis 
The left branch shows the frequency individual high FODMAP food or category elimination 
attributed to GI symptoms and the reported frequency of sy ptom improvement subsequent to 
removal. The right branch shows the frequency of individuals that attribute at least one high 
FODMAP food or category plus gluten to GI symptoms.  
*Athletes that avoid at least one high FODMAP food or food category of total questionnaire 
population. 
a Athletes that attribute at least one high FODMAP food or food category to GI symptoms. 
b Athletes that eliminate at least one high FODMAP food or food category due to GI symptoms. 
c Athletes that report GI symptom improvement subsequent to elimination of at least one high 
FODMAP food or food category due to GI symptoms.  
Unsure=not removed long enough to determine change in GI symptoms 
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4.5 Results  
4.5.1 Study Participants and Demographics  
Demographic information including age, sport-category and competitive level are shown in 
Table 4.1.  Nine hundred and twenty-four athletes completed the survey. Fourteen athletes 
were removed due to not meeting the inclusion criteria (coeliac disease (n=5) or under 18 years 
of age (n=9). Analysis was conducted on 910 athletes (female=528, male=377, no sex 
selected=5), between the ages of 18 to over 50 years, from a broad-range of sports and 
competitive levels, including 47 World and Olympic medallists. Fifty-five percent (n=501) 
reported avoidance of least one food that can be categorized as high FODMAP. Of this group 
64.7% (n=324) were female and 35.1% (n=176) were male (no sex selected, n=1). Of the entire 
athlete questionnaire population lactose was the high FODMAP food category (44.2%, n=402 
of 910) most frequently attributed to lactose-related GI issues. Subsequent elimination of 
lactose-containing foods was reported by 35.1% (n=319 of 910) of the questionnaire 
population.  
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Recreational=train but not regularly competitive; recreational competitive=train and race 
semi-regularly.  
4.5.2 GI symptoms attributed to high FODMAP foods and high FODMAP foods plus gluten 
Ninety-three percent (92.8%, n=465 of 501) attributed at least one high FODMAP food or 
category to be linked to negative GI symptoms. The remaining (n=36) indicated that the same 
foods that are high FODMAP foods triggered other symptoms, such as, skin conditions or 
 Athletes eliminating at least 1 high FODMAP 
food or FODMAP category due to GI symptoms 
 n=465 % of n=465  % of n=910 
Sex   
Male 161 34.6% 19.3% 
Female 303 65.2.7% 35.6% 
Age   
18-24 138 29.7% 15.2% 
25-30 123 26.5% 13.5% 
31-40 113 24.3% 12.4% 
41-50 61 13.1% 6.7% 
>50 20 4.3% 2.2% 
Sport category   
Endurance 309 66.5% 34.0% 
Power 35 7.5% 3.8% 
Skill 11 2.4% 1.2% 
Swim/rowing 29 6.2% 3.2% 
Intermittent 56 12.0% 6.2% 
Weight classified/ Aesthetic 7 1.5% 0.8% 
Winter 9 1.9% 1.0% 
Fitness 9 1.9% 1.0% 
Competitive Level 
Recreational  122 26.2% 13.4% 
Recreational competitive 111 23.9% 12.2% 
Provincial/state 45 9.7% 4.9% 
National 84 18.1% 9.2% 
International 38 8.2% 4.2% 
World/Olympic qualifier 29 6.2% 3.2% 
World/Olympic medallist 29 6.2% 3.2% 
Professional 7 1.5% 0.8% 
Table 4.1 Demographics of athletes eliminating at least one high FODMAP food 
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fatigue, which is likely related to other food constituents concurrently present.  Of the 92.8% 
attributing high FODMAP foods to GI symptoms, lactose (86.5%, n=402 of 465) was reported 
as the largest trigger followed by GOS (23.9%, n=111 of 465), fructose (23.0%, n=107 of 465), 
fructans (6.2%, n=29 of 465) and polyols (5.4%, n=25 of 465). Gluten alongside high 
FODMAP food avoidance is shown in Figure 4.1. Lactose and gluten together were most 
frequently attributed to GI symptoms by 52.7% (n=245 of 465) of respondents eliminating at 
least one FODMAP due to GI symptoms.  
4.5.3 Removal of FODMAP the aim to improve GI symptoms  
Seventy-eight percent (n=362 of 465) of athletes eliminated at least one high FODMAP food 
or category from their diet with the intention to improve GI symptoms (Figure 4.1). Aimed at 
reducing GI symptoms lactose was the most highly eliminated (88.1%, n=319 of 362), followed 
by fructose (23.8%, n=86 of 362), GOS (22.4%, n=81 of 362), polyols (6.1%, n=22 of 362) 
and fructans (5.2%, n=19 of 362; Figure 4.2). Of the athletes eliminating at least one high 
FODMAP food/category to improve GI symptoms, 82.6% (n=299 of 362) reported symptom 
improvement (Figure 4.1). Figure 4.1 and Figure 4.2 shows the frequency of reported GI 
symptom improvement subsequent to high FODMAP food elimination. 
 
Figure 4.2 – Athletes reporting high FODMAP food category elimination attributed to GI 
symptoms (n) and subsequent symptom improvement (n); GOS=galactooligosaccharides. 
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4.6 Discussion  
This questionnaire is the first to quantify the number of athletes avoiding foods that are 
categorized as high FODMAP and to assess the subsequently reported GI symptom 
improvement. Although our results may be not be more generalizable beyond female 
endurance athletes due the over representation of this cohort, over half of the questionnaire 
population reported the elimination of at least one high FODMAP food or category with 93% 
self-reporting that these triggered adverse GI symptoms. Subsequent to high FODMAP food 
removal aimed at reducing GI symptoms, athletes reported symptom improvement rates 
ranging from 68.2% (polyols) to 83.7% (lactose; Figure 4.2). The effects of various high 
FODMAP foods or groups of foods on exercise-induced GI symptoms or in athletes on a daily 
basis have not yet been investigated.  Our study, now confirms that athletes remove sources of 
lactose, and to a lesser degree other high FODMAP foods, with the intention to improve GI 
symptoms. 	
Lactose was the most highly reported FODMAP identified as a trigger for GI symptoms with 
a correspondingly high frequency of perceived symptom improvements with its elimination 
(Figure 4.2). GI symptoms from lactose-containing foods, can be caused by lactose 
malabsorption, but can also mask the symptoms caused by other FODMAPs or cow’s milk 
protein allergy (99). Lactose plus gluten elimination were reported by 52.7% of athletes 
avoiding at least one high FODMAP food or category due to GI symptoms. This finding 
parallels a recent Australian survey that indicated wheat avoidance to be greatly correlated with 
dairy avoidance (52.9%) and predicted by sex (female) (176). Gluten avoidance and gluten-
free diets have been discussed previously by our research group (96, 97). Our dataset does not 
allow delineation of the triggering mechanism(s) of undiagnosed functional GI disorders or the 
possibility of undiagnosed coeliac disease. It is important to acknowledge that the widespread 
rates of lactose malabsorption are influenced by factors such as ethnicity, genetics, lactase 
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activity, co-ingested foods, quantity ingested, lactose fermentation pathways and complicating 
conditions (93, 105, 113). Our observational data identifies that 44.2% (n=402 of 910) of this 
athlete questionnaire population report lactose-related GI issues and subsequent lactose 
avoidance (35.1%, n=319 of 910); comparable to the general population (35%) (93).  Lactose 
elimination, as queried in our study, could range from avoidance of all lactose sources or 
limiting exclusively concentrated sources, or avoidance only prior to training. If athletes are 
eliminating lactose to reduce GI symptoms, individualized dietary strategies should be applied 
to ensure adequate calcium intake as this is of concern when eliminating lactose-containing 
foods (105).  
Other high FODMAP foods, including foods or food classifications containing fructose, GOS, 
fructans and polyols, were reported as GI symptom triggers less frequently. These rates may 
have been higher with a more comprehensive list of food examples provided within 
questionnaire (Appendix 4). Eliminating fructose containing foods due to GI symptoms was 
reported in 9.5% (n=86 of 910) of the current study population, which is much lower than the 
60% of healthy individuals reported by hydrogen breath test to malabsorb a dose of ≥40 g of 
fructose (135). The lower rates found in our data may be due to the fact that in habitual eating 
fructose is often co-ingested with other sugars, which enhances absorption (150). Fructose 
malabsorption rates calculated using breath testing techniques may report higher frequencies 
compared to symptom-based estimates as positive breath tests can occur in the absence of GI 
symptoms (150). However, fructose has garnered particular attention as consumption of high 
doses or in excess of co-ingested glucose has shown fructose to be incompletely absorbed and 
cause bloating, abdominal pain/discomfort and flatulence (135). In populations with fructose 
intolerance, adherence to a reduced fructose diet has decreased GI symptoms (80). 
Furthermore, athlete populations may consume high fructose intakes as fructose is a common 
ingredient in sports foods and fruits (e.g. ripe bananas, watermelon, apples), may be consumed 
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in elevated quantities to meet athlete energy demands, and are popular staples at race feed 
stations. Nonetheless, our results indicate that athletes report less fructose-containing food 
elimination to reduce GI symptoms when considering population-based malabsorption rates. 
For individuals restricting fructose-containing foods, strategies shown to attenuate fructose-
induced GI symptoms including eating balanced macronutrients or glucose alongside fructose 
could be implemented to increase fructose tolerance and minimize dietary restriction (135).  
Fructan-containing foods may also be of particular concern for athletes as these carbohydrates 
are commonly found in wheat products. Only 5% of fructans are digested in all individuals, 
which may augment GI symptoms during exercise. Our previous research has quantified that 
41% of non-coeliac athletes follow a gluten-free diet, and that 81% of these athletes attribute 
reduced GI symptoms to gluten removal (97), despite our intervention study finding no 
difference in GI symptoms with a gluten-free diet (96). However, available literature suggests 
that it is the reduced fructan and GOS quantity in a gluten-free diet that modulates GI symptoms 
and not gluten-itself (52, 118). It is pertinent to investigate if the generally higher fructan 
content or other constituents of wheat versus gluten-free grain products (14, 52) augment GI 
symptoms, as many sport foods are wheat-based and some athlete’s diets are heavily reliant on 
wheat-based foods to meet carbohydrate demands.  
Conclusions: This is the first study to investigate dietary habits surrounding the elimination of 
foods high in FODMAPs to reduce reported GI symptoms in recreational to Olympic and 
World-class level athletes. With the aim to decrease GI symptoms, over 50% of athletes report 
avoiding at least one high FODMAP food source or FODMAP category: predominantly lactose 
(and dairy) and fructose. Athletes’ guts are under repetitive stress and may be more susceptible 
to GI symptom triggers such as short-chain carbohydrates or the high fibre or lactose content 
inherent in some high FODMAP foods. Unnecessary dietary elimination, without appropriate 
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food substitutions, should also be carefully evaluated as inadequate nutrient and prebiotic 
intake may risk optimal fuelling and compromise healthy gut bacterial populations (62). This 
novel data provides essential underpinning evidence to support the future investigation of 
individualized approaches to investigate the effects of certain high FODMAP foods, 
predominantly lactose, in athletes with persistent exercise-induced GI symptoms.  
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Chapter 5: Case Study: Utilizing a low FODMAP diet to combat 
exercise-induced gastrointestinal symptoms  
An original version of this chapter has been published in the International Journal of Sport 
Nutrition and Exercise Metabolism as a case study and appears in the literature as: 
Lis D, Ahuja KD, Stellingwerff T, Kitic CM, Fell J. Case Study: Utilizing a low FODMAP 
diet to combat exercise-induced gastrointestinal symptoms. Int J Sport Nutr Exerc. Metab. 
2016. 26(5): 481-7. 
Thompson Reuters journal impact factor: 2.2  
SJR journal ranking: Q2   
Altmetrics score: unavailable  
5.1 Rationale 
Elimination of high FODMAP foods with the aim to reduce GI distress is a strategy already 
employed by half of the athlete population surveyed in the earlier questionnaire-based study 
(Chapter 4). Conventional sport nutrition recommendations commonly suggest that lactose 
may be problematic if ingested prior to intensive exercise. Beyond lactose, the potential role 
of FODMAPs in healthy athletes without IBS, but with exercise-induced GI injury and 
consequential symptoms is unknown. Frequently athletes implement nutrition strategies before 
the effects have been assessed scientifically. With this in mind, and the comparable 
symptomology reported in IBS patients and athletes with exercise-associated GI distress, this 
single athlete case study investigated the effects of a short-term low FODMAP diet intervention 
in a multi-sport athlete with persistent exercise-associated GI symptoms. This case study also 
purposefully established methodology for a crossover low vs high FODMAP dietary trial 
(Chapter 6).           
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5.2 Abstract                   
Purpose: Athletes employ various dietary strategies in attempts to attenuate exercise-induced 
gastrointestinal (GI) symptoms to ensure optimal performance. This case-study outlines one of 
these GI-targeted approaches via the implementation of a short-term low FODMAP 
(Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols) diet, with the 
aim to attenuate persistent running specific GI symptoms in a recreationally competitive 
multisport athlete (male, 86 kg, 57.9 ml.kg.min-1 VO2max, 10-15 hrs.week-1 training, with no 
diagnosed GI disorder). Methods: Using a single-blinded approach a habitual diet was 
compared to a 6-day low FODMAP intervention diet (81 ± 5g vs 7.2 ± 5.7g FODMAPs.day-1) 
for their effect on GI symptoms and perceptual wellbeing. Training was similar during the 
habitual and dietary intervention periods. Post-exercise (During) GI symptom ratings were 
recorded immediately following training. Daily GI symptoms and the Daily Analysis of Life 
Demands for Athletes (DALDA) were recorded at the end of each day. Results: Daily and 
During GI symptom scores (scale 0-9) ranged from 0-4 during the habitual dietary period while 
during the low FODMAP dietary period all scores were 0 (no symptoms at all). DALDA scores 
for ‘worse than normal’ ranged from 3-10 vs 0-8 in the habitual and low FODMAP dietary 
periods, respectively, indicating improvement. Conclusions: This intervention was effective 
for this GI symptom prone athlete; however, randomized-controlled trials are required to assess 
the suitability of low FODMAP diets for reducing GI distress in other symptomatic athletes. 
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5.3 Background 
Gastrointestinal (GI) symptoms are common in up to 70% of endurance athletes (38), and aside 
from mechanical, psychological and physiological triggers, several dietary factors are believed 
to influence symptoms (39). Strategies to improve GI symptoms in athletes include: lower fibre 
(low residue) or fat intake; reduced fructose load; minimizing dehydration, and; consuming 
multiple transporter carbohydrates (39). Training the gut to tolerate increased amounts of 
carbohydrate and fluids has also been shown to increase carbohydrate oxidation and may 
theoretically reduce the likelihood of GI distress (32). In some cases, regardless of the 
intervention, GI symptoms persist and novel individualized dietary approaches need to be 
employed. In the current case study, conventional interventions to reduce exercise-induced GI 
symptoms were unsuccessful.  Therefore, a dietary approach utilizing a low FODMAP 
(Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols) diet was trialed 
over 6-days (3-day lead-in and 3-days of intense running-dominant training) in an attempt to 
mitigate GI issues.  
FODMAPs, a family of short-chain carbohydrates, are in foods including wheat (fructans), 
pears (excess fructose), cow’s milk (lactose), legume beans (Galactooligosaccharides; GOS), 
and nectarines (polyols) (148). A low FODMAP diet is often implemented in clinical practice 
as a potentially efficacious treatment for irritable bowel syndrome (IBS; (54, 148).  In IBS 
patients, the malabsorption of FODMAPs increases colonic fluid and gas, which subsequently 
may trigger or amplify GI symptoms including bloating, flatulence, abdominal pain, loose stool 
or diarrhoea (152).   The GI-related symptomology experienced in individuals with IBS is 
analogous to those reported by athletes under conditions of exercise stress where splanchnic 
hypoperfusion, gut ischemia, altered motility, reduced intestinal absorption and mechanical 
factors compromise gut integrity (55, 167).  Despite some GI-adaptions in trained individuals, 
splanchnic blood flow is still reduced by up to 80% at 70% VO2max (133). Given the 
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compromised gut environment common during strenuous exercise (159), it is plausible that 
high intakes or residual presence of FODMAPs in the colon may trigger or amplify GI 
symptoms during or after exercise. This case study intervention is an attempt to assess the 
impact of a low FODMAP diet on a recreationally competitive athlete with persistent exercise-
induced GI distress. The outcome was favorable and provides an impetus for larger systematic 
research of low FODMAP diets in athletes with GI distress.   
5.4 Presentation & Assessment of Athlete  
This 31-year old recreationally competitive athlete (86 kg, 183.7 cm, 10% body fat, 57.9 
ml.kg.min-1 VO2max, training 10-15 hrs.week-1) has a history of GI distress and is currently 
training for multisport events, culminating with Ironman Melbourne 2016. Ongoing nutrition 
support by an accredited sport dietitian (lead author) revealed persistent GI symptoms during 
and after high intensity or endurance training (heart rate >155 bpm or training >60-minutes), 
primarily experienced during running. Previous screening was negative for coeliac disease (tTg 
IgG and tTg IgA antibodies) and there was no history of self-reported functional bowel 
disorders, self-diagnosed GI condition or food intolerance. Prior self-implemented 
interventions aimed at reducing GI symptoms included: avoidance of spicy foods and caffeine 
before training, and sports drink and all foods during training. He had also previously trialled 
a gluten-free diet (GFD) without success. It is not possible to quantify the fructan or GOS 
intake during that GFD period. Consequently, FODMAPs were considered as a potential 
symptom modulator (118) and investigated. 
 
Figure 5.1 – Case study intervention timeline. 
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After the collection of the screening information, an assessment of FODMAP intake via 
Complete Nutrition Assessment Questionnaire (CNAQ; Barrett & Gibson, 2010)       and 
background GI symptom questionnaire evaluation, quantifying frequency of symptoms (0 
“never” to 9 “always) was conducted (96, 130). The presence and severity of upper and lower 
abdominal symptoms were determined using a 10-point scale ranging from 0 “no problem at 
all” to 9 ‘‘the worst it has ever been”, as previously applied (96). The response from the 
background GI symptom questionnaire indicated moderate to severe (>4) upper and lower 
abdominal symptoms (Table 5.1). FODMAP intake was estimated to be 50.8 g FODMAP.day-
1 (Table 5.2), which is considered to be a high FODMAP diet (123). Based on the result of the 
background GI questionnaire and CNAQ analysis the athlete was requested to record a detailed 
habitual diet and exercise log alongside questionnaires assessing GI symptoms and perceptual 
wellbeing.  
5.4.1 Habitual Dietary Period  
The 6-day habitual diet was analysed for FODMAPs, average energy and macronutrient intake 
(FoodWorks Professional 7 Xyris, Brisbane, Australia; Table 2). During the habitual diet, GI 
symptom questionnaires were completed at the end of each day (Daily; GI symptoms occurring 
outside of exercise) and also immediately post-exercise (During; GI symptom occurring during 
exercise). Information about life stressors and symptoms of stress were also collected daily 
using the Daily Analysis of Life Demands in Athletes (DALDA) over a range of training 
sessions, including cycling, swimming, and various running intensities/durations. DALDA 
requires participants to rate each variable as “worse than normal,” “normal,” and “better than 
normal” and is a pragmatic tool to evaluate stress and stress response (139). 
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Table 5.1 Baseline, Daily and During GI symptoms scores for running training days  
*Day 4,5 and 6 of the habitual and Low FODMAP dietary periods 
  GI symptom scores >4 are considered moderate to severe. 
5.4.2 Low FODMAP Intervention  
To minimize potential bias of reported GI symptoms, the athlete was blinded to the 
intervention. This was achieved by informing the athlete that ‘specific carbohydrates’ would 
be modified in the intervention period but that the intervention may worsen, improve or have 
no effect on symptoms. This dietary intervention period took place the week following the 
Section Symptom Background (Baseline) Habitual  Low FODMAP 
Daily        Min         
Max 
 Min      Max 
Upper       
Reflux/Heartburn 2 1 2  0 0 
Belching 2 1 2  0 0 
Bloating 4 1 3  0 0 
Upper abdominal cramp 4 0 1  0 0 
Vomiting 0 0 0  0 0 
Nausea 0 0 0  0 0 
Lower       
Lower abdominal cramp 4 1 3  0 0 
Side stitch 2 0 2  0 0 
Flatulence 7 3 4  0 0 
Urge to defecate 5 0 3  0 0 
Diarrhoea 5 0 0  0 0 
Intestinal bleeding 0 0 0  0 0 
During Exercise       
Upper       
Reflux/Heartburn  0 2  0 0 
Belching  0 2  0 0 
Bloating  0 0  0 0 
Upper abdominal cramp  0 0  0 0 
Vomiting  0 0  0 0 
Nausea  0 0  0 0 
Lower       
Lower abdominal cramp  0 3  0 0 
Side stitch  0 3  0 0 
Flatulence  0 4  0 0 
Urge to defecate  0 3  0 0 
Diarrhoea  0 3  0 0 
Intestinal bleeding  0 0  0 0 
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habitual dietary period on identical days of the week with similar training loads (Tuesday-
Sunday).  
Nutritional intervention consisted of a detailed meal plan that replicate the foods, nutrient 
profile and fluids taken during the habitual period, but exchanged high FODMAP foods for 
alternative foods low or void of FODMAPs. For example, habitual breakfast consisted of dried 
fruit and nut muesli with cow’s milk yogurt and milk. The intervention low FODMAP 
breakfast included low FODMAP muesli, consisting of a small quantity of oats, seeds, puffed 
rice mixed with lactose-free yogurt and milk. 
Training was also replicated throughout both dietary phases to ensure the stress placed on the 
gut was consistent. Training was monitored and closely replicated using Garmin Connect and 
included: swim 60-minutes (Tuesday); cycle 60-minutes (Wednesday); rest (Thursday); run 
intervals 70-minutes (Friday); cycle 180-minutes and steady state run 65-minutes (Saturday) 
and; run intervals 65-minutes (Sunday). Three days of a low FODMAP diet leading into the 
first of three running-focused training days was chosen with the goal to transit any residual 
FODMAPs through the gut before the first strenuous running day (Friday). Dietary and 
exercise log, GI symptoms and DALDA questionnaires were recorded and analysed in the same 
manner as the habitual dietary period.  
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Table 5.2 Composition of dietary intake during the habitual and low FODMAP dietary periods 
Dietary Component CNAQ 
Background 
macronutrient and 
FODMAP intake 
Habitual Low 
FODMAP 
Total energy (kcal) 2456 2586 ± 416 2527 ± 407 
Total carbohydrate (g) 242  295 ± 68 303 ± 69 
Total protein (g) 119 136 ± 9 132 ± 24 
Fat (g) 93 88 ± 22 85 ± 28 
Fibre (g) 25.9 34 ± 9 33 ± 6 
Total FODMAPs (g) 50.8 81.0 ± 5.0 7.2 ± 5.7 
Fructose (g) 23.5 20.9 ± 7.9 8.8 ± 4.0 
Excess fructose (g) 3.4  0.5 ± 0.6 0.3 ± 0.1 
Lactose (g) 42 70.3 ± 3.1 0.5 ± 0.7 
Total oligosaccharides (g) 3 7.1 ± 3.9 6.2 ± 6.0 
Fructooligosaccarides (g) 1.6 6.5 ± 4.0 5.9 ± 5.7 
Galactooligosaccarides (g) 1.2 0.6 ± 0.2 0.3 ± 0.5 
Raffinose (g) 0.3 0.4 ± 0.2 0.3 ± 0.5 
Stachylose (g)  0.9 0.2 ± 0.1 0.1 ± 0.1 
Total Polyols (g) 2.6 3.1 ± 2.2 0.2 ± 0.4 
Sorbitol (g) 1 0.3 ± 0.2 0.2 ± 0.3 
Mannitol (g) 1.6 2.7 ± 2.1 0.0 ± 0.1 
Dietary macronutrients and fibre were calculated using FoodWorks dietary software, which is 
based on the Australian Food Composition tables. Total FODMAPs = excess fructose + lactose 
+ sorbitol + mannitol + fructans + galactooligosaccharides (GOS). All values are represented 
as mean (SD) for the two 6-day dietary periods (habitual and low FODMAP intervention).  
Bold text indicates additive constituents for total FODMAPs.   
5.5 Outcomes  
5.5.1 Nutrient & FODMAP Intake  
Daily food intake was effectively replicated from the habitual dietary record with the only 
meaningful variance being in FODMAP foods (Table 5.2). FODMAP intake during the habitual 
diet was 81.0 ± 5.0 g FODMAPs.day-1 while the intervention diet provided 7.2 ± 5.7g 
FODMAPs.day-1. 
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5.5.2 GI symptoms (Background, Daily & During exercise) & DALDA 
Table 5.1 shows individual minimum and maximum symptoms scores reported for Daily and 
During GI symptoms for days 4, 5 and 6; the days when strenuous running training sessions 
were completed and GI symptoms were more severe. Compared to the habitual diet, the Daily 
GI symptoms severity scores were lower on the low FODMAP diet (0-4 during vs 0; no 
symptoms at all); indicating a measureable improvement (Table 5.1). Similar improvement 
was observed for the During GI symptom severity scores (0-4 during the habitual diet vs 0; no 
symptoms at all during the low FODMAP diet). DALDA scores of “worse than normal” ranged 
from 3-10 (average 6.1) during the habitual diet compared to 0-8 (average 3.7) during the low 
FODMAP diet. The cumulative GI symptoms scores for Daily and During (Figure 5.2) further 
show that total symptoms scores were higher each day of the habitual diet than on the low 
FODAMP diet. This illustrates higher Daily and During GI symptoms throughout the habitual 
diet on intensified running days. However, on day 6, During GI symptoms scores were zero 
for the habitual diet. This may have been the result of the self-selected breakfast (eggs, milk, 
banana) on the day-6 (pre-exercise meal) being lower in fructan and lactose content compared 
to his usual breakfast (muesli, milk and yogurt). It is plausible that the lowered FODMAP 
quantity in breakfast on day-6 contributed to the absence of During GI symptoms in the 
habitual period. Although during the habitual dietary period GI symptoms scores were 
predominantly minor, the athlete, blinded to the intervention, verbally confirmed an 
improvement in symptoms supported by his statement; “symptoms were remarkably better 
compared to habitual period and were basically non-existent during exercise or during the day 
throughout the intervention period.”  
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Figure 5.2 – Cumulative Daily GI symptoms scores; HAB=habitual, LFOD=low FODMAP.  
5.6 Reflections 
Many endurance athletes who struggle with persistent exercise-induced GI distress fail to 
resolve these potentially debilitating symptoms through commonly recommended dietary 
approaches. Although a subjective measure, GI symptoms have the potential to negatively 
impact performance (77) and thus it may be important to assess even lower severity symptoms 
(<3), particularly at the elite level where very small changes can have important performance 
impacts (71). Athletes and some practitioners believe that interventions such as low-residue or 
GFDs will improve GI issues (39, 97). GFDs are naturally low in fructan and GOS, and may 
actually be the modulating factors in reported symptom improvement and not gluten itself (52). 
However, the athlete in this case study indicated no improvement with a previous GFD. Instead 
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the results suggest a low FODMAP intervention as a potentially novel approach to improve GI 
symptoms occurring with strenuous exercise, where the gut is compromised (167).  
Through this case study, we are unable to identify whether an individual FODMAP or a 
combination of foods rich in FODMAPs were responsible for the GI distress reported by the 
athlete during the habitual diet.  The habitual diet was extremely high in lactose and lactose 
may be a primary trigger, however, the athlete had not reported lactose intolerance.  In an 
athletic population it is important to note that lactose intakes may be greater than the general 
population (8, 64) due to heavy dependence on dairy as a source of high quality protein and to 
replace sweat calcium loses (60). Reliance on dairy protein has also been shown to support an 
increase or maintenance of lean body mass and support bone collagen formation during period 
of energy restriction (81) which many endurance athletes engage in to improve power to weight 
ratio. In conjunction with a short-term low FODMAP diet before races or key running training 
sessions, self-administration of low doses of lactose containing foods (e.g. ½ cup of cow’s 
milk) were subsequently recommended assess tolerance.  
Several factors should be considered with the implementation of a low FODMAP dietary 
approach in athletes pertaining to assessment, counselling strategies and execution of the diet. 
Counselling strategies that curtail a “placebo effect” are integral to measuring real symptom 
change and the magnitude of change verses the influence of the belief in an intervention (10). 
Prior to implementing a low FODMAP diet, integration of appropriate dietetic and medical 
practitioners is imperative, particularly with severe or persistent cases of GI distress, to rule 
out functional GI disorders and other triggers (e.g. nutritional, physiological or psychological). 
Similarly, a low FODMAP diet for athletes should be administered by a dietitian experienced 
in sport nutrition and low FODMAP diet administration. This intervention is also best tested 
in the off-season and trialled under conditions where symptoms occur. For athletes that respond 
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positivity to a low FODMAP diet the intervention length should be minimized to reduce 
unnecessary dietary restriction. Food choice is key to the successful implementation of low 
FODMAPs diet as it has the potential to be lower in prebiotics, which may influence the 
microbiome composition (174). Limited research regarding the nutritional adequacy of a low 
FODMAP diet and long-term effects raises concern surrounding the nutritional suitability of 
this diet, especially for athletes, if appropriate variety and quantity is not integrated (153). An 
objective of the intervention should also include identifying, via strategic re-introduction of 
foods, specific high FODMAP foods that trigger symptoms, as not all FODMAPs may be 
culprits. Therefore, our recommendation to the athlete was to follow a low FODMAP diet 2 to 
3 days before events or critical training sessions to alleviate symptoms, namely; bloating, 
intestinal cramps, flatulence, urge to defecate.  
Psychological stresses also conceivably influence GI symptoms and were therefore 
additionally monitored. DALDA responses of ‘worse than normal’ were higher during the 
habitual dietary period alongside more severe GI symptoms compared to the low FODMAP 
period, plausibly indicating a perceived reduction in gut distress. Several studies have found 
unique gut-brain axis relations associating psychological stress with increased GI disorders and 
symptoms (12, 84, 158). The reverse may also occur, as psychological stress levels are likely 
to increase with GI symptoms, especially in competitive situations. Therefore, monitoring 
stress triggers and stress response should correspondingly be part of an athlete nutrition plan 
relating to GI distress.     
Overall, a reduced FODMAP diet led to a successful resolution of GI symptoms that were 
predominantly triggered during running for the athlete. These results provide a foundation and 
practical approach to initiate extended research investigating the effects of FODMAPs in 
athletes with persistent exercise-induced GI symptoms.  
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Chapter 6: A preliminary study of FODMAP modulation as a novel 
strategy to reduce gastrointestinal distress in athletes 
6.1 Rationale 
Measurable GI symptom improvements reported in the low FODMAP case study intervention 
(Chapter 5), alongside the quantification of FODMAP elimination among athletes (Chapter 4), 
underpin the rationale for an intervention study assessing the effects of this diet in a larger 
athlete cohort with GI distress. As a preliminary investigation of the efficacy of a low 
FODMAP diet in healthy athletes with GI distress a single-blinded randomized, crossover 
dietary intervention of a high versus low FODMAP diet was executed. In this study, healthy 
runners with self-reported GI distress adhered to either a low or high FODMAP diet in a single-
blinded crossover design. While controlling and replicating diet and exercise, GI symptoms 
and psychological wellbeing were evaluated. As a preliminary yet foundational study, the 
results suggest FODMAP modification may be a promising sport nutrition strategy to reduce 
GI symptoms in some athletes. This chapter has been submitted and is under review.  
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6.2 Abstract  
Purpose: Gastrointestinal (GI) distress in endurance athletes is prevalent and detrimental to 
performance. Adverse GI symptomatology can be analogous with irritable bowel syndrome, 
where fermentable oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) 
reduction has demonstrated efficacy. This study investigated a low FODMAP (LFOD) diet on 
GI distress parameters in runners with a history of non-clinical exercise-associated GI 
symptoms. Methods: Eleven recreationally competitive runners (5 males, 6 females; 5km 
personal best 23:00±4:02 min:sec) participated in the study. Runners were allocated to a 
randomized 6-day LFOD or high FODMAP (HFOD) diet separated by a 1-day wash-out in a 
controlled, single-blinded crossover study. In each period participants completed strenuous 
running sessions consisting of 5x1000m interval (day 4) and a 7km threshold run (day 5). GI 
symptoms (during-exercise and daily) and the Daily Analysis of Life Demand for Athletes 
(DALDA) questionnaires were completed. Area under the curve (AUC) was calculated for 
daily GI symptoms across each dietary period and analysis was conducted using multilevel 
mixed-effects linear regression for comparison between the two diets. Results: A significantly 
smaller AUC for daily GI symptoms.6-days-1 during the LFOD compared to HFOD (mean 
difference -13.4, 95% CI [-22, -4.60], P=0.003) was observed. The specific GI symptoms 
significantly lower during LFOD were flatulence (P<0.001), urge to defecate (P=0.04), loose 
stool (P=0.03) and diarrhoea (P=0.004). No significant differences in during exercise 
symptoms or DALDA responses were observed between diets (P>0.05).  Conclusion: 
Preliminary findings suggest that short-term FODMAP reduction may be an intervention to 
minimize daily GI symptoms in runners with exercise-related GI distress.  
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6.3 Introduction 
Optimal athletic performance can be directly compromised by gastrointestinal (GI) 
dysfunction. High rates of GI distress are reported to occur in 30-50% of endurance athletes 
(39, 52). Although most symptoms occurring are mild to moderate, severe symptoms may 
impair training capacity and performance (39). During strenuous exercise GI symptoms are 
triggered in part by significant splanchnic hypoperfusion, as blood is shunted away from the 
GI tract towards the working muscles, which instigates acute enterocyte injury, increased 
intestinal permeability and altered motility (167). Symptoms associated with exercise-induced 
GI distress are numerous, but many are analogous with clinical indications associated with 
irritable bowel syndrome (IBS) (55, 148, 167). In particular, lower abdominal symptoms such 
as diarrhoea, bloating, abdominal pain and flatulence share remarkable similarities in both 
conditions. Interestingly, fermentable oligosaccharides, disaccharides, monosaccharides and 
polyols (FODMAP) restriction has been emerging as an efficacious treatment for IBS 
symptoms (34, 54, 148).  Therefore, it is plausible that FODMAP manipulation may also 
positively affect exercise-associated GI symptoms (64, 152). 
Nutritionists and athletes employ various dietary strategies to reduce exercise-associated GI 
distress, including limiting dietary fibre and lactose, eating low-residue foods around 
competition, training the gut to tolerate larger carbohydrate loads or removing gluten (35, 37). 
A gluten-free diet has become a popular regimen to supposedly alleviate exercise-associated 
in noncoeliac athletes (98) and IBS-related GI symptoms (16) although negligible peer-
reviewed evidence exists supporting these anecdotal claims (98).  Conversely, data in non-
athlete clinical populations propose that GI symptom improvement associated with gluten 
elimination may actually be modulated by the subsequent reduction in FODMAP content that 
generally accompanies a gluten-free diet, and not necessarily gluten elimination itself (52, 
118). A low FODMAP diet is predicted to be the next popular equivalent to the gluten-free diet 
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(41).  
FODMAPs are poorly absorbed short chain carbohydrates that have been shown to increase 
osmotic load in the small intestine and colonic gas volume, which instigates adverse symptoms 
in hypersensitive individuals (152). Examples of foods restricted with a low FODMAP diet 
include: lactose-containing products such as cow’s milk, a range of fruit high in fructose, 
wheat-based products, onions and garlic encompassing fructans and galactooligosaccharides, 
and fruits with stones (pits) or confectionary with naturally occurring or added polyols. In 
Western diets up to 40 g of undigested carbohydrates reach the colon daily  including an 
average of 1-10 g.day-1 of inulin and oligofructans (166). In sensitive individuals, FODMAPs 
can cause adverse GI symptoms. FODMAPs are also important dietary constituents offering 
favourable prebiotic effects such as acting as a substrate for beneficial microbial populations, 
increasing stool bulk, enhancing micronutrient absorption and immune function (104), so 
unnecessary restriction is not advocated. To date, studies suggest that healthy individuals 
without IBS would not  benefit from restricting FODMAP intake (64, 123)  and a prolonged 
strict low FODMAP diet does not appear to be a common practise amongst athletes (95). 
However, in athletes looking to reduce GI symptoms self-reported data indicates that over half 
eliminate high FODMAP foods, without necessarily realizing that these foods were considered 
part of the FODMAP family (95). Up to 88% of these athletes report subsequent symptom 
improvement (95). Therefore, it is plausible that the physiological mechanisms and symptoms 
associated with exercise-associated GI injury increase sensitivity to all, or some FODMAPs, 
and it is relevant to consider if symptoms could be reduced with FODMAP restriction in 
endurance athletes.  
We have recently published a case study showing positive outcomes of a low FODMAP dietary 
intervention in a multisport athlete (94). Based on these results, and encouraging clinical 
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research on low FODMAP diets (152), it is imperative that the manipulation of short-chain 
carbohydrate be investigated as a novel tool for individualized dietary management aimed at 
attenuating GI distress in a group of healthy athletes. Hence, the aim of this preliminary study 
was to examine the effect of a low FODMAP versus a high FODMAP diet on symptoms of 
self-reported GI distress and perceived wellbeing in recreationally competitive runners with a 
history of GI symptoms. Our a priori hypothesis was that a short-term low FODMAP diet 
would reduce the severity of GI symptoms appearing daily and during strenuous running 
sessions.   
6.4 Methods 
6.4.1 Participants 
Eleven recreational competitive runners (>25 km running per week) aged 18-50 years with 
self-reported persistent exercise-associated GI symptoms were invited to participate in this 
study. Inclusion criteria included: a minimum of three chronic GI symptoms (e.g. nausea, 
bloating, diarrhoea) with score greater than 4 (quite often) on the background GI questionnaire 
(131), a habitual high FODMAP intake of ≥20 g FODMAP.day-1 (62) as assessed with the 
Complete Nutrition Assessment Questionnaire (CNAQ; http://www.cnaq.com.au/) (8) and the 
capacity to complete two consecutive days of prescribed strenuous running training during the 
study. Exclusion criteria included: a history of food intolerance (e.g. diagnosed lactose 
intolerance), known coeliac disease or known familial history of coeliac disease, clinically 
diagnosed noncoeliac gluten sensitivity or IBS, current adherence to any special diet, or any 
pre-existing medical condition that could be affected by dietary intervention. Ethics approval 
was obtained from the Tasmanian Health and Medical Human Research Ethics Committee 
(H0015151). All participants provided signed informed consent. 
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6.4.2 Experimental Design  
Utilizing a single-blind, crossover design participants were randomized to receive either a high 
FODMAP (HFOD) or a low FODMAP (LFOD) diet for 6-days, separated by a 1-day washout 
(28), followed by the alternative diet (Figure 6.1). Randomization was generated using 
GraphPad QuickCals software. Participants were informed that they would be assigned 
“Specific Carbohydrate Diet A or B” for the first dietary period then the alternate diet for the 
subsequent dietary period, with no specific reference to FODMAPs or gluten.  Participants 
self-selected their training schedule based on study guidelines (see details below). All training 
was replicated during the subsequent dietary period. Participants were asked to record their 
daily exercise, food intake and complete a post-exercise GI questionnaire, daily GI 
questionnaire and Daily Analysis of Life Demands (DALDA) questionnaire each day 
throughout the two dietary periods. 
 
Figure 6.1 Schematic showing participant selection and study design. LFOD=Low FODMAP diet, 
HFOD=High FODMAP diet, GI=gastrointestinal, DALDA=Daily Analysis of Life Demands for 
Athletes. 
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Food Preparation & Provision: Participants were provided with pre-made frozen lunch and 
dinner meals (prepared, weighed and frozen in a commercial kitchen; Matson’s Catering, 
Launceston, Australia), breakfast (cereals, breads, milk, yoghurt) and snack foods (muesli bars, 
crackers).  As the study participants were blinded, all food was packaged in the same opaque 
containers and labelled according to each dietary period (e.g. week-1 muesli bars, day-2 lunch). 
Alongside the controlled study food provisions, the participants were able to self-select from a 
suggested list (of choose and avoid) and supplement the study food with fresh fruits, vegetables 
and nuts with the stipulation that a counterpart substitution be exchanged in the second dietary 
period. A registered dietitian (lead researcher) provided dietary education to participants on 
nutrition intake recording and appropriate food selections.  LFOD and HFOD meals were 
established based on previous research (123), Monash University’s low FODMAP diet 
resources (http://www.med.monash.edu/cecs/gastro/fodmap/) and typical athlete diets (21). 
Recipes for LFOD and HFOD were similar, but ingredients modified to alter the FODMAP 
content (Table 6.1). Meals were matched for content of total energy, protein, carbohydrate, fat 
and fibre; however, resistant starch information was not available due to the absence of 
comprehensive resistant starch food composition tables. Each meal was analysed for FODMAP 
content using a FODMAP specific database (FoodWorks Professional 7, Xyris, Brisbane, 
Australia) to ensure that LFOD meals contained less <0.5 g FODMAP.meal-1 (63). An example 
of the study meals for each diet are provided in Table 6.1. The prototype study menu presented 
a macronutrient profile containing carbohydrate 5-7 g.kg-1, protein 1.2-1.7 g.kg-1 and fat 0.8-
1.2  g.kg-1 (107) (FoodWorks Professional 7, Xyris, Brisbane, Australia).  
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Table 6.1 Example of high and low FODMAP diets  
a low FODMAP muesli made with rice crispies, corn flakes, quinoa flakes, shredded coconut, 
and pumpkin seeds  
b low FODMAP pesto pasta made with: cherry tomatoes, eggplant, garlic infused oil, pine nuts, 
basil, parsley  
c high FODMAP pesto pasta made with: cauliflower, asparagus, pistachios nuts, basil, parsley, 
garlic 
d low FODMAP vegetables included: small portion sweet potato, red bell pepper, spinach 
e high FODMAP vegetables included: larger portion of sweet potato, beetroot, garlic, red onion 
 
Exercise and Prescribed Running: Participants self-selected their training schedule based on 
study guidelines which indicated: day 1 and 2 to be light to moderate intensity training, day 3 
to be rest or very light non-running exercise (e.g. yoga, swimming). Day 4 and 5 were 
prescribed very intense running sessions and day 6 was entirely self-selected exercise or rest. 
Day 4 (interval session) consisted of a 10-minute self-prescribed warm up with increasing 
intensity, 5 x 1000 m interval pace (100% of predicted vVO2max) with 3-minute brisk walk or 
Meal Low FODMAP diet High FODMAP diet 
Breakfast low FODMAP mueslia 
lactose-free milk 
blueberries 
coffee/tea with lactose-free milk 
muesli with dried fruit and nuts 
milk 
apple 
coffee/tea with milk 
Snack corn Cruskits 
lactose-free yogurt 
grapes 
rye Cruskits 
yogurt 
nectarine 
Lunch maple glazed salmon on quinoa/rice 
pesto pastab 
honey glazed salmon on durum 
wheat pest pastac 
Snack gluten-free biscuits 
cheddar cheese 
tomato, cucumber 
wheat biscuits 
cheddar cheese 
snap peas, cucumber 
Dinner   grilled chicken and vegetables on 
quinoad 
grilled chicken and vegetables on 
couscouse 
Snack lactose-free yogurt 
strawberries 
coffee/tea with lactose-free milk 
yogurt 
cantaloupe 
coffee/tea with milk 
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light jog between intervals followed by a 10-minute self-selected cool down. Day 5 (threshold 
session) consisted of a 7 to 10-minute self-selected warm up with increasing intensity, 7 km at 
threshold pace (~90% of predicted vVO2max) followed by a 10-minute self-selected cool down. 
Prescribed running sessions were individually monitored using participants’ personal Garmin 
GPS running watches (Forerunner® 735XT, 630XT, 235 or 910XT) and all training was 
replicated in the second intervention period. Interval and threshold paces were individually 
prescribed based on calculations from a recent race performance using VDOT (velocity at 
vVO2max) tables (33). Running sessions were completed on flat terrain, at the same time of day 
(±30 min) over the period of data collection (December 2015 to February 2016).  
Gastrointestinal Symptom Monitoring: During-exercise GI questionnaires and daily GI 
questionnaires were used to assess the occurrence and severity of upper and lower abdominal 
symptoms determined using a 10-point scale ranging from 0 “no problem at all” to 9 ‘‘the worst 
it has ever been” (131). Section 1 of the questionnaire addresses upper abdominal symptoms: 
reflux, heartburn, burping, bloating, stomach pain/cramps, vomiting and nausea. Section 2 
addresses lower abdominal symptoms: flatulence, urge to defecate, left abdominal pain (side 
stitch), right abdominal pain (side stitch), loose stool, diarrhoea and intestinal bleeding (131). 
Participants completed the during-exercise GI questionnaire immediately following their 
training session and the daily GI questionnaire at the end of each day at the same time. GI 
symptom scores were tabulated for each day and exercise session (131). Mean scores for daily 
GI symptoms, during-exercise GI symptoms, and incremental area under the curve (AUC) for 
daily GI symptoms across all 6-days of each dietary period were compared between the diets.  
 
Perceptual Wellbeing Monitoring: Participants completed the DALDA questionnaire at the 
end of each day.  This questionnaire is used to assess general stress levels (Part A) and to 
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determine stress-reaction symptoms (Part B) (139) using a rating scheme of “worse than 
normal,” “normal,” or “better than normal”  for variables. Scores were tabulated and the “worse 
than normal” and “better than normal” scores compared between the two dietary periods.  
6.4.3 Statistical Analysis 
All GI symptoms and DALDA scores and dietary variables were treated as continuous data 
(129)and compared between the two diets using multilevel mixed-effects repeated measure 
linear regression adjusted for order and period effects (Stata 13.0, StataCorp LP, College 
Station, TX). Regression residuals were tested for assumptions of linear regression 
(heteroscedasticity, skewness, kurtosis or linearity). Where regression residuals did not meet 
the assumptions of linear regression the analyses were repeated with multilevel mixed-effects 
ordered logistic regression. For consistency, all comparison results are presented as mean 
difference (95% Confidence Interval). For each dietary intake variable, the mean±SD was 
calculated and compared between the diets using mixed-effects ordered logistic regression.  P 
values (P<0.05) are from the relevant analyses (linear regression or ordered logistics regression 
in case of violation of linear regression assumptions). Incremental AUC, above zero, for daily 
GI symptoms was calculated from total daily GI symptom scores over each 6-day diet 
(GraphPad Prism, version 6.0, San Diego, CA) and compared between the two diets.  
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6.4 Results 
6.4.1 Participants details and compliance 
Dietary intake (Table 6.2), GI symptom assessment (Figure 6.2) and DALDA results were 
available for 11 of 12 participants (5 males, 6 females, 41±10 years, weight 69.0±12.0 kg, 
height 171.1±10.0 cm, 5 km personal best 23:00±04:02 min:sec). One participant was removed 
due to incomplete data. Background GI symptoms, primarily boating, flatulence, urge to 
defecate and loose stool were predominant and were reported to occur quite often to always 
(score of ≥4 to 9). Total habitual FODMAP intake was 43.8±16.9 g FODMAPs.day-1. The 
prescribed running sessions were completed as assigned, and exercise volume matched in each 
period (HFOD total exercise volume 50:12:43 hh:min:sec, 0:56:51±0:25:33 daily mean±SD; 
LFOD 50:36:42, 0:57:18±0:23:55) with no significant differences in temperature (16.2±5.2 vs 
15.7±4.9°C) or humidity (64.0±14.9 vs 55.3±19.6%) for the LFOD or HFOD dietary periods, 
respectively. No order or period effects were found for total daily GI symptoms, during-
exercise GI symptoms or DALDA on any of analysed variables except for loose stool (mean 
difference -0.35, 95% CI [-0.79, -0.01], P=0.03).  
All participants consumed the prescribed diets and dietary intake was analysed from food 
intake records for HFOD and LFOD. The composition of the diets is shown in Table 6.2. The 
two test diets were similarly matched for total energy, carbohydrate, and fibre. Protein and fat 
were statistically different between the diets (P=0.03 and P=0.003, respectively). These 
differences are of negligible clinical significance given the 5g protein and 7g fat daily 
variances. As designed, FODMAP intake differed significantly between the two diets being 
41.4±7.9 g.day-1 HFOD and 8.1±3.5 g.day-1 LFOD (P<0.0001).  
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Table 6.2 Composition of dietary intake during the habitual and low FODMAP dietary periods 
Dietary Component HFOD LFOD P value 
Total energy (kcal) 3181 ± 403 3198 ±429   0.724 
Total carbohydrate (g) 323 ± 63 327 ± 67   0.569 
Total protein (g) 158 ± 16 153 ± 20    0.030* 
Fat (g) 130 ± 12 137 ± 15    0.003* 
Fibre (g) 32 ± 5 30 ± 5   0.318 
Total FODMAPs (g) 41.4 ± 7.9   8.1 ± 3.5 <0.0001* 
Excess fructose (g)     1.9 ± 0.54   0.5 ± 0.4 <0.0001* 
Lactose (g) 28.0 ± 8.6   0.9 ± 0.3 <0.0001* 
Total oligosaccharides (g)  8.7 ± 1.9           5.5 ± 3.2 0.001* 
Fructooligosaccarides (g) 7.3 ± 1.8 4.5 ± 2.7 <0.001* 
Galactooligosaccarides (g) 1.4 ± 0.3 1.0 ± 0.5 0.006* 
Total Polyols (g) 2.9 ± 0.9 1.3 ± 0.7 <0.0001* 
Sorbitol (g) 1.8 ± 0.9 0.9 ± 0.4 0.001* 
Mannitol (g) 1.1 ± 0.3 0.4 ± 0.5 <0.0001* 
Energy, macronutrients and fibre were calculated using FoodWorks dietary software, which 
is based on the Australian Food Composition tables. Total FODMAPs = excess fructose + 
lactose + sorbitol + mannitol + fructans + galactooligosaccharides (GOS). Bold text indicates 
additive constituents for total FODMAPs.   
Data is presented as group (n=11) mean ± standard deviation (SD) for HFOD and LFOD. 
*Significance between HFOD and LFOD (P<0.05).  
 
6.4.2 Gastrointestinal Symptoms: Daily and During Exercise  
Daily GI symptoms scores were collected each day of the study and tabulated. Individual AUC 
responses show that 82.0% (9 of 11) of participants had a smaller AUC for daily GI symptom 
scores.6-days-1 during the LFOD compared to HFOD (mean difference -13.4, 95% CI [-22, -
4.60], P=0.003; Figure 6.2a). The group AUC (Figure 6.2b) was lower in LFOD (31.4±24.6; 
mean±SD) compared to HFOD (44.6±33.6). Specific daily GI symptoms that were reduced 
during LFOD included: flatulence (mean difference -1.12 95% CI [-1.55, -0.75], P<0.001), 
urge to defecate (mean difference -0.41, 95% CI [-0.81, -0.02], P=0.04), loose stool (mean 
difference -0.38, 95% CI [-0.73, -0.04], P=0.03) and diarrhoea (mean difference -0.45, 95% CI 
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[-0.75, -0.14], P=0.004). The mean GI symptoms scores for day 1 to 6 were higher during 
HFOD compared to LFOD (mean difference -2.45, 95% CI [-4.21, -0.69], P=0.006; Figure 
6.2c).  
During-exercise GI symptoms scores for the HFOD and LFOD dietary periods for day 4 and 
day 5, when prescribed strenuous running sessions, were compared. Half of the participants 
rated GI symptoms during the prescribed running sessions to be moderate to severe (≥3). 
Burping was the one symptom that was significantly higher (mean difference 0.30, 95% CI 
[0.01, 0.58], P=0.04) during LFOD compared to HFOD. No significant differences in any other 
GI symptoms were found during the prescribed running sessions between HFOD and LFOD.   
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Figure 6.2 – (a) Individual area under the curve (AUC) for daily gastrointestinal (GI) symptom 
scores over 6-days for LFOD vs HFOD (n=11). (b) Mean group AUC during LFOD compared to 
HFOD for daily GI symptom scores. (c) Mean total daily GI symptom scores for each day (day 1-
6) of the dietary period for all participants (error bars represent standard deviations) on LFOD and 
HFOD (P=0.006); * Denotes significance (P=0.003). 
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6.4.3 Perceptual Wellbeing 
Overall wellbeing was measured using DALDA and the worse and better than normal scores 
were compared for each dietary period, as well as the scores on the prescribed training days 
(day 4 and 5). Total worse than normal scores for stress (part A) and stress response (part B) 
combined were not different (mean difference -0.45, 95% CI [-1.30, 0.40], P=0.30) during 
HFOD (3.71±3.18) compared to LFOD (3.30±3.31). Similarly, total better than normal scores 
for the HFOD (2.59±2.80) and LFOD (2.97±3.66) were not significantly different across each 
dietary period (mean difference 0.43, 95% CI [-0.52, 1.37], P=0.38). Total worse than normal 
scores on day 4 or day 5 were not different (mean difference -0.82, 95% CI [-2.26, 0.63], 
P=0.30; mean difference -0.91, 95% CI [-2.35, 0.53], P=0.25, respectively). Total better than 
normal scores on day 4 or day 5 were not different (mean difference 0.5, 95% CI [-1.11, 2.11], 
P=0.55; mean difference 1.23, 95% CI [-0.39, 2.84], P=0.10, respectively). 
6.5 Discussion 
Dietary intake, and its interactions with strenuous exercise, are of particular importance to 
athletes as resulting GI distress is a common problem potentially impairing training capacity 
and performance (37). This is the first study to examine the effects of a short-term low 
FODMAP diet on GI symptoms and perceptual wellbeing in athletes with a history of exercise-
associated GI distress. The aim of this preliminary study was to investigate if self-reported and 
case-study outcomes, demonstrating beneficial effects of FODMAP reduction on exercise-
associated GI symptoms (94, 95), could be substantiated in a larger cohort. Results from this 
preliminary study indicate that a low FODMAP diet had a positive effect on daily GI symptoms 
in 82% of participants.  
6.5.1 Effect of low FODMAPs on daily GI symptoms  
In participants with persistent exercise-associated GI symptoms, 9 of the 11 reported a 
reduction in daily GI symptoms on a short-term low FODMAP diet (Figure 6.2). To date, low 
CHAPTER 6 
 101 
FODMAP diet research has predominantly focused on clinical populations, specifically 
individuals with IBS. Discernible symptomatic improvements in approximately 70% of IBS 
patients encourage the use of this diet as first line treatment (152). A limited number of 
investigations have included healthy controls (64, 116, 123) and results suggest that although 
healthy individuals demonstrate functional changes with FODMAP ingestion, GI symptoms 
remain very minor or non-existent (116, 123).  Low level GI symptoms likely have a negligible 
impact on athletic performance, but more moderate to severe symptoms may be detrimental 
(55). Although healthy populations, including healthy athletes, would not be hypothesized to 
benefit from FODMAP reduction with reduced GI symptoms, it is interesting to consider if the 
unique physiological, mechanical and nutritional stress encountered by endurance athletes (38, 
168) could increase susceptibility to any dietary triggers, such as FODMAPs, for some of these 
athletes. GI symptoms are largely variable but our preliminary data suggests that a short-term 
low FODMAP diet may be efficacious in the management of daily GI symptoms (Figure 6.2); 
particularly lower abdominal GI symptoms, in healthy athletes. Although no difference in GI 
symptoms were observed during exercise, the ability to reduce daily GI symptoms would be 
very advantageous in extended events like the Tour de France, rigorous training camps or 
multi-event athletics, which feature sequential days of intensive and extensive exercise.  
6.5.2 Effect of low FODMAPS on exercise specific GI symptoms  
GI symptoms during prescribed running sessions were similar for the HFOD and LFOD dietary 
periods. In race conditions 4–32% of athletes report GI distress and some symptoms are so 
severe that withdrawal from competition results (131). Numerous factors exacerbate GI 
symptoms during exercise including mechanical impact, physiological stress and dietary 
intake. Significantly greater GI issues are reported during prolonged events (e.g. Ironman), as 
compared to relatively shorter events, such as the marathon (131). Ingestion of carbohydrates 
as consumed in endurance sport, particularly solutions with a high osmolality, are associated 
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with the development of GI symptoms during exercise (130, 136). Exercise duration in the 
current study did not warrant carbohydrate ingestion (75), however it is interesting to consider 
if ingestion of short-chain carbohydrates during exercise or pre-existing FODMAPs in the GI 
tract would have additive osmotic actions and consequent symptoms (39, 159). It is likely that 
the chosen exercise duration (45-60 min.day-1), coupled with no CHO ingestion during 
exercise, curtailed any measurable difference in during exercise GI symptoms between the 
diets. Although this study did not investigate mechanistic hypotheses it may be conceivable 
that GI symptoms during exercise could be exacerbated with the presence or during exercise 
intake of FODMAPs. In general GI symptom reduction, our preliminary findings do support 
further research of the hypothesis that FODMAP reduction would positively affect the severity 
or occurrence of exercise-associated GI symptoms.  
6.5.3 Effects of altering FODMAPS on perceptual wellbeing  
Extreme and persistently high chronic training loads are associated with greater psychosomatic 
stress. Psychological wellbeing, personality traits and psychosocial factors, such as stress, also 
have the potential to influence perceptions of GI symptom presence and severity (84, 108). The 
reverse may also occur, in that GI symptoms caused by exercise may be reflected by reductions 
in overall perceptual wellbeing. In the current study DALDA evaluation was conducted 
alongside each dietary intervention with the aim to capture the relationship between perceptual 
wellbeing and GI symptoms influenced by diet and exercise stress. In athletes, the 
multifactorial nature of GI distress is well known and the influence of psychological wellbeing 
or stress on alterations of the autonomic nervous system has been recognized (83, 158). These 
changes in homeostatic balance have been characterized by slowing of gastric emptying, 
increased distal colonic motility and acceleration of intestinal transit, further contributing to 
adverse GI symptoms (20). In the present study, it is possible that DALDA was not a sensitive 
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enough tool to detect any FODMAP related changes. A more chronic fatigue state over several 
days/week or longer is likely required to capture changes in DALDA responses (1, 65).  
6.5.4 Reflections for future studies  
Dietary control was achieved; however, three reasons are suggested as to why no difference in 
GI symptoms were observed during the prescribed strenuous running sessions. First, daily GI 
symptoms on the LFOD diet were lower compared to HFOD. Lower pre-exercise 
symptomology during the LFOD may have skewed perceptions of the during exercise GI 
symptoms toward being more exaggerated (greater net difference) resulting in reporting of 
higher during exercise symptom scores for LFOD. Secondly, although residual FODMAPs are 
suggested to transit through the GI tract in less than 3-days  (35) a longer period of LFOD may 
be necessary to augment further symptom reduction. Changes in the gut microbiome occur 
over time as the biomass evolves and it is possible that the full benefits of the diet are not 
realized until 7-days (62) or a few weeks (152). Most importantly, exercise duration has been 
correlated with GI distress (131) and longer running sessions may be required to distinguish 
differences in GI symptoms between the diets. A greater effect may be observed under more 
extreme exercise conditions and future research should consider this element in the 
methodology.  
6.5.5 FODMAP manipulation considerations for the practitioner  
Our developing work proposes that FODMAP manipulation may be an innovative addition to 
the sport nutrition practitioners’ toolbox for management of exercise-associated GI distress. 
Certain considerations must be considered when trialling short-chain carbohydrate restriction 
with athletes as dietary requirements are individual and unnecessary food restriction may 
compromise optimal fuelling (114). When appropriately planned, under the guidance of a 
dietetic professional, a low FODMAP diet can be matched for energy, macronutrients and fibre 
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(Table 6.2). Although differences in protein and fat intake were statistically significant 
between LFOD and HFOD, 7 and 5 g, respectively, these findings are not clinically significant. 
As a source of high quality protein, cow-based dairy is often consumed at or above the general 
population recommendation of two to four servings per day(24). Coinciding high lactose 
intakes are likely (Table 6.2) and should be investigated as a primary trigger for GI symptoms 
with appropriate high protein substitutes made, such as lactose free milk. A low FODMAP diet 
should be considered once typical GI symptom triggers have first been assessed, such as lactose 
(35, 37).   
Intakes of prebiotic fructooligosaccharides and galactooligosaccharides, found in high amounts 
in wheat and legumes, are restricted with a low FODMAP diet, which is concerning. These 
prebiotics stimulate healthy colonic Bifidobacterium. After 4-weeks of a restricted fermentable 
carbohydrate diet Bifidobacteria populations were decreased in IBS patients (153). Immune 
health may be compromised with lower Bifidobacterium count, which is an important 
consideration for overall athlete immunity and health (57). In athletes, it is unclear if risk 
associated with decreased healthy bacterial populations due to diet may be more or less 
apparent as exercise further alters diet-microbe-host metabolic interactions and may support 
higher gut microorganisms diversity (29, 122). Exercise and an athletes’ diet could offer a 
protective element against a decrease in healthy gut bacterial populations associated with 
FODMAP restriction. Given the restrictive nature and novelty of this dietary approach a 
systematic and individualized approach will be obligatory for successful and efficacious 
implementation of a low FODMAP diet in an athletic setting.  
6.5.7 Conclusions 
Results from this study have shown that a short-term LFOD results in significantly lower daily 
GI symptoms over the intervention period compared to a HFOD diet in athletes with a self-
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reported history of persistent exercise-associated GI distress. Exercise-associated GI distress 
and pathophysiology of IBS are multifactorial, but both conditions feature similar 
symptomatology. Although, more work is needed to determine the effectiveness of a low 
FODMAP diet, our preliminary findings suggest this dietary approach may be applicable 
beyond the clinical realm and offer a novel strategy to reduce GI symptoms in some 
symptomatic but clinically healthy athletes.  
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Chapter 7: Commercial hype vs. reality:  Our current scientific 
understanding of gluten and athletic performance 
This chapter has been published in Current Sports Medicine Reports as an invited review and 
appears as: 
Lis DM, Fell JW, Ahuja KD, Kitic CM, Stellingwerff T. Commercial hype versus Reality: Our 
current scientific understanding of gluten and athletic performance. Curr Sports Med Rep. 
2016;15(4):262-8.  
Thompson Reuters journal impact factor: 1.336 
SJR journal ranking: Q3  
Altmetrics score: 32 
7.1 Rationale 
Rapid explosion in the gluten-free market alongside an extraordinary high uptake of GFDs 
amongst NCA has far outpaced evidence-based research in this area. Upon commencement of 
my PhD investigations NCA had already rapidly been adopting a gluten-free lifestyle with no 
evidence base supporting the purported beneficial effects of this diet for athletes not clinically 
requiring gluten-avoidance. Due to the paucity of evidence-based research investigating the 
effects of GFDs or FODMAP manipulation in clinically healthy athletes Chapter 7 is presented 
as a review of the literature towards the end of my thesis document and includes my seminal 
work in this area. This invited and published review provides an overview of the clinical 
conditions in which a GFD is required followed by a description of the rationale, beliefs and 
experiences pertaining to GFD for NCA. Athlete perceptions and dietary behaviours are 
examined alongside evidence-based research. Lastly, other confounding dietary factors, a 
belief effect and the role of FODMAPs are examined. This literature review underpins the 
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focus and application of this thesis to determine the effects of a GFD or low FODMAP diet in 
clinically healthy NCA.  
CHAPTER 7 
 108 
7.2 Abstract  
Recent explosion in the prevalence of gluten-free athletes, exacerbated by unsubstantiated 
commercial health claims has led to some professional athletes touting gluten-free to be the 
secret to their success. Forty-one percent of athletes report adhering to a gluten-free diet (GFD), 
which is four-fold higher than population-based clinical requirements. Many noncoeliac 
athletes believe gluten-avoidance results in gastrointestinal wellbeing, reduced inflammation 
and provides an ergogenic edge, despite the fact that limited data yet exists to support any of 
these benefits.  There are several plausible associations between endurance-based exercise and 
gastrointestinal permeability whereby a GFD may be beneficial. However, the implications of 
confounding factors, including the risks of unnecessary dietary restriction, financial burden, 
food availability, psychosocial implications, alterations in short-chain carbohydrates 
(FODMAPs) and other wheat constituents emphasize the need for further evaluation.  
Summary Statement: The recent prevalence of gluten-free athletes has illustrated the 
multifaceted and potentially detrimental or beneficial effects of a gluten-free diet on 
performance.   
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7.3 Introduction 
The concept of performance extends beyond the actual physical wins or losses in sport. It also 
encompasses aspects of individual wellbeing performance that are influenced by dietary 
intakes and beliefs that ultimately may provide a competitive edge (Figure 7.1). Noncoeliac, 
non-gluten sensitive gluten-free athletes (NCA) have rapidly become a prevalent group 
adopting a gluten-free diet (GFD) as a means to optimize health and gain a performance edge. 
Athletes’ who follow a GFD, fully or partially, for non-clinical reasons are already four times 
higher than the 5-10% of the general population requiring gluten-avoidance for clinical reasons 
(97, 142), which include coeliac disease (CD), wheat allergy and noncoeliac gluten sensitivity 
(NCGS). The rapid uptake of GFDs with high adherence rates are further exacerbated by 
illustrious commercial claims equating GFDs with enhanced health, as well as some high 
profile athletes touting this diet to be the secret to their athletic success (68).   
This explosion of gluten-free products and NCA adopting this diet raises the question: Is there 
anything unique about a GFD that may benefit the athlete in competitive performance and/or 
performance-related parameters including: gastrointestinal (GI) health, inflammation, dietary 
healthiness and perceptual wellbeing? It continues to be debatable whether the unique 
physiological stress of athletic training creates an increased susceptibility (39) to gluten or if 
rates of NCGS are higher in endurance athletes who already have increased GI issues (131). In 
this review, we examine GFD research conducted on athletes, as well as clinical and 
population-based dietary investigations with findings potentially applicable to an athletic 
population. Although the contemporary nature of this area provides limited NCA-specific 
evidence, this review further explores theoretical connections associated with gluten and gut 
injury, inflammation, dietary choices and the belief effect to increase understanding of the 
gluten-free movement amongst NCA and how these elements require further research, or may 
ultimately impact health and performance.   
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Figure 7.1 – Schematic overview of the potential negative or positive effects/interactions of gluten 
on athletic performance or health performance.   ED=eating disorder, UCP-1=uncoupling protein, 
GI=gastrointestinal, FODMAP=Fermentable oligosaccharides, disaccharides, monosaccharides 
and polyols. 
7.4 Gluten-related clinical conditions  
Gluten is a storage protein composite, with the alcohol-soluble gliadins defined as prolamins 
and the alcohol-insoluble glutenins as glutelins (3). Although all grain products, even those 
considered gluten-free, contain prolamins, only the prolamins found in wheat (gliadin), rye 
(secalin) and barley (horedin) are the primary peptides associated with immunologic reactions 
in CD. Gluten is also present in other food products through the addition of grain-based 
foodstuffs, present as gluten-itself (e.g. soy sauce) or via cross-contamination, such as is 
common in oats (86). Average intakes of gluten vary (142) geographically and individually. In 
Western diets gluten intake ranges from 10-20 g.day-1 with some individuals consuming up to 
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50 g gluten.day-1 (142). Grain-containing foods and sports foods are a common source of 
carbohydrate dense nourishment and it is plausible that many athletes ingest above average 
gluten-containing foods quantities to meet elevated energy and carbohydrate requirements.  
Athletes with clinical gluten-related conditions generally experience improvements or 
complete resolution of a spectrum of intra-intestinal and extra-intestinal symptoms with strict 
gluten elimination (102). For example, in clinical case reports, athletes presenting with 
symptoms representative of ill health, including GI issues and poor nutrient status, exhibited 
improvements in health status, training and competition capacities subsequent to CD diagnosis 
and the implementation of a GFD (46, 92). However, the vast majority of NCA are self-
diagnosing clinical conditions (Figure 7.2), NCGS in particular, and subsequently self-
prescribing gluten-avoidance. GI symptoms commonly reported in endurance athletes are also 
believed to be caused by gluten and self-selection of a GFD is readily implemented as a 
perceived treatment (97). One of the primary reasons for self-diagnosis is likely the arduous 
double-blind gluten elimination and re-challenge currently employed as the ‘best practise’ 
diagnostic tool to determine true NCGS (27), after CD and wheat allergy have been ruled out. 
Recent research appears to be developing biomarkers (4)  to assess NCGS, however, contrary 
to popular belief  no scientifically validated diagnostic biomarker is readily available to 
confirm NCGS. It is risky for athletes to self-diagnose medical conditions and subsequently 
adopt a GFD as underlying medical or physiological conditions could be overlooked. Further, 
non-scholarly advice potentially influencing athletes GFD decisions often lack the 
individualization required to optimize dietary intake supporting peak athletic performance and 
may risk injudicious outcomes.   
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Figure 7.2 –  For athletes adhering to a GFD at least 50% of the time the basis for prescription of 
a GFD. NCGS: non-coeliac gluten sensitivity, IBS: irritable bowel syndrome, BW: bloodwork, dx: 
diagnosis, hx: history, CD: coeliac disease, RD: registered dietitian. 
Modified, by permission, from D. Lis, T. Stellingwerff, C. Shing, K.D.K. Ahuja, and J.W. Fell, 
2015, “Exploring the popularity, experiences, and beliefs surrounding gluten-free diets in 
noncoeliac athletes,” International Journal of Sport Nutrition and Exercise Metabolism, 25(1) 
http://dx.doi.org/10.1123/ijsnem.2013-0247. © Human Kinetics, Inc. 
7.5 Gluten-related beliefs on athletic performance  
Amongst the 41% of athletes (n=910) that adhere to a GFD over half believe gluten avoidance 
improves competitive performance (97). Even in athletes not adhering to a GFD approximately 
a quarter believe gluten avoidance has an ergogenic effect (22, 97). Regardless of the prevalent 
belief in the performance benefits of a GFD our research group has conducted the only study 
that has investigated the effects of this diet in NCA on exercise performance (96). This double-
blind placebo controlled crossover trial examined the effects of the effects of a 7-day GFD or 
gluten-containing diet on 15-minute time-trial (TT) performance (97). All food was provided, 
except for fresh fruit and vegetables, and habitual exercise was replicated between trials, with 
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16 g.day-1 of either gluten or placebo (whey protein) provided in an indistinguishable study 
food bar. There was no statistical difference between treatments for cycling performance 
(Figure 7.3). Some question remains of whether a longer intervention may account for 
differential gut flora habituation and thus potentially influence immune parameters or GI 
symptoms. However, this is not supported by a 4-week GFD in healthy subjects, which 
demonstrated a reduction in healthy gut bacterial populations (90). Performance is influenced 
by a plethora of factors and is difficult to accurately measure; however, in our study 
performance improvement was 100% negligible using magnitude based inference statistics as 
well as classic statistical approaches (P=0.37). More research is required to definitively elicit 
whether gluten has any effect on competitive or wellbeing performance.  Regardless, this 
seminal study does not support the popular belief that a short-term GFD has a performance 
enhancing effect. 
 
Figure 7.3 – Overall 15-minute time trial performance (kJ) in response to gluten-containing diet 
(GCD) and gluten-free diet (GFD). ¾ individual performance  n means (SD), n=13. Reprinted 
with permission, from Lis D, Stellingwerff T, Kitic CM, Ahuja KD, Fell J. No effects of short-term 
gluten-free diet on performance in noncoeliac athletes. Med Sci Sports Exerc. 2015; 47:2563-70. 
http://www.ncbi.nlm.nih.gov/pubmed/25970665. Medicine & Science in Sports & Exercise. 
 
Although, no direct performance effect has been shown with a GFD when athletes are blinded 
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to the intervention, in reality athletes are not blinded to dietary changes. Psychological 
influences and the ‘belief’ in the effects of a GFD on performance and related parameters, such 
as pain, have the potential to influence outcomes (10). Beedie et al. (10) and Halson & Martin 
(66) have discussed the “belief effect” in sport showing a 1-3% improvement in performance. 
A dietary placebo effect may result in a positive (placebo) effect on performance, experienced 
both objectively (e.g. improved performance) and/or subjectively (e.g. reduced pain or 
exertion) (10, 66). Although, no research yet supports any benefits of a GFD for NCA, in 
actuality the belief in the ergogenic benefits of a GFD may positively influence performance 
in the field. It is also noteworthy to deliberate situationally appropriate circumstances where a 
GFD can be used to “tap into” an athlete’s belief in a dietary intervention to their advantage 
(10, 157).  However, one needs to appreciate that the complications potentially accompanying 
a GFD for NCA could be unfavourable to health and performance due to issues in dietary 
adequacy and other complications, as outlined below.  
7.6 Gluten and wellbeing performance  
Athletes place their bodies under unique and repetitive stress. Perhaps there are unique aspects 
to the physical stress of elite training and competition that does provide an underpinning 
mechanism, which may cause athletes to be more clinically susceptible to gluten. 
7.6.1 Exercise gastrointestinal distress  
GI distress is reported to occur in 30-50% of endurance athletes (39) and numerous elements 
can initiate or intensify GI symptoms in an individualized manner during primarily endurance 
exercise including: mechanical (splanchnic hypoperfusion), physiological (dehydration), 
psychological (stress) and climatic (heat; 11). Dietary factors such as fibre quantity, 
carbohydrate type and load (32, 38, 131) and wheat constituents in sensitive individuals may 
also contribute to GI symptoms (25). Hypothetically, and similarly to NCGS and CD (171), 
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injury to the intestinal barrier endured by athletes could also create a GI environment more 
sensitive to gluten, or similar multi-systemic GI side effects of clinical gluten conditions.  
Although the gut is partially trainable and splanchnic blood flow is increased with cumulative 
training  (55), elite endurance athletes commonly undergo multiple training sessions per day, 
which is far less than the 4-5 days required for epithelial cell repair. Investigative research 
suggests a possible role of increased intestinal permeability leading to excessive absorption of 
gluten-derived peptides in NCGS (25) which could further potentiate immune related 
responses. Dehydration and heat further compromise intestinal integrity and athletes training 
or competing in these conditions may experience exacerbated GI injury (167). Altered 
digestion of short-chain carbohydrates may also augment GI symptoms triggered during 
exercise. Reductions in GI symptoms are the most popular rationale for eliminating gluten (97) 
although our study described above did not show any effect of gluten on GI symptoms (96).  
7.7 Immune health 
Illness can have a negative impact on health and performance. For athletes that engage in 
prolonged, strenuous exercise a “J-shaped curve” model has been used to show the relationship 
between excessive exercise and increased illness rates (119). Numerous dietary strategies are 
recommended to maintain a robust immune system in athletes (57) but to date a GFD is not 
one of them for NCA. Many NCA believe gluten elicits undesirable inflammatory responses 
(97) and in combination with excessive exercise could have an additive toll on the immune 
system. Our controlled intervention study, discussed above, does not support this conviction. 
Inflammatory markers (interleukin (IL)-1b, IL-6, IL-8, IL-10, IL-15, tumor necrosis factor 
(TNF)-a) assessed in response to exercise (pre-, during and post-TT) on the last day of each 
intervention period showed no significant difference between the gluten-containing diet or 
GFD (96). Similarly, in IBS patients with belief that gluten triggered symptoms no difference 
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in c-reactive protein was found after a high gluten, low gluten or a control diet for 1-week in a 
crossover design (16).    
In contrast to short-term human studies rodent-based research in noncoeliac C57B/6 male mice 
has shown increased IL-6 expression and a trend towards higher TNF levels with an 8-week 
gluten-containing diet compare to a GFD, suggesting a proinflammatory profile (48). Aside 
from the obvious disparities in rodent versus human metabolism and disassociation to exercise, 
the dissimilar observations between studies could be owing to a longer intervention length in 
the rodent study, unconnected to exercise and cytokines measurements taken from adipose 
tissue. Nonetheless, gluten or wheat constituents are central to the inflammatory response in 
sensitive individuals (171) and this can be associated to the above-mentioned exercise-induced 
intestinal permeability (38, 167). Therefore, the substantial and repeated stress placed on an 
athletes’ immune status and the subsequent effects on the inflammatory state, highlights the 
need for a greater understanding on the effects of gluten or wheat constituents as a component 
of immunonutrition strategies. 
7.8 Body composition  
Athletes eliminate gluten to promote weight loss or improve body composition for sport (97) 
although evidence to support this is lacking (50). Most research has analysed weight changes 
pre- and post GFD adherence in CD (161) but the dietary control is inconsistent and the 
complexity of confounding factors (e.g. type 1 diabetes, chronic inflammation) limit its 
applicability to NCA. Surprisingly, in CD populations there is an increased risk of obesity with 
GFD adherence suggested to be linked to increased nutrient absorption and intakes of high 
fat/sugar gluten-free products (161). While there are no studies in noncoeliac humans 
investigating the effect of gluten on body composition, studies in male C57B/6 mice suggest 
that a gluten-containing diet compared to an isocaloric GFD increases fat deposits, regardless 
of whether the diet is high fat or of normal fat content (48, 151). The increased body weight 
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and adipose tissue in gluten-fed mice was also associated with impaired glucose homeostasis, 
a decrease in fasting and non-fasted oxygen uptake and lowered energy expenditure and 
increased adipocyte content of proinflammatory cytokines (48). This data has limited 
transferability to NCA as the macronutrient breakdown of the diets were not representative of 
typical athlete diet recommendations (162). In general, athletes aim to optimize power to 
weight ratio by achieving low body fat levels and if a gluten-containing diet promoted adiposity 
it would obviously be counterproductive.  
7.9 Gluten and nutritional adequacy  
Our recent questionnaire based publication showed that the majority of NCA adopting a GFD 
(at least 50% of the time) are recreationally competitive endurance athletes (~70% of 910 
respondents) with the conviction that it is healthier, improves conscientiousness of food 
choices and promotes overall more balanced eating (97). It is debatable whether a GFD equates 
to dietary changes resulting in a healthier or less healthy diet, or if other dietary habits are 
subsequently modified resulting in improved or worsened eating behaviours. Hype about this 
diet brings in the question of dietary and nutritional adequacy and the issue of suboptimal 
fuelling risk as described in other elimination-type diets (156).  
NCA adhering to a GFD do so in varying degrees; ranging from periodic gluten elimination, 
elimination 1-2 weeks before competition or up to 100% of the time (97). Although adherence 
rates vary, enhanced dietary mindfulness is suggested as an outcome to avoidance of gluten-
containing products (51, 97). Converting to a GFD plausibly results in some athletes increasing 
their conscientiousness of healthy balanced eating, increasing fruit and vegetable and whole 
grain intake and decreasing processed food selections (51); food choices all underpinning good 
sport nutrition practises. The variable nature of dietary choice highlights the fact that individual 
food selection may be an instrumental predictor of the overall healthfulness and nutritional 
adequacy of a GFD for NCA (147). However, the proliferation of the gluten-free food products 
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market results in both an increase of unhealthy gluten-free products as well as the production 
of more nutrient-rich pseudo-cereals, such as amaranth, buckwheat and quinoa, replacing corn 
and rice flour (127). These substitutions could potentially reduce the risk of omitted dietary 
sources of B-vitamins and iron that are critical for metabolism and athletic adaptations.  
An athletes’ dietary intake is unique in that it must be optimized to maintain sufficient energy 
intake and to augment training adaptation and health. Nutrition interventions may purposefully 
integrate periodised energy deficits to augment sport-specific body composition.  However, 
elimination diets have been linked to non-strategic suboptimal energy intakes and could 
potentiate low energy availability and associated risks, especially in endurance athletes (156). 
Analysis of the capacity of a GFD to support athletic energy demands has not been conducted 
so it is unknown if the dietary restriction associated with this diet compromises energy 
availability. Clinical investigation in this area is dated and fails to account for newer gluten-
free food alternatives now accessible. The only recent study investigating energy intakes in 
GFD compared the nutritional status of patients with CD adhering to a strict long-term (2-year) 
GFD to healthy controls and found energy intake to be similar in both groups (6). However, 
the multifactorial nature of fuelling athletes also encompasses unique and complex eating 
behaviours that may overlap with avoidance of gluten-containing grains. Some behaviours may 
include restriction of grain-based foods completely, consumption of a limited low energy 
density diet or with orthorexia nervosa behaviours under the blanket of a GFD, particularly in 
weight dependant sports (114). Additive factors such as limited accessibility to gluten-free 
foods when travelling or competing abroad further complicate the ability of a GFD to reliably 
support athlete energy requirements (67).  
Macronutrient and some micronutrient requirements for athletes are often higher compared to 
the general population (162). Historically, a GFD has been associated with suboptimal intake 
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of protein, fibre, B-vitamins and iron alongside increased fat and sugar intake (161). For 
athletes there is the additional concern of insufficient carbohydrate associated with the 
exclusion of gluten-containing foods (97). Contemporary studies, conducted in different 
countries with varying methodologies, have presented conflicting evidence concerning the 
macronutrient and micronutrient adequacy of gluten-free foods for the general population 
(161). Three studies have profiled the nutritional quality of 63 to 3213 gluten-free food 
products (e.g. staple items: pasta, breads, ready-to-eat breakfast cereals) compared to gluten-
containing equivalents and also compared the Health Star Rating (an algorithm based on 
energy, total sugar, sodium, saturated fat, fibre and protein) (175) or macro- and micronutrient 
composition (85, 112). For athletes choosing gluten-free products, there is no obvious nutrient 
shortfall in most of these products compared to gluten-containing equivalents, but no health 
benefit either.  
Quantification of the healthfulness of gluten-free foods is important to discuss as there exists a 
belief among athletes that eating gluten-free equates to healthier food choices (97). Aside from 
being an effective treatment for the spectrum of gluten-related disorders evidence-based 
research supporting a GFD as a “healthier” option for NCA is lacking (50). Several studies 
have analysed a GFD for nutritional appropriateness compared to a gluten-containing diet using 
diverse methodologies in CD populations. Approaches used include prospective dietary 
analysis (140), virtual comparative analysis (111) and GFD compared against controls (6). 
Some statistical differences were found with lower protein or lower fibre but there were no 
consistent findings across all studies that clearly indicate a difference in this non-athletic 
population. The slightly lower protein content indicated across gluten-free products and a GFD 
is negligible and of little practical significant as athletes are recommended to rely upon 
meat/alternatives and dairy as sources of protein, not grains (162). Overall, these studies 
indicate that the distribution of macronutrients was similar between a GFD and gluten-
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containing diet (6, 111, 140), however there have been no studies published examining 
nutritional adequacy of GFDs in varying elite athlete populations. Due to the scarce evidence 
in this area and inherent error associated with diet record collection it is not possible to 
conclude whether a GFD provides an optimal macro- or micronutrient profile for athletes, thus 
GFD adequacy should be assessed individually. 
 
Some athletes are so focused on eating gluten-free that they overlook the importance of eating 
a balanced diet to support training and recovery. Complications possibly arising from 
unnecessary food restriction may include; increased anxiety around food (orthorexia nervosa), 
time commitment, expense, social concerns and interference with appropriate medical 
intervention (51, 149). An enormous amount of time and money is spent by individuals with 
CD on label and food checking, at an estimated 10-20 hours per month (132),  plus an estimated 
206-267% increase in food expenses (51, 112). Social consequences also present, such as 
difficulty eating outside of the home, with friends, family or team (51) or in various 
training/competition locations where gluten-free foods may be less available or inaccessible 
may compromise optimal fuelling. For some athletes, the lifestyle complications and 
challenges in supporting optimal fuelling or nutrient intake on a GFD may be an unnecessary 
burden if a GFD is not a clinical necessity. See et al. (86) summarize they key dietary planning 
strategies which may reduce the nutritional risks historically associated with a GFD, however 
athletes’ unique nutritional requirements may be elevated and capability of a GFD to reliably 
meet these has not been evaluated. It is therefore prudent to acknowledge that dietary 
restriction, or an elimination diet, may pose a risk for optimal fuelling for sport performance, 
particularly for athletes already under fuelling. 
 
7.10 Are FODMAPs a major gluten symptom confounder?   
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Gluten-free markets are predicted to experience continued growth, but emerging market reports 
also predict low FODMAP diets to eventually become the ‘new’ gluten-free (106). FODMAPs 
are a family of short-chain carbohydrates (including fructans), are found naturally in foods, 
and are particularly prevalent in wheat, some fruits/vegetables and legumes (9), and thus 
appropriately named as Fermentable Oligosaccharides, Disaccharides, Monosaccharides And 
Polyols. Coincidently a GFD also reduces fructan and galactooligosaccharides intake and some 
researchers suggest that the change in dietary fructan load, rather than gluten itself, is the 
primary GI symptom modulator (52, 115). For some individuals, fructans and other FODMAPs 
are poorly absorbed in the small intestine where they increase luminal fluid content and 
possibly affect gastric motility (152). Poorly absorbed, they subsequently transit to the colon 
as products for fermentation by colonic bacteria, resulting in GI symptoms such as diarrhoea 
and flatulence (152). Although no data is yet published in athletes without IBS, it is conceivable 
that residual FODMAPs in the small intestine (ileum) and colon or intake of FODMAPs during 
training potentiate GI distress during and after strenuous exercise.  
A low FODMAP diet is a strategy efficaciously applied in the treatment of IBS (152), but also 
practiced by some athletes to decrease GI symptoms (41). Investigation of the role of 
FODMAPs in athletes with persistent excise-induced GI symptoms is in its infancy.  However, 
preliminary work has been conducted by our group quantifying high FODMAP food/category 
elimination in athletes (95). Self-reported data indicates that 51% of athletes (n=465 of 910) 
eliminate at least one high FODMAP food or food category with the aim to reduce GI 
symptoms. After elimination, reported symptom improvement ranged from 68.2% (polyols) to 
83.7% (lactose) (95). In this study athletes self-selected FODMAP categories that were queried 
alongside a short list of high FODMAP food examples (e.g. fructose: apples, mango, honey) 
and they may have been familiar with FODMAPs and/or only the high FODMAP foods listed. 
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Lactose (86.8%, n=402 of 465) was the most frequently eliminated followed by 
galactooligosaccharides, fructose, fructans and polyols to a much lesser extent. Lactose 
elimination was also the most frequently reported to occur alongside gluten avoidance which 
parallels population-based and clinical findings (95, 176). From an intervention perspective, 
one case-study report  of a multi-sport athlete with persistent running-specific exercise-induced 
GI symptoms reported measurable symptom improvement with a 3-day low FODMAP diet 
prior to and throughout 3-days of strenuous running training (94). Though there are limitations 
associated with self-report data these initial findings from our group suggest that perceived 
gluten-triggered GI symptoms in athletes might be due to FODMAPs, particularly fructans and 
lactose as potential symptom modulators, although more placebo-controlled double-blind 
studies are required to confirm this.  
7.11 Conclusion 
Widespread media validation continues to drive the popularity of GFDs forward, yet this diet 
has not been shown to affect, either positive or negatively, competitive performance or 
symptoms of GI health and inflammation and/or nutritional status in NCA. Sport nutrition 
practitioners are faced with a unique challenge when advising on the appropriateness of GFDs 
for NCA, as most NCA self-prescribe this diet based on non-peer reviewed evidence. 
Theoretically mechanisms unique to athletes may increase susceptibility to gluten locally and 
systemically with exercise-induced GI injury, but these have not been directly explored. Direct 
confounding factors of concern with gluten-avoidance in athletes include caloric fuelling 
challenges, unnecessary restrictive eating practises or the risk of overlooking appropriate 
medical diagnosis.  While this “belief effect” may be responsible for NCA perceived benefits 
of going gluten-free, practitioners determining the appropriateness of a GFD for a NCA should 
first consider possible underlying GI disorders or other food intolerance, as well as potential 
risks associated with unnecessary food restrictions and cost. Current limited evidence does not 
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support the performance or health benefits of a GFD for NCA. Adoption of this diet should be 
carefully deliberated and prescribed under appropriate medical and/or dietetic guidance.    
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Chapter 8: Thesis summary, future directions and conclusions  
8.1 Thesis Summary 
The most important findings arising from the studies undertaken in this thesis are established 
upon both observational and intervention studies. Observational investigations quantified the 
GFD movement amongst athletes worldwide, concluding that fourfold more athletes follow 
this dietary regime than estimated to be clinically required. GI symptoms were confirmed as a 
predominant rationale for NCA going gluten free alongside the belief that a GFD reduced 
inflammation and provided an ergogenic edge. Elimination of foods high in FODMAPs was 
also confirmed to be a prevalent dietary strategy utilized by NCA aimed at reducing GI distress. 
Although widespread belief exists in the beneficial effects of these diets, particularly GFDs, 
the findings from this thesis work were the first to disseminate qualitative and quantitative 
conclusions about dietary practises, experiences, beliefs and sources of information regarding 
GFDs and high FODMAP foods amongst NCA (95, 97).  
Further seminal work was conducted to investigate the effects of a short-term GFD in NCA on 
performance and related parameters including: systemic inflammation, intestinal injury and 
perceptual wellbeing (96). Under well-controlled diet and exercise conditions a GFD 
demonstrated neither a beneficial nor a negative effect on performance. Measures of GI health, 
inflammation and perceptual wellbeing were also similar during the GCD compared to GFD 
periods in NCA (96). In the succeeding preliminary investigations, FODMAP restriction did 
show emerging promising results (e.g. GI symptom reduction). Measurable GI symptom 
reduction was observed in a multisport athlete with persistent exercised-associated GI 
symptoms while following a short-term low FODMAP intervention diet compared to his 
habitual high FODMAP diet (94). Similarly, a low FODMAP diet demonstrated a reduction in 
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daily GI symptoms compared to a high FODMAP diet in clinically healthy runners with 
persistent exercise-associated GI distress.  
A GFD and avoidance of high FODMAP foods are prevalent and emerging dietary strategies 
adopted by athletes predominantly to reduce GI symptoms. Athletes often self-implement 
perceived beneficial dietary strategies that lack supportive evidence. A belief effect may 
underpin the perceived benefits or the intervention may actually have an impact which has yet 
to be scientifically validated. Also, going gluten-free may consequently reduce the intake of 
certain FODMAPs, or vice versa, low FODMAP can result in reduced in gluten intake. The 
research conducted within this thesis is the first to bridge practical behaviours relating to GFD 
and FODMAPS and quantify the effects of these dietary regimes on GI symptoms and 
performance in athletes. Findings from this thesis have rapidly become an influential evidence-
base for sport nutrition practitioners advising on the effects of GFD for NCA (5). Further, these 
results have provided novel insight regarding the use of FODMAP manipulation, rather than 
gluten, to address GI issues in symptomatic athletes. Overall, the work conducted in this thesis 
suggests that a GFD does not have a beneficial or negative effect on performance, GI health, 
inflammation or overall wellbeing. Instead, FODMAP manipulation may be an effective and 
innovative addition to the sport nutrition practitioner’s toolbox for management of exercise-
associated GI distress. Practitioner supported, systematic and individualized approaches will 
be required for the successful, and potentially efficacious implementation of this dietary 
approach.   
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8.2 Limitations 
8.2.1 Dietary intervention length  
The applicability of lengthier dietary intervention periods depends on the primary research 
question and the logistical methodologies for prolonged dietary control, which become 
exponentially more difficult during long-term interventions. In many ways, a shorter 
intervention, as modelled in the studies within this thesis (Chapter 3, 5, 6), are ideal for 
investigating GI distress due to the rapid turnover of GI tract proteins. Animal based and 
unpublished human data (152, 170) has demonstrated that protein turnover in the GI tract is 
five times higher than muscle protein synthesis; essentially yielding a new GI tract in 5 to 7 
days. However, it can be argued that longer interventions would allow time more time for 
physiological changes to manifest, such as changes in the microbiome, and may better capture 
effects of dietary interventions on GI measures.  
Another element to consider in both short and long term interventions is energy balance. 
Negative energy balance, common in endurance athletes (160), can decrease the rate of protein 
synthesis (122). In both long and short-term interventions reduced epithelial protein synthesis 
is likely to impair gut barrier function and increase permeability. This may be a reason low 
energy availability has been associated with frequent GI symptoms (160). Coupled with 
exercise stress and dietary triggers, negative energy balance could be a perfect storm for 
amplified GI issues. However, currently, no one has examined the effects of gut function or 
inflammation in various states of energy availability.  Although the work conducted within this 
thesis only briefly discussed the effects of energy balance on GI symptoms this is likely a 
confounding element of acute and chronic GI health in athletes and requires further 
investigation. 
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Adverse symptoms triggered by gluten and/or FODMAPs are reported to improve in a few 
hours to days after dietary elimination (47, 123); however, study methodology with a longer 
duration of dietary adherence would be valuable to account for differential gut flora habituation 
as changes in the microbiota influence GI and immune health, performance and related 
parameters (64, 90, 154). It is important to note that the effects of dietary manipulation on 
various outcomes of athletic performance may be difficult to monitor as training adaptations 
that can also occur over a longer intervention period (weeks to months) would likely confound 
dietary-influenced performance changes. In addition, any negative dietary influences on 
microbiota composition and population may be countered by the promotion of gut micro-
organism diversity by exercise and observation of any negative outcomes may require longer 
interventions (29). In healthy controls a reduction in bacterial abundance and favourable 
bacterial populations have been shown in a low FODMAP compared to a higher habitual 
FODMAP diet as well as a GFD compared to a habitual GCD, demonstrated after 3-4 weeks 
of adherence (40, 62, 90). While it would be ideal to implement lengthier interventions, these 
are more intrusive for the athlete and would challenge dietary adherence and the ability to 
control and replicate training and food intake. Nonetheless, future investigations are 
encouraged to incorporate longer dietary interventions and possibly longer washout periods, 
provided the methodology enabled adequate control and adherence.   
8.2.2. Prescribed exercise   
Intestinal injury and GI symptoms are largely influenced by physiological and mechanistic 
factors which are further increased with longer, more strenuous exercise and specific 
modalities, such as running (38). IFABP measures taken before, during and after the cycling 
performance trial in the GFD study (Chapter 3) indicate that exercise stress was adequate to 
induce acute epithelial injury and thus intestinal permeability (100, 169). In the prescribed 
running bouts (Chapter 5, 6) intestinal permeability was not measured, so it is unknown if the 
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mechanical and physiological stress of these sessions were robust enough to cause epithelial 
injury, which would expectedly augment GI symptoms. Increased permeability is sometimes 
associated with GI symptoms (125); however, a measurable difference in GI symptoms during 
exercise was not observed with either the gluten or low FODMAP interventions (Chapter 3, 5, 
6). To gauge changes in GI symptoms between diets, more stress placed on the gut may have 
been required to measure possible dietary impacts. Forthcoming investigations should consider 
exercise performance protocols that are longer and/or multi-day or under heat stress, more 
strenuous, with the mechanical load of running and the requirement of during-exercise fuelling. 
For example, perhaps a marathon race simulation is required to detect greater changes in GI 
symptoms between groups, particularly during exercise. Additionally, it would be practical to 
assess the effects of gluten-containing versus gluten-free and low FODMAP vs high FODMAP 
sport food ingestion during exercise sessions that warrant carbohydrate ingestion (75).  
8.3. Future studies arising from thesis results 
8.3.1. Analysis of nutrition quality of a GFD and low FODMAP diets in free-living athletes 
Wide-ranging beliefs exist surrounding the nutrition adequacy of a GFD or the subsequent 
dietary changes that may occur. Several investigations, with varied methodology, have 
attempted to quantify the nutritional adequacy of a GFD in clinical and healthy control 
populations (111, 134). Based on the review of the literature there is no conclusive evidence 
that energy, macro- or micronutrient intakes are significantly different with a GFD compared 
to a GCD. However, athletes may have elevated energy and nutrient needs compared to the 
general population. Dietary restriction may risk suboptimal dietary intake, compromise ideal 
fuelling for athletic demands, amplify risk of developing orthorexia nervosa and make it more 
challenging to fuel abroad. Although our findings did not support any benefit of a GFD for 
NCA, future research should investigate the adequacy of a GFD in free-living NCA athletes, 
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self-selecting food, and further quantify likely environmental and psychosocial challenges as 
well as character traits of gluten-free athletes (15, 86, 149). 
Low FODMAP diets have been shown to be nutritionally adequate in clinical and healthy 
populations (64, 123); however, advanced dietary support and planning has been applied in 
these studies.  The nutritional adequacy of self-selected low FODMAP diets has not been 
investigated alongside the elevated and unique nutritional requirements characteristic of 
athletes (162). Dietary restriction has the potential to compromise optimal nutritional intake as 
well as trigger related psychosomatic stress. In free-living athletes, future studies should 
consider evaluation of self-selected short- and long-term low FODMAP diets for potential 
influences on nutritional intake as well as overall wellbeing.  
8.3.2. Preceding gluten-free dietary beliefs  
Inclusion criteria for the dietary intervention studies required participants to not be on any 
special diet 6-weeks prior to the intervention. It is likely that participants had a range of beliefs 
regarding the effects of a GFD on health and performance which was representative of our 
questionnaire-based findings (97). Although recruitment and ethical approval may prove 
challenging, future studies should consider inclusion criteria that requires participants to 
believe they have NCGS but are agreeable to eat gluten in a blinded manner. It would be further 
interesting to assess the probable belief effect (10, 66) associated with gluten and use a 
deception technique to evaluate the effects of informing participants they were eating a GFD 
when they were in fact being fed hidden gluten.  
8.3.3. Parallel design GFD and FODMAPs  
There is great potential to design a parallel group design to assess the effects of gluten and 
FODMAPs on performance, GI health and a myriad of parameters influencing performance. 
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Logistics and elevated sample sizes would prove challenging; however, a crossover design in 
this manner could include the following four diet clusters:  
1. gluten-free with high FODMAPs 
2. gluten-free with low FODMAP 
3. gluten-containing with high FODMAPs 
4. gluten- containing with low FODMAP 
This study design could potentially delineate if gluten, FODMAPs or both were major triggers 
for GI symptoms in NCA.   
8.3.4. FODMAP reintroduction   
In clinical practise, adherence to a complete long-term low FODMAP diet is not advised (54). 
In a systematic manner practitioners aim to determine the specific FODMAPs eliciting GI 
symptoms and individually reintroduce tolerable amounts of other high FODMAP foods (7). 
Relatedly, carbohydrate absorptive capacity of the intestine is adaptable and modified by the 
carbohydrate content of the diet (75, 79). Increases in intestinal carbohydrate transporters are 
shown with higher dietary carbohydrate intakes, thus improving the ability to ingest, oxidize 
and tolerate more carbohydrate (125). Improved ability to tolerate and oxidize greater amounts 
of carbohydrates is favourable for athletes engaging in sports with high carbohydrate demands 
for fuel (32). It is interesting to consider that, in some athletes with FODMAP sensitivity, a 
period of strategic reintroduction may increase the amount or type of FODMAPs tolerated 
without detrimental symptoms. Expanding practical athlete-specific FODMAP approaches are 
essential in applying this diet external of the clinical setting. Future studies should investigate 
the reintroduction of FODMAPs and the potential to increase tolerance to specific FODMAP 
triggers.    
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8.4. Concluding comments pertaining to practical application  
Novel evidence from the research conducted throughout this thesis will expand the sport 
nutrition practitioner’s strategies to treat exercise-associated GI symptoms. Although, our GFD 
intervention study did not support the beneficial effects of a GFD on GI symptoms or the 
parameters assessed, practise-based nuances should be considered when assessing the 
appropriateness of a GFD in the field when working with athletes. A low FODMAP diet did 
demonstrate promising beneficial effects on GI symptoms in some athletes potentially 
supporting its efficacy. FODMAP reduction may be a strategy auxiliary the sport nutrition 
practitioners’ toolbox for the treatment of GI distress in scenarios where a gluten-free or low 
FODMAP approach may be appropriate.  
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RESULT CONTINUED
Exploring	the	popularity,	experiences	and	
beliefs	surrounding	gluten-free	diets	in	
non-coeliac	athletes
Dana	Lis1,Trent	Stellingwerff,	PhD2,	Cecilia	Shing,	PhD1,	Kiran Ahuja,	PhD1,	James	Fell,	PhD1
1	Sport	Performance	Optimisation Team,	School	of	Human	Life	Sciences,	University	of	Tasmania,	Australia	
2Canadian	Sports	Institute	Pacific,	British	Columbia,	Canada.	
Contact: Dana.Lis@utas.edu.au
INTRODUCTION
AIM
METHODS
Subjects: Athletes, non-coeliac, (n=910, female=528, male=377, no gender
selected=5) recruited globally.
Overview: A 17-question electronic survey using SurveyMonkey collected
data about athletes and GFDs:
(1) Demographics (age, gender, sport, level of competition)
(2) GFD adherence, if any
(3) Rate of gastrointestinal (GI) symptom occurrence and additional
symptoms
(4) Perceptions pertaining about GFDs and athletic
(5) Sources of GFD information
Survey development: Survey was developed/refined following feedback
from registered dietitians working across the National and Olympic level.
Data Management: Some responses were re-categorised or combined
prior to data analysis. Survey design was targeted to identify GFD
adherence in three sub-categories (adherence to a GFD 50-75%, 75-89%
and 90-100% of the time). Responses were analogous to support grouping
athletes into two groups:
1. GFD>50: athletes that adhered to a GFD over 50% of the time.
2. GFD<50: athletes that adhered to a GFD less than 50% of the time.
Statistical	Analysis: Excel	(version	14.3.7,	USA)	to	download	and	collate	
survey	data.	GraphPad Prism	(version	6.02,	USA)	for	graphic	
representation.	Stata (STATA	version	SE12,	USA)	to	compare	the	responses	
between	the	GFD>50	and	GFD<50	groups	with	logistical	regression.
CONCLUSION
•The	41.2%	of	NCA	athletes	following	a	GFD	is	greater	than	the	prevalence	in	
the	general	population	estimated	to	benefit	clinically	from	a	GFD	(~5-10%)	
(Hadjivassiliou	et	al.	2010,	Sapone et	al	2012).	
•Prescription	of	a	GFD	amongst	athletes	does	not	result	from	evidence-based	
practice	suggesting	two	possible	hypotheses:	(1)	athletes	follow	a	GFD	due	to	
perceived	physiological	improvements	that	may	coincide	simultaneously	with	
other	dietary	changes;	(2)	the	perception	that	gluten	elimination	will	provide	
health	benefits	and	an	ergogenic	edge	in	NCA.	
Figure 2. GI distress
More frequent GI distress,
26%-50% and over 50% of the
time were reported in the
GFD>50 compared to the
GFD<50 group.
Adherence	to	a	gluten-free	diet	(GFD)	for	non-coeliac	athletes	has	become	
increasingly	popular	despite	a	lack	of	either	supportive	medical	or	
ergogenic	evidence.	
This	study	aimed	to	quantify	the	demographics	of	non-coeliac	athletes	
(NCA)	and	determine	related	experiences,	perceptions	and	sources	of	
information	related	to	a	GFD.
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RESULTS
Table	1.	Demographic	characteristics	of	athletes Experiences	/	Symptoms	
Gluten	removal	reportedly	resolved	symptoms	believed	to	be	triggered	by	
gluten	in	87.4%	of	GFD>50.	Symptoms	categorized:	
abdominal/gastrointestinal,	nutritional,	physiological	and	skin	indicators.	
Abdominal/gastrointestinal symptoms alone (16.7%) and in conjunction with
two (30.7%) or three (35.7%) additional symptoms were the most highly
reported to be triggered by gluten in GFD>50 athletes.
Figure	1.	Sources	of	GFD	
information
Online,	trainer/coach	and	other	
athletes	were	the	most	
accessed	sources	GFD	
information.	
Figure	3	A.	Perceived	dietary	changes	that	occur	with	adherence	to	a	GFD.	
B.	Perceived	physiological	changes	GFD>50	and	GFD<50	that	occur	with	
adherence	to	a	GFD.	CD:	coeliac	disease,	GS:	gluten	sensitivity.	
*Significantly different between GFD>50 and GFD<50.
GFD	Adherence
41%	of	athletes	followed	a	50-100%	of	the	time	(GFD>50).	
GFD>50	group:
• GFD	90-100%	of	the	time	(50.0%)
• GFD	75-89%	of	the	time	(7.5%)
• GFD	50-74%	of	the	time	(42.0%)
58.8%	of	athletes	followed	a	GFD	less	than	50%	of	the	time	(GFD<50).	
GFD<50	group:	
• Purchased	gluten-free	products	once	in	a	while	(10.7%)
• GFD	sporadically	(few	days/month)	(9.3%)
• GFD	1-2	weeks	before	competition	(0.7%)
• Did	not	eat	GFD	(38.8%)
GFD>50	n
GFD<50	
GFD>50	n
GFD<50	
GFD>50	n
GFD<50	
A B
GFD<50
(n=535)
GFD>50
(n=375)
Age n (%) n (%)
18-24 years 169 (31.6%) 95 (25.3%)
25-30	years 127 (23.8%) 98 (26.1%)
31-40 years* 126 (23.6%) 109 (29.1%)
41-50 years 64 (12.0%) 48 (12.8%)
>50 years 29 (5.4%) 20 (5.3%)
Sport category n (%) n (%)
Endurance* 335 (62.6%) 262 (69.9%)
Power 40 (7.5%) 26 (6.9%)
Skill 10 (1.9%) 11 (2.9%)
Swim/rowing 38 (7.1%) 19 (5.1%)
Intermittent 77 (14.4%) 28 (7.5%)
Weight classified,		
aesthetic
19 (3.6%) 7 (1.9%)
Winter 9 (1.7%) 9 (2.4%)
Fitness 7 (1.3%) 13 (3.5%)
Level of competition n (%) n (%)
Recreational* 116 (21.7%) 121 (32.3%)
Recreational competitive 122 (22.8%) 9 (2.4%)
Provincial/state 62 (11.6%) 26 (6.9%)
National 104 (19.4%) 60 (16.0%)
International 57 (10.7%) 33 (8.8%)
World/Olympic qualifier 35 (6.5%) 21 (5.6%)
World/Olympic medallist 29 (5.4%) 18 (4.8%)
Professional 10 (1.9%) 5 (1.3%)
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Appendix 4 – Gluten-free diet survey tool 
 
  
1. I am an athlete competing in the following sport. 
Cycling (track, mountain, road) 
Triathlon and other multisport (all distance) 
Ultra--endurance 
Middle and Long Distance Running 
Swimming 
Rowing 
Sprinting, Jumping & Throwing 
Field-Based Team 
Skill--based (curling, archery, shooting) 
Court and Indoor Team 
Racket 
Strength and Power (Olympic lifting) 
Weight-classed (wrestling, boxing) 
Gymnastics 
Figure and Speed Skating 
Hockey and Ringette 
Winter-ski 
Winter-snowboard 
Other (please specify) 
 
2. What level of performance would you currently rank 
yourself? 
Recreational/Active 
Recreational Competitive (compete at high level) 
Provincial/State (e.g. compete at provincial/state 
championships) 
National (e.g. compete at National championships) 
International (e.g. routinely compete as an invited athlete at 
international competitions or World Cups) 
World or Olympic Qualifier + International Competitor 
World or Olympic medalist + International Competitor 
Professional Athlete (e.g. major league soccer) 
Other (please specify) 
 
3. What is your gender? 
Female 
Male 
 
4. What age bracket do you fall into? 
< 18 
18-24 
25-30 
31-40 
41-50 
50+ 
 
 
 
5. What best describes your dietary intake habits with 
regards to your frequency of gluten free diet? 
100% of the time 
90-99% of the time 
76-89% of the time 
50-75% of the time 
Sporadically (a few days a month or a few weeks here and 
there) 
Buy gluten free products once in a while 
Around competition time (1–2 weeks before) 
Not at all 
Other (please specify) 
0% of the time 
 
6. How often do you experience gastrointestinal issues 
during exercise? 
(Gastrointestinal issues include but are not limited to 
bloating, diarrhea and gas). 
1-5% of the time 
6-5% of the time 
16-25% of the time 
26-35% of the time 
36-50% of the time 
> 50% of the time 
 
7. Regardless of if you have in the past or currently 
follow a gluten free diet, what are your viewpoints about 
a gluten free diet (check all that apply)? 
It is overall healthier 
Reduces gastrointestinal distress (bloating, flatulence, 
diarrhea, constipation) 
Reduces fatigue or improves energy 
Reduces inflammation 
Improves immune system function 
Improves exercise performance 
Improves recovery after exercise 
Only applicable for people clinically diagnosed with celiac 
disease or gluten sensitivity people 
Is not for me because I do not experience any of the related 
symptoms 
 
 
8. Have you experienced any of the following symptoms 
that you associate with dietary intake (check all that 
apply)? 
Abdominal bloating, gas, pain, cramping or distention 
Unexplained weight loss/obesity 
Chronic diarrhea (can be accompanied by constipation) 
Pale, foul smelling stool (steatorrhea) 
Anemia or other nutritional deficiencies 
Irritability, anxiety, depression, fatigue 
Bone or joint pain 
Hypoglycemia 
Muscle cramps, mouth sores, hair loss 
Missed menstrual periods 
Gluten ataxia (loss of full control of bodily movements) 
Tingling or numbness in extremities 
Bone density loss (osteoporosis/osteopenia) 
Extremely itchy rash 
Other (please specify) 
 
9. If you answered YES to any of the above, what dietary 
components do you think these symptoms may have 
been caused by (check all that apply)? 
Dairy (milk, cheese, yogurt…) 
Excess fructose (apple, mango, honey…) 
Fructans (asparagus, beet root, garlic, leeks…) 
Fructose (apple sauce, pears, agave…) 
Galactans (legumes, beans, lentils) 
Gluten (wheat bread, bran flakes, whole wheat pasta…) 
High fat or fried foods 
Lactose (milk, ice cream, custard, soft cheese…) 
Polyols (apricot, cauliflower, sorbitol…) 
Very high fiber foods (brussel sprouts, broccoli, bran 
flakes…) 
Don’t know 
Other (please specify) 
 
10. Have you tried eliminating any of the dietary 
components you have checked off in 
question 9? 
Yes 
No 
 
11. Has removing the dietary components indicated in 
question 9 reduced symptoms you have in indicated in 
question 8? 
Yes 
No 
I have not removed for long enough to notice a difference 
 
12. What other dietary changes do you think may take 
place consciously or unconsciously with the elimination 
of gluten (check all that apply)? 
More conscientious overall nutrition intake 
Less processed foods 
Less sugary foods 
More fruit and vegetables 
More gluten free whole grains 
More balanced meals 
None 
Other (please specify 
13. What other physiological changes do you think may 
take place consciously or 
unconsciously with the elimination of gluten (check all 
that apply)? 
Improved exercise performance 
Decrease inflammation 
Decreased illness 
Better body composition 
Better training adaptations 
Less fatigue from training 
Decreased fatigue on a daily basis 
Less muscle stiffness, soreness 
Less gastrointestinal issues (i.e. boating) during exercise 
Other (please specify) 
 
14. Do you believe that removing gluten from the diet 
improves exercise performance (e.g. sprint faster, run 
longer, cycle at high power output)? 
Yes 
No 
Not sure 
 
15. What best describes any basis you have been given 
for a gluten free diet. 
Clinically diagnosed with gluten sensitivity by physician using 
a gluten free challenge test 
Clinically diagnosed with Irritable Bowel Syndrome 
(IBS)/similar condition that is made worse with gluten. 
Clinically diagnosed wheat allergy 
Self--diagnoses based on symptoms 
Family history of celiac disease 
Naturopath diagnosis based on bloodwork 
No identifiable symptoms, but decided to follow gluten free 
diet 
I have been told eating gluten free diet is good, but have not 
tried it yet. 
None, I have not been told anything about a gluten free diet. 
Other (please explain) 
 
16. What best describes the advice you were given 
about a gluten free diet? 
Follow a gluten free diet all the time 
Follow a gluten free diet before and during competition 
Follow a gluten free diet as much as you can 
Try a gluten free diet and see if it help with performance and 
symptoms 
None, I have not been given advice on a gluten free diet 
Other (please specify) 
 
17. Where have you accessed information about gluten 
free diets and athletic performance (check all that 
apply)? 
Online forums 
Celiac or gluten intolerance information websites 
Academic journals 
Registered Dietitian 
Nutritionist 
Trainer 
Coach 
Naturopath 
Other athletes 
I have not read any information 
Other (please specify) 
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Appendix 5 – GI symptom questionnaires 
 
 
 
 
 
DAILY GI QUESTIONAIRRE  
Modified from Beate Pfeiffer • University Birmingham  
 
1 
Participant #: 
 
                                                                                                 Date:             Time:   
*Complete this at the end of the day 
Were you on your menstrual cycle today?  yes      no     N/A 
 
What time?   How long?  
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B Lower abdominal symptoms 0 1 2 3 4 5 6 7 8 9 
Flatulence           
Urge to defecate           
Left abdominal pain (cramp)           
Right abdominal pain (cramp)            
Loose Stool           
Diarrhoea           
Intestinal Bleeding           
 
What time?   How long?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GI problems  DURING THE DAY outside of training 
Please rate if you experienced any of the following symptoms DURING THE DAY: 
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A Upper abdominal symptoms 0 1 2 3 4 5 6 7 8 9 
Reflux           
Heartburn           
Burping           
Bloating           
Stomach pain / cramps           
Vomiting           
Nausea           
